id	sid	tid	token	lemma	pos
cord-006393-jcj9nqfu	1	1	key	key	JJ
cord-006393-jcj9nqfu	1	2	:	:	:
cord-006393-jcj9nqfu	1	3	cord-006393-jcj9nqfu	cord-006393-jcj9nqfu	JJ
cord-006393-jcj9nqfu	1	4	authors	author	NNS
cord-006393-jcj9nqfu	1	5	:	:	:
cord-006393-jcj9nqfu	1	6	Tutschka	Tutschka	NNP
cord-006393-jcj9nqfu	1	7	,	,	,
cord-006393-jcj9nqfu	1	8	Peter	Peter	NNP
cord-006393-jcj9nqfu	1	9	J.	J.	NNP
cord-006393-jcj9nqfu	1	10	title	title	NN
cord-006393-jcj9nqfu	1	11	:	:	:
cord-006393-jcj9nqfu	2	1	The	the	DT
cord-006393-jcj9nqfu	2	2	use	use	NN
cord-006393-jcj9nqfu	2	3	of	of	IN
cord-006393-jcj9nqfu	2	4	immunoglobulin	immunoglobulin	NN
cord-006393-jcj9nqfu	2	5	in	in	IN
cord-006393-jcj9nqfu	2	6	bone	bone	NN
cord-006393-jcj9nqfu	2	7	marrow	marrow	NN
cord-006393-jcj9nqfu	2	8	transplantation	transplantation	NN
cord-006393-jcj9nqfu	2	9	date	date	NN
cord-006393-jcj9nqfu	2	10	:	:	:
cord-006393-jcj9nqfu	2	11	1990	1990	CD
cord-006393-jcj9nqfu	2	12	journal	journal	NN
cord-006393-jcj9nqfu	2	13	:	:	:
cord-006393-jcj9nqfu	2	14	J	J	NNP
cord-006393-jcj9nqfu	2	15	Clin	Clin	NNP
cord-006393-jcj9nqfu	2	16	Immunol	Immunol	NNP
cord-006393-jcj9nqfu	2	17	DOI	doi	NN
cord-006393-jcj9nqfu	2	18	:	:	:
cord-006393-jcj9nqfu	3	1	10.1007	10.1007	CD
cord-006393-jcj9nqfu	3	2	/	/	SYM
cord-006393-jcj9nqfu	3	3	bf00918696	bf00918696	NNP
cord-006393-jcj9nqfu	3	4	sha	sha	NNP
cord-006393-jcj9nqfu	3	5	:	:	:
cord-006393-jcj9nqfu	4	1	482407fc2628230fb547d8fc3d1c151c76f1abbd	482407fc2628230fb547d8fc3d1c151c76f1abbd	NNP
cord-006393-jcj9nqfu	4	2	doc_id	doc_id	CD
cord-006393-jcj9nqfu	4	3	:	:	:
cord-006393-jcj9nqfu	5	1	6393	6393	CD
cord-006393-jcj9nqfu	5	2	cord_uid	cord_uid	NNS
cord-006393-jcj9nqfu	5	3	:	:	:
cord-006393-jcj9nqfu	6	1	jcj9nqfu	jcj9nqfu	NNP
cord-006393-jcj9nqfu	7	1	The	the	DT
cord-006393-jcj9nqfu	7	2	role	role	NN
cord-006393-jcj9nqfu	7	3	of	of	IN
cord-006393-jcj9nqfu	7	4	bone	bone	NN
cord-006393-jcj9nqfu	7	5	marrow	marrow	NN
cord-006393-jcj9nqfu	7	6	transplantation	transplantation	NN
cord-006393-jcj9nqfu	7	7	is	be	VBZ
cord-006393-jcj9nqfu	7	8	to	to	TO
cord-006393-jcj9nqfu	7	9	restore	restore	VB
cord-006393-jcj9nqfu	7	10	lymphohematopoietic	lymphohematopoietic	JJ
cord-006393-jcj9nqfu	7	11	function	function	NN
cord-006393-jcj9nqfu	7	12	of	of	IN
cord-006393-jcj9nqfu	7	13	a	a	DT
cord-006393-jcj9nqfu	7	14	recipient	recipient	NN
cord-006393-jcj9nqfu	7	15	whose	whose	WP$
cord-006393-jcj9nqfu	7	16	marrow	marrow	NN
cord-006393-jcj9nqfu	7	17	has	have	VBZ
cord-006393-jcj9nqfu	7	18	been	be	VBN
cord-006393-jcj9nqfu	7	19	destroyed	destroy	VBN
cord-006393-jcj9nqfu	7	20	,	,	,
cord-006393-jcj9nqfu	7	21	either	either	CC
cord-006393-jcj9nqfu	7	22	by	by	IN
cord-006393-jcj9nqfu	7	23	disease	disease	NN
cord-006393-jcj9nqfu	7	24	or	or	CC
cord-006393-jcj9nqfu	7	25	by	by	IN
cord-006393-jcj9nqfu	7	26	the	the	DT
cord-006393-jcj9nqfu	7	27	preparative	preparative	JJ
cord-006393-jcj9nqfu	7	28	therapy	therapy	NN
cord-006393-jcj9nqfu	7	29	employed	employ	VBN
cord-006393-jcj9nqfu	7	30	in	in	IN
cord-006393-jcj9nqfu	7	31	an	an	DT
cord-006393-jcj9nqfu	7	32	attempt	attempt	NN
cord-006393-jcj9nqfu	7	33	to	to	TO
cord-006393-jcj9nqfu	7	34	eradicate	eradicate	VB
cord-006393-jcj9nqfu	7	35	the	the	DT
cord-006393-jcj9nqfu	7	36	patient	patient	NN
cord-006393-jcj9nqfu	7	37	's	's	POS
cord-006393-jcj9nqfu	7	38	lymphohematopoietic	lymphohematopoietic	JJ
cord-006393-jcj9nqfu	7	39	malignancy	malignancy	NN
cord-006393-jcj9nqfu	7	40	.	.	.
cord-006393-jcj9nqfu	8	1	The	the	DT
cord-006393-jcj9nqfu	8	2	restoration	restoration	NN
cord-006393-jcj9nqfu	8	3	of	of	IN
cord-006393-jcj9nqfu	8	4	lymphohematopoietic	lymphohematopoietic	JJ
cord-006393-jcj9nqfu	8	5	function	function	NN
cord-006393-jcj9nqfu	8	6	through	through	IN
cord-006393-jcj9nqfu	8	7	the	the	DT
cord-006393-jcj9nqfu	8	8	donor	donor	NN
cord-006393-jcj9nqfu	8	9	graft	graft	NN
cord-006393-jcj9nqfu	8	10	occurs	occur	VBZ
cord-006393-jcj9nqfu	8	11	in	in	IN
cord-006393-jcj9nqfu	8	12	stages	stage	NNS
cord-006393-jcj9nqfu	8	13	,	,	,
cord-006393-jcj9nqfu	8	14	requires	require	VBZ
cord-006393-jcj9nqfu	8	15	several	several	JJ
cord-006393-jcj9nqfu	8	16	months	month	NNS
cord-006393-jcj9nqfu	8	17	,	,	,
cord-006393-jcj9nqfu	8	18	and	and	CC
cord-006393-jcj9nqfu	8	19	is	be	VBZ
cord-006393-jcj9nqfu	8	20	often	often	RB
cord-006393-jcj9nqfu	8	21	not	not	RB
cord-006393-jcj9nqfu	8	22	completed	complete	VBN
cord-006393-jcj9nqfu	8	23	until	until	IN
cord-006393-jcj9nqfu	8	24	1	1	CD
cord-006393-jcj9nqfu	8	25	to	to	IN
cord-006393-jcj9nqfu	8	26	2	2	CD
cord-006393-jcj9nqfu	8	27	years	year	NNS
cord-006393-jcj9nqfu	8	28	after	after	IN
cord-006393-jcj9nqfu	8	29	transplantation	transplantation	NN
cord-006393-jcj9nqfu	8	30	.	.	.
cord-006393-jcj9nqfu	9	1	These	these	DT
cord-006393-jcj9nqfu	9	2	sequential	sequential	JJ
cord-006393-jcj9nqfu	9	3	steps	step	NNS
cord-006393-jcj9nqfu	9	4	of	of	IN
cord-006393-jcj9nqfu	9	5	immuno	immuno	JJ
cord-006393-jcj9nqfu	9	6	-	-	JJ
cord-006393-jcj9nqfu	9	7	reconstitution	reconstitution	NN
cord-006393-jcj9nqfu	9	8	are	be	VBP
cord-006393-jcj9nqfu	9	9	associated	associate	VBN
cord-006393-jcj9nqfu	9	10	with	with	IN
cord-006393-jcj9nqfu	9	11	a	a	DT
cord-006393-jcj9nqfu	9	12	number	number	NN
cord-006393-jcj9nqfu	9	13	of	of	IN
cord-006393-jcj9nqfu	9	14	definable	definable	JJ
cord-006393-jcj9nqfu	9	15	and	and	CC
cord-006393-jcj9nqfu	9	16	predictable	predictable	JJ
cord-006393-jcj9nqfu	9	17	immune	immune	JJ
cord-006393-jcj9nqfu	9	18	deficiencies	deficiency	NNS
cord-006393-jcj9nqfu	9	19	and	and	CC
cord-006393-jcj9nqfu	9	20	seem	seem	VBP
cord-006393-jcj9nqfu	9	21	to	to	TO
cord-006393-jcj9nqfu	9	22	be	be	VB
cord-006393-jcj9nqfu	9	23	responsible	responsible	JJ
cord-006393-jcj9nqfu	9	24	for	for	IN
cord-006393-jcj9nqfu	9	25	the	the	DT
cord-006393-jcj9nqfu	9	26	pattern	pattern	NN
cord-006393-jcj9nqfu	9	27	of	of	IN
cord-006393-jcj9nqfu	9	28	complications	complication	NNS
cord-006393-jcj9nqfu	9	29	that	that	WDT
cord-006393-jcj9nqfu	9	30	emerges	emerge	VBZ
cord-006393-jcj9nqfu	9	31	after	after	IN
cord-006393-jcj9nqfu	9	32	transplantation	transplantation	NN
cord-006393-jcj9nqfu	9	33	.	.	.
cord-006393-jcj9nqfu	10	1	Most	Most	JJS
cord-006393-jcj9nqfu	10	2	of	of	IN
cord-006393-jcj9nqfu	10	3	these	these	DT
cord-006393-jcj9nqfu	10	4	complications	complication	NNS
cord-006393-jcj9nqfu	10	5	are	be	VBP
cord-006393-jcj9nqfu	10	6	either	either	CC
cord-006393-jcj9nqfu	10	7	the	the	DT
cord-006393-jcj9nqfu	10	8	result	result	NN
cord-006393-jcj9nqfu	10	9	of	of	IN
cord-006393-jcj9nqfu	10	10	,	,	,
cord-006393-jcj9nqfu	10	11	or	or	CC
cord-006393-jcj9nqfu	10	12	associated	associate	VBN
cord-006393-jcj9nqfu	10	13	with	with	IN
cord-006393-jcj9nqfu	10	14	,	,	,
cord-006393-jcj9nqfu	10	15	infections	infection	NNS
cord-006393-jcj9nqfu	10	16	that	that	WDT
cord-006393-jcj9nqfu	10	17	also	also	RB
cord-006393-jcj9nqfu	10	18	occur	occur	VBP
cord-006393-jcj9nqfu	10	19	in	in	IN
cord-006393-jcj9nqfu	10	20	an	an	DT
cord-006393-jcj9nqfu	10	21	almost	almost	RB
cord-006393-jcj9nqfu	10	22	predictable	predictable	JJ
cord-006393-jcj9nqfu	10	23	pattern	pattern	NN
cord-006393-jcj9nqfu	10	24	.	.	.
cord-006393-jcj9nqfu	11	1	In	in	IN
cord-006393-jcj9nqfu	11	2	the	the	DT
cord-006393-jcj9nqfu	11	3	various	various	JJ
cord-006393-jcj9nqfu	11	4	phases	phase	NNS
cord-006393-jcj9nqfu	11	5	of	of	IN
cord-006393-jcj9nqfu	11	6	immune	immune	JJ
cord-006393-jcj9nqfu	11	7	deficiency	deficiency	NN
cord-006393-jcj9nqfu	11	8	following	follow	VBG
cord-006393-jcj9nqfu	11	9	sequentially	sequentially	RB
cord-006393-jcj9nqfu	11	10	after	after	IN
cord-006393-jcj9nqfu	11	11	transplantation	transplantation	NN
cord-006393-jcj9nqfu	11	12	,	,	,
cord-006393-jcj9nqfu	11	13	the	the	DT
cord-006393-jcj9nqfu	11	14	humoral	humoral	JJ
cord-006393-jcj9nqfu	11	15	immune	immune	JJ
cord-006393-jcj9nqfu	11	16	system	system	NN
cord-006393-jcj9nqfu	11	17	is	be	VBZ
cord-006393-jcj9nqfu	11	18	greatly	greatly	RB
cord-006393-jcj9nqfu	11	19	affected	affect	VBN
cord-006393-jcj9nqfu	11	20	,	,	,
cord-006393-jcj9nqfu	11	21	thus	thus	RB
cord-006393-jcj9nqfu	11	22	raising	raise	VBG
cord-006393-jcj9nqfu	11	23	the	the	DT
cord-006393-jcj9nqfu	11	24	possibility	possibility	NN
cord-006393-jcj9nqfu	11	25	that	that	IN
cord-006393-jcj9nqfu	11	26	passively	passively	RB
cord-006393-jcj9nqfu	11	27	administered	administer	VBN
cord-006393-jcj9nqfu	11	28	antibodies	antibody	NNS
cord-006393-jcj9nqfu	11	29	in	in	IN
cord-006393-jcj9nqfu	11	30	the	the	DT
cord-006393-jcj9nqfu	11	31	form	form	NN
cord-006393-jcj9nqfu	11	32	of	of	IN
cord-006393-jcj9nqfu	11	33	immune	immune	JJ
cord-006393-jcj9nqfu	11	34	globulin	globulin	NN
cord-006393-jcj9nqfu	11	35	therapy	therapy	NN
cord-006393-jcj9nqfu	11	36	might	may	MD
cord-006393-jcj9nqfu	11	37	be	be	VB
cord-006393-jcj9nqfu	11	38	beneficial	beneficial	JJ
cord-006393-jcj9nqfu	11	39	in	in	IN
cord-006393-jcj9nqfu	11	40	all	all	DT
cord-006393-jcj9nqfu	11	41	phases	phase	NNS
cord-006393-jcj9nqfu	11	42	of	of	IN
cord-006393-jcj9nqfu	11	43	the	the	DT
cord-006393-jcj9nqfu	11	44	marrow	marrow	NN
cord-006393-jcj9nqfu	11	45	transplant	transplant	NN
cord-006393-jcj9nqfu	11	46	procedure	procedure	NN
cord-006393-jcj9nqfu	11	47	.	.	.
cord-006393-jcj9nqfu	12	1	This	this	DT
cord-006393-jcj9nqfu	12	2	paper	paper	NN
cord-006393-jcj9nqfu	12	3	attempts	attempt	VBZ
cord-006393-jcj9nqfu	12	4	to	to	TO
cord-006393-jcj9nqfu	12	5	summarize	summarize	VB
cord-006393-jcj9nqfu	12	6	the	the	DT
cord-006393-jcj9nqfu	12	7	use	use	NN
cord-006393-jcj9nqfu	12	8	of	of	IN
cord-006393-jcj9nqfu	12	9	immune	immune	JJ
cord-006393-jcj9nqfu	12	10	globulin	globulin	NN
cord-006393-jcj9nqfu	12	11	preparations	preparation	NNS
cord-006393-jcj9nqfu	12	12	in	in	IN
cord-006393-jcj9nqfu	12	13	clinical	clinical	JJ
cord-006393-jcj9nqfu	12	14	bone	bone	NN
cord-006393-jcj9nqfu	12	15	marrow	marrow	NN
cord-006393-jcj9nqfu	12	16	transplantation	transplantation	NN
cord-006393-jcj9nqfu	12	17	,	,	,
cord-006393-jcj9nqfu	12	18	showing	show	VBG
cord-006393-jcj9nqfu	12	19	the	the	DT
cord-006393-jcj9nqfu	12	20	rationale	rationale	NN
cord-006393-jcj9nqfu	12	21	for	for	IN
cord-006393-jcj9nqfu	12	22	and	and	CC
cord-006393-jcj9nqfu	12	23	some	some	DT
cord-006393-jcj9nqfu	12	24	of	of	IN
cord-006393-jcj9nqfu	12	25	the	the	DT
cord-006393-jcj9nqfu	12	26	results	result	NNS
cord-006393-jcj9nqfu	12	27	of	of	IN
cord-006393-jcj9nqfu	12	28	therapeutic	therapeutic	JJ
cord-006393-jcj9nqfu	12	29	immune	immune	JJ
cord-006393-jcj9nqfu	12	30	globulin	globulin	NN
cord-006393-jcj9nqfu	12	31	administration	administration	NN
cord-006393-jcj9nqfu	12	32	.	.	.
cord-006393-jcj9nqfu	13	1	Intravenous	intravenous	JJ
cord-006393-jcj9nqfu	13	2	immune	immune	JJ
cord-006393-jcj9nqfu	13	3	globulin	globulin	NN
cord-006393-jcj9nqfu	13	4	(	(	-LRB-
cord-006393-jcj9nqfu	13	5	IV1	IV1	NNP
cord-006393-jcj9nqfu	13	6	G	G	NNP
cord-006393-jcj9nqfu	13	7	)	)	-RRB-
cord-006393-jcj9nqfu	13	8	is	be	VBZ
cord-006393-jcj9nqfu	13	9	now	now	RB
cord-006393-jcj9nqfu	13	10	widely	widely	RB
cord-006393-jcj9nqfu	13	11	used	use	VBN
cord-006393-jcj9nqfu	13	12	in	in	IN
cord-006393-jcj9nqfu	13	13	bone	bone	NN
cord-006393-jcj9nqfu	13	14	marrow	marrow	NN
cord-006393-jcj9nqfu	13	15	transplantation	transplantation	NN
cord-006393-jcj9nqfu	13	16	,	,	,
cord-006393-jcj9nqfu	13	17	despite	despite	IN
cord-006393-jcj9nqfu	13	18	the	the	DT
cord-006393-jcj9nqfu	13	19	fact	fact	NN
cord-006393-jcj9nqfu	13	20	that	that	IN
cord-006393-jcj9nqfu	13	21	critical	critical	JJ
cord-006393-jcj9nqfu	13	22	randomized	randomize	VBN
cord-006393-jcj9nqfu	13	23	,	,	,
cord-006393-jcj9nqfu	13	24	controlled	control	VBN
cord-006393-jcj9nqfu	13	25	studies	study	NNS
cord-006393-jcj9nqfu	13	26	necessary	necessary	JJ
cord-006393-jcj9nqfu	13	27	to	to	TO
cord-006393-jcj9nqfu	13	28	permit	permit	VB
cord-006393-jcj9nqfu	13	29	utilization	utilization	NN
cord-006393-jcj9nqfu	13	30	on	on	IN
cord-006393-jcj9nqfu	13	31	a	a	DT
cord-006393-jcj9nqfu	13	32	scientific	scientific	JJ
cord-006393-jcj9nqfu	13	33	basis	basis	NN
cord-006393-jcj9nqfu	13	34	have	have	VBP
cord-006393-jcj9nqfu	13	35	largely	largely	RB
cord-006393-jcj9nqfu	13	36	not	not	RB
cord-006393-jcj9nqfu	13	37	been	be	VBN
cord-006393-jcj9nqfu	13	38	done	do	VBN
cord-006393-jcj9nqfu	13	39	yet	yet	RB
cord-006393-jcj9nqfu	13	40	.	.	.
cord-006393-jcj9nqfu	14	1	This	this	DT
cord-006393-jcj9nqfu	14	2	paper	paper	NN
cord-006393-jcj9nqfu	14	3	attempts	attempt	VBZ
cord-006393-jcj9nqfu	14	4	to	to	TO
cord-006393-jcj9nqfu	14	5	give	give	VB
cord-006393-jcj9nqfu	14	6	an	an	DT
cord-006393-jcj9nqfu	14	7	overview	overview	NN
cord-006393-jcj9nqfu	14	8	of	of	IN
cord-006393-jcj9nqfu	14	9	the	the	DT
cord-006393-jcj9nqfu	14	10	use	use	NN
cord-006393-jcj9nqfu	14	11	of	of	IN
cord-006393-jcj9nqfu	14	12	immune	immune	JJ
cord-006393-jcj9nqfu	14	13	globulins	globulin	NNS
cord-006393-jcj9nqfu	14	14	and	and	CC
cord-006393-jcj9nqfu	14	15	the	the	DT
cord-006393-jcj9nqfu	14	16	rationale	rationale	NN
cord-006393-jcj9nqfu	14	17	for	for	IN
cord-006393-jcj9nqfu	14	18	their	-PRON-	PRP$
cord-006393-jcj9nqfu	14	19	use	use	NN
cord-006393-jcj9nqfu	14	20	in	in	IN
cord-006393-jcj9nqfu	14	21	clinical	clinical	JJ
cord-006393-jcj9nqfu	14	22	marrow	marrow	NN
cord-006393-jcj9nqfu	14	23	transplantation	transplantation	NN
cord-006393-jcj9nqfu	14	24	.	.	.
cord-006393-jcj9nqfu	15	1	Prior	prior	RB
cord-006393-jcj9nqfu	15	2	to	to	IN
cord-006393-jcj9nqfu	15	3	bone	bone	NN
cord-006393-jcj9nqfu	15	4	marrow	marrow	NN
cord-006393-jcj9nqfu	15	5	transplantation	transplantation	NN
cord-006393-jcj9nqfu	15	6	the	the	DT
cord-006393-jcj9nqfu	15	7	recipient	recipient	NN
cord-006393-jcj9nqfu	15	8	's	's	POS
cord-006393-jcj9nqfu	15	9	marrow	marrow	NN
cord-006393-jcj9nqfu	15	10	must	must	MD
cord-006393-jcj9nqfu	15	11	be	be	VB
cord-006393-jcj9nqfu	15	12	completely	completely	RB
cord-006393-jcj9nqfu	15	13	eradicated	eradicate	VBN
cord-006393-jcj9nqfu	15	14	.	.	.
cord-006393-jcj9nqfu	16	1	The	the	DT
cord-006393-jcj9nqfu	16	2	hematopoietic	hematopoietic	JJ
cord-006393-jcj9nqfu	16	3	system	system	NN
cord-006393-jcj9nqfu	16	4	and	and	CC
cord-006393-jcj9nqfu	16	5	the	the	DT
cord-006393-jcj9nqfu	16	6	immune	immune	JJ
cord-006393-jcj9nqfu	16	7	system	system	NN
cord-006393-jcj9nqfu	16	8	are	be	VBP
cord-006393-jcj9nqfu	16	9	88S	88	NNS
cord-006393-jcj9nqfu	16	10	then	then	RB
cord-006393-jcj9nqfu	16	11	rebuilt	rebuild	VBN
cord-006393-jcj9nqfu	16	12	,	,	,
cord-006393-jcj9nqfu	16	13	almost	almost	RB
cord-006393-jcj9nqfu	16	14	in	in	IN
cord-006393-jcj9nqfu	16	15	their	-PRON-	PRP$
cord-006393-jcj9nqfu	16	16	entirety	entirety	NN
cord-006393-jcj9nqfu	16	17	.	.	.
cord-006393-jcj9nqfu	17	1	This	this	DT
cord-006393-jcj9nqfu	17	2	rebuilding	rebuilding	NN
cord-006393-jcj9nqfu	17	3	of	of	IN
cord-006393-jcj9nqfu	17	4	the	the	DT
cord-006393-jcj9nqfu	17	5	lymphohematopoietic	lymphohematopoietic	JJ
cord-006393-jcj9nqfu	17	6	system	system	NN
cord-006393-jcj9nqfu	17	7	does	do	VBZ
cord-006393-jcj9nqfu	17	8	not	not	RB
cord-006393-jcj9nqfu	17	9	occur	occur	VB
cord-006393-jcj9nqfu	17	10	immediately	immediately	RB
cord-006393-jcj9nqfu	17	11	;	;	:
cord-006393-jcj9nqfu	17	12	instead	instead	RB
cord-006393-jcj9nqfu	17	13	,	,	,
cord-006393-jcj9nqfu	17	14	it	-PRON-	PRP
cord-006393-jcj9nqfu	17	15	goes	go	VBZ
cord-006393-jcj9nqfu	17	16	through	through	IN
cord-006393-jcj9nqfu	17	17	several	several	JJ
cord-006393-jcj9nqfu	17	18	separate	separate	JJ
cord-006393-jcj9nqfu	17	19	,	,	,
cord-006393-jcj9nqfu	17	20	sequential	sequential	JJ
cord-006393-jcj9nqfu	17	21	phases	phase	NNS
cord-006393-jcj9nqfu	17	22	which	which	WDT
cord-006393-jcj9nqfu	17	23	are	be	VBP
cord-006393-jcj9nqfu	17	24	associated	associate	VBN
cord-006393-jcj9nqfu	17	25	with	with	IN
cord-006393-jcj9nqfu	17	26	an	an	DT
cord-006393-jcj9nqfu	17	27	almost	almost	RB
cord-006393-jcj9nqfu	17	28	predictable	predictable	JJ
cord-006393-jcj9nqfu	17	29	pattern	pattern	NN
cord-006393-jcj9nqfu	17	30	of	of	IN
cord-006393-jcj9nqfu	17	31	complications	complication	NNS
cord-006393-jcj9nqfu	17	32	,	,	,
cord-006393-jcj9nqfu	17	33	especially	especially	RB
cord-006393-jcj9nqfu	17	34	infectious	infectious	JJ
cord-006393-jcj9nqfu	17	35	complications	complication	NNS
cord-006393-jcj9nqfu	17	36	.	.	.
cord-006393-jcj9nqfu	18	1	In	in	IN
cord-006393-jcj9nqfu	18	2	the	the	DT
cord-006393-jcj9nqfu	18	3	preengraftment	preengraftment	NN
cord-006393-jcj9nqfu	18	4	phase	phase	NN
cord-006393-jcj9nqfu	18	5	,	,	,
cord-006393-jcj9nqfu	18	6	pancytopenia	pancytopenia	NNP
cord-006393-jcj9nqfu	18	7	is	be	VBZ
cord-006393-jcj9nqfu	18	8	the	the	DT
cord-006393-jcj9nqfu	18	9	most	most	RBS
cord-006393-jcj9nqfu	18	10	important	important	JJ
cord-006393-jcj9nqfu	18	11	event	event	NN
cord-006393-jcj9nqfu	18	12	.	.	.
cord-006393-jcj9nqfu	19	1	This	this	DT
cord-006393-jcj9nqfu	19	2	is	be	VBZ
cord-006393-jcj9nqfu	19	3	followed	follow	VBN
cord-006393-jcj9nqfu	19	4	by	by	IN
cord-006393-jcj9nqfu	19	5	an	an	DT
cord-006393-jcj9nqfu	19	6	early	early	JJ
cord-006393-jcj9nqfu	19	7	postengraftment	postengraftment	NN
cord-006393-jcj9nqfu	19	8	phase	phase	NN
cord-006393-jcj9nqfu	19	9	,	,	,
cord-006393-jcj9nqfu	19	10	characterized	characterize	VBN
cord-006393-jcj9nqfu	19	11	immunobiologically	immunobiologically	RB
cord-006393-jcj9nqfu	19	12	by	by	IN
cord-006393-jcj9nqfu	19	13	acute	acute	JJ
cord-006393-jcj9nqfu	19	14	graft	graft	NN
cord-006393-jcj9nqfu	19	15	-	-	HYPH
cord-006393-jcj9nqfu	19	16	vs	vs	IN
cord-006393-jcj9nqfu	19	17	-	-	HYPH
cord-006393-jcj9nqfu	19	18	host	host	NN
cord-006393-jcj9nqfu	19	19	disease	disease	NN
cord-006393-jcj9nqfu	19	20	(	(	-LRB-
cord-006393-jcj9nqfu	19	21	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	19	22	)	)	-RRB-
cord-006393-jcj9nqfu	19	23	and	and	CC
cord-006393-jcj9nqfu	19	24	severe	severe	JJ
cord-006393-jcj9nqfu	19	25	combined	combine	VBN
cord-006393-jcj9nqfu	19	26	immunodeficiency	immunodeficiency	NN
cord-006393-jcj9nqfu	19	27	.	.	.
cord-006393-jcj9nqfu	20	1	The	the	DT
cord-006393-jcj9nqfu	20	2	late	late	JJ
cord-006393-jcj9nqfu	20	3	postengraftment	postengraftment	NN
cord-006393-jcj9nqfu	20	4	phase	phase	NN
cord-006393-jcj9nqfu	20	5	is	be	VBZ
cord-006393-jcj9nqfu	20	6	characterized	characterize	VBN
cord-006393-jcj9nqfu	20	7	by	by	IN
cord-006393-jcj9nqfu	20	8	chronic	chronic	JJ
cord-006393-jcj9nqfu	20	9	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	20	10	and	and	CC
cord-006393-jcj9nqfu	20	11	immunodeficiency	immunodeficiency	NN
cord-006393-jcj9nqfu	20	12	but	but	CC
cord-006393-jcj9nqfu	20	13	of	of	IN
cord-006393-jcj9nqfu	20	14	a	a	DT
cord-006393-jcj9nqfu	20	15	more	more	RBR
cord-006393-jcj9nqfu	20	16	humoral	humoral	JJ
cord-006393-jcj9nqfu	20	17	type	type	NN
cord-006393-jcj9nqfu	20	18	.	.	.
cord-006393-jcj9nqfu	21	1	Almost	almost	RB
cord-006393-jcj9nqfu	21	2	predictably	predictably	RB
cord-006393-jcj9nqfu	21	3	we	-PRON-	PRP
cord-006393-jcj9nqfu	21	4	first	first	RB
cord-006393-jcj9nqfu	21	5	see	see	VBP
cord-006393-jcj9nqfu	21	6	bacterial	bacterial	JJ
cord-006393-jcj9nqfu	21	7	infections	infection	NNS
cord-006393-jcj9nqfu	21	8	followed	follow	VBN
cord-006393-jcj9nqfu	21	9	by	by	IN
cord-006393-jcj9nqfu	21	10	nonbacterial	nonbacterial	JJ
cord-006393-jcj9nqfu	21	11	,	,	,
cord-006393-jcj9nqfu	21	12	viral	viral	JJ
cord-006393-jcj9nqfu	21	13	infections	infection	NNS
cord-006393-jcj9nqfu	21	14	,	,	,
cord-006393-jcj9nqfu	21	15	particularly	particularly	RB
cord-006393-jcj9nqfu	21	16	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	21	17	pneumonias	pneumonia	NNS
cord-006393-jcj9nqfu	21	18	.	.	.
cord-006393-jcj9nqfu	22	1	Later	later	RB
cord-006393-jcj9nqfu	22	2	,	,	,
cord-006393-jcj9nqfu	22	3	there	there	EX
cord-006393-jcj9nqfu	22	4	are	be	VBP
cord-006393-jcj9nqfu	22	5	some	some	DT
cord-006393-jcj9nqfu	22	6	well	well	RB
cord-006393-jcj9nqfu	22	7	-	-	HYPH
cord-006393-jcj9nqfu	22	8	defined	define	VBN
cord-006393-jcj9nqfu	22	9	infections	infection	NNS
cord-006393-jcj9nqfu	22	10	with	with	IN
cord-006393-jcj9nqfu	22	11	encapsulated	encapsulate	VBN
cord-006393-jcj9nqfu	22	12	organisms	organism	NNS
cord-006393-jcj9nqfu	22	13	,	,	,
cord-006393-jcj9nqfu	22	14	the	the	DT
cord-006393-jcj9nqfu	22	15	latter	latter	JJ
cord-006393-jcj9nqfu	22	16	sometimes	sometimes	RB
cord-006393-jcj9nqfu	22	17	even	even	RB
cord-006393-jcj9nqfu	22	18	very	very	RB
cord-006393-jcj9nqfu	22	19	late	late	JJ
cord-006393-jcj9nqfu	22	20	after	after	IN
cord-006393-jcj9nqfu	22	21	bone	bone	NN
cord-006393-jcj9nqfu	22	22	marrow	marrow	NN
cord-006393-jcj9nqfu	22	23	transplantation	transplantation	NN
cord-006393-jcj9nqfu	22	24	.	.	.
cord-006393-jcj9nqfu	23	1	In	in	IN
cord-006393-jcj9nqfu	23	2	the	the	DT
cord-006393-jcj9nqfu	23	3	preengraftment	preengraftment	NN
cord-006393-jcj9nqfu	23	4	phase	phase	NN
cord-006393-jcj9nqfu	23	5	there	there	EX
cord-006393-jcj9nqfu	23	6	is	be	VBZ
cord-006393-jcj9nqfu	23	7	complete	complete	JJ
cord-006393-jcj9nqfu	23	8	aplasia	aplasia	NN
cord-006393-jcj9nqfu	23	9	with	with	IN
cord-006393-jcj9nqfu	23	10	absolute	absolute	JJ
cord-006393-jcj9nqfu	23	11	neutropenia	neutropenia	NN
cord-006393-jcj9nqfu	23	12	and	and	CC
cord-006393-jcj9nqfu	23	13	a	a	DT
cord-006393-jcj9nqfu	23	14	severe	severe	JJ
cord-006393-jcj9nqfu	23	15	lymphopenia	lymphopenia	NN
cord-006393-jcj9nqfu	23	16	.	.	.
cord-006393-jcj9nqfu	24	1	Immunoglobulin	immunoglobulin	NN
cord-006393-jcj9nqfu	24	2	levels	level	NNS
cord-006393-jcj9nqfu	24	3	decrease	decrease	VBP
cord-006393-jcj9nqfu	24	4	to	to	IN
cord-006393-jcj9nqfu	24	5	less	less	JJR
cord-006393-jcj9nqfu	24	6	than	than	IN
cord-006393-jcj9nqfu	24	7	50	50	CD
cord-006393-jcj9nqfu	24	8	%	%	NN
cord-006393-jcj9nqfu	24	9	of	of	IN
cord-006393-jcj9nqfu	24	10	normal	normal	JJ
cord-006393-jcj9nqfu	24	11	about	about	RB
cord-006393-jcj9nqfu	24	12	3	3	CD
cord-006393-jcj9nqfu	24	13	weeks	week	NNS
cord-006393-jcj9nqfu	24	14	after	after	IN
cord-006393-jcj9nqfu	24	15	bone	bone	NN
cord-006393-jcj9nqfu	24	16	marrow	marrow	NN
cord-006393-jcj9nqfu	24	17	transplantation	transplantation	NN
cord-006393-jcj9nqfu	24	18	.	.	.
cord-006393-jcj9nqfu	25	1	The	the	DT
cord-006393-jcj9nqfu	25	2	patient	patient	NN
cord-006393-jcj9nqfu	25	3	's	's	POS
cord-006393-jcj9nqfu	25	4	defenses	defense	NNS
cord-006393-jcj9nqfu	25	5	have	have	VBP
cord-006393-jcj9nqfu	25	6	also	also	RB
cord-006393-jcj9nqfu	25	7	been	be	VBN
cord-006393-jcj9nqfu	25	8	weakened	weaken	VBN
cord-006393-jcj9nqfu	25	9	by	by	IN
cord-006393-jcj9nqfu	25	10	severe	severe	JJ
cord-006393-jcj9nqfu	25	11	impairment	impairment	NN
cord-006393-jcj9nqfu	25	12	of	of	IN
cord-006393-jcj9nqfu	25	13	the	the	DT
cord-006393-jcj9nqfu	25	14	physical	physical	JJ
cord-006393-jcj9nqfu	25	15	barrier	barrier	NN
cord-006393-jcj9nqfu	25	16	functions	function	NNS
cord-006393-jcj9nqfu	25	17	due	due	IN
cord-006393-jcj9nqfu	25	18	to	to	IN
cord-006393-jcj9nqfu	25	19	the	the	DT
cord-006393-jcj9nqfu	25	20	very	very	RB
cord-006393-jcj9nqfu	25	21	aggressive	aggressive	JJ
cord-006393-jcj9nqfu	25	22	preparative	preparative	JJ
cord-006393-jcj9nqfu	25	23	therapy	therapy	NN
cord-006393-jcj9nqfu	25	24	necessary	necessary	JJ
cord-006393-jcj9nqfu	25	25	for	for	IN
cord-006393-jcj9nqfu	25	26	bone	bone	NN
cord-006393-jcj9nqfu	25	27	marrow	marrow	NN
cord-006393-jcj9nqfu	25	28	transplantation	transplantation	NN
cord-006393-jcj9nqfu	25	29	.	.	.
cord-006393-jcj9nqfu	26	1	This	this	DT
cord-006393-jcj9nqfu	26	2	gives	give	VBZ
cord-006393-jcj9nqfu	26	3	rise	rise	NN
cord-006393-jcj9nqfu	26	4	to	to	IN
cord-006393-jcj9nqfu	26	5	infections	infection	NNS
cord-006393-jcj9nqfu	26	6	derived	derive	VBN
cord-006393-jcj9nqfu	26	7	primarily	primarily	RB
cord-006393-jcj9nqfu	26	8	from	from	IN
cord-006393-jcj9nqfu	26	9	the	the	DT
cord-006393-jcj9nqfu	26	10	bacterial	bacterial	JJ
cord-006393-jcj9nqfu	26	11	microflora	microflora	NN
cord-006393-jcj9nqfu	26	12	reservoirs	reservoir	NNS
cord-006393-jcj9nqfu	26	13	of	of	IN
cord-006393-jcj9nqfu	26	14	the	the	DT
cord-006393-jcj9nqfu	26	15	patient	patient	NN
cord-006393-jcj9nqfu	26	16	,	,	,
cord-006393-jcj9nqfu	26	17	such	such	JJ
cord-006393-jcj9nqfu	26	18	as	as	IN
cord-006393-jcj9nqfu	26	19	gram	gram	NN
cord-006393-jcj9nqfu	26	20	-	-	HYPH
cord-006393-jcj9nqfu	26	21	negative	negative	JJ
cord-006393-jcj9nqfu	26	22	bacteria	bacteria	NNS
cord-006393-jcj9nqfu	26	23	from	from	IN
cord-006393-jcj9nqfu	26	24	the	the	DT
cord-006393-jcj9nqfu	26	25	gastrointestinal	gastrointestinal	JJ
cord-006393-jcj9nqfu	26	26	tract	tract	NN
cord-006393-jcj9nqfu	26	27	and	and	CC
cord-006393-jcj9nqfu	26	28	grampositive	grampositive	JJ
cord-006393-jcj9nqfu	26	29	bacteria	bacteria	NNS
cord-006393-jcj9nqfu	26	30	from	from	IN
cord-006393-jcj9nqfu	26	31	the	the	DT
cord-006393-jcj9nqfu	26	32	integument	integument	NN
cord-006393-jcj9nqfu	26	33	such	such	JJ
cord-006393-jcj9nqfu	26	34	as	as	IN
cord-006393-jcj9nqfu	26	35	Staphylococcus	Staphylococcus	NNP
cord-006393-jcj9nqfu	26	36	epidermidis	epidermidi	NNS
cord-006393-jcj9nqfu	26	37	from	from	IN
cord-006393-jcj9nqfu	26	38	the	the	DT
cord-006393-jcj9nqfu	26	39	skin	skin	NN
cord-006393-jcj9nqfu	26	40	.	.	.
cord-006393-jcj9nqfu	27	1	In	in	IN
cord-006393-jcj9nqfu	27	2	recent	recent	JJ
cord-006393-jcj9nqfu	27	3	experience	experience	NN
cord-006393-jcj9nqfu	27	4	gram	gram	NN
cord-006393-jcj9nqfu	27	5	-	-	HYPH
cord-006393-jcj9nqfu	27	6	positive	positive	JJ
cord-006393-jcj9nqfu	27	7	bacteria	bacteria	NNS
cord-006393-jcj9nqfu	27	8	have	have	VBP
cord-006393-jcj9nqfu	27	9	replaced	replace	VBN
cord-006393-jcj9nqfu	27	10	gram	gram	NN
cord-006393-jcj9nqfu	27	11	-	-	HYPH
cord-006393-jcj9nqfu	27	12	negative	negative	JJ
cord-006393-jcj9nqfu	27	13	bacteria	bacteria	NNS
cord-006393-jcj9nqfu	27	14	as	as	IN
cord-006393-jcj9nqfu	27	15	the	the	DT
cord-006393-jcj9nqfu	27	16	dominant	dominant	JJ
cord-006393-jcj9nqfu	27	17	sources	source	NNS
cord-006393-jcj9nqfu	27	18	of	of	IN
cord-006393-jcj9nqfu	27	19	infection	infection	NN
cord-006393-jcj9nqfu	27	20	.	.	.
cord-006393-jcj9nqfu	28	1	In	in	IN
cord-006393-jcj9nqfu	28	2	15	15	CD
cord-006393-jcj9nqfu	28	3	to	to	TO
cord-006393-jcj9nqfu	28	4	20	20	CD
cord-006393-jcj9nqfu	28	5	%	%	NN
cord-006393-jcj9nqfu	28	6	of	of	IN
cord-006393-jcj9nqfu	28	7	patients	patient	NNS
cord-006393-jcj9nqfu	28	8	in	in	IN
cord-006393-jcj9nqfu	28	9	the	the	DT
cord-006393-jcj9nqfu	28	10	preengraftment	preengraftment	NN
cord-006393-jcj9nqfu	28	11	phase	phase	NN
cord-006393-jcj9nqfu	28	12	bacteremia	bacteremia	NN
cord-006393-jcj9nqfu	28	13	is	be	VBZ
cord-006393-jcj9nqfu	28	14	present	present	JJ
cord-006393-jcj9nqfu	28	15	,	,	,
cord-006393-jcj9nqfu	28	16	usually	usually	RB
cord-006393-jcj9nqfu	28	17	associated	associate	VBN
cord-006393-jcj9nqfu	28	18	with	with	IN
cord-006393-jcj9nqfu	28	19	sepsis	sepsis	NN
cord-006393-jcj9nqfu	28	20	and	and	CC
cord-006393-jcj9nqfu	28	21	circulatory	circulatory	JJ
cord-006393-jcj9nqfu	28	22	collapse	collapse	NN
cord-006393-jcj9nqfu	28	23	.	.	.
cord-006393-jcj9nqfu	29	1	There	there	EX
cord-006393-jcj9nqfu	29	2	are	be	VBP
cord-006393-jcj9nqfu	29	3	several	several	JJ
cord-006393-jcj9nqfu	29	4	theoretical	theoretical	JJ
cord-006393-jcj9nqfu	29	5	ways	way	NNS
cord-006393-jcj9nqfu	29	6	to	to	TO
cord-006393-jcj9nqfu	29	7	prevent	prevent	VB
cord-006393-jcj9nqfu	29	8	those	those	DT
cord-006393-jcj9nqfu	29	9	early	early	JJ
cord-006393-jcj9nqfu	29	10	infections	infection	NNS
cord-006393-jcj9nqfu	29	11	.	.	.
cord-006393-jcj9nqfu	30	1	First	first	RB
cord-006393-jcj9nqfu	30	2	,	,	,
cord-006393-jcj9nqfu	30	3	one	one	PRP
cord-006393-jcj9nqfu	30	4	could	could	MD
cord-006393-jcj9nqfu	30	5	try	try	VB
cord-006393-jcj9nqfu	30	6	to	to	TO
cord-006393-jcj9nqfu	30	7	develop	develop	VB
cord-006393-jcj9nqfu	30	8	less	less	RBR
cord-006393-jcj9nqfu	30	9	toxic	toxic	JJ
cord-006393-jcj9nqfu	30	10	preparative	preparative	JJ
cord-006393-jcj9nqfu	30	11	regimens	regimen	NNS
cord-006393-jcj9nqfu	30	12	so	so	IN
cord-006393-jcj9nqfu	30	13	that	that	IN
cord-006393-jcj9nqfu	30	14	the	the	DT
cord-006393-jcj9nqfu	30	15	barrier	barrier	NN
cord-006393-jcj9nqfu	30	16	function	function	NN
cord-006393-jcj9nqfu	30	17	was	be	VBD
cord-006393-jcj9nqfu	30	18	less	less	RBR
cord-006393-jcj9nqfu	30	19	impaired	impaired	JJ
cord-006393-jcj9nqfu	30	20	.	.	.
cord-006393-jcj9nqfu	31	1	The	the	DT
cord-006393-jcj9nqfu	31	2	preparative	preparative	JJ
cord-006393-jcj9nqfu	31	3	regimen	regimen	NN
cord-006393-jcj9nqfu	31	4	that	that	IN
cord-006393-jcj9nqfu	31	5	we	-PRON-	PRP
cord-006393-jcj9nqfu	31	6	developed	develop	VBD
cord-006393-jcj9nqfu	31	7	in	in	IN
cord-006393-jcj9nqfu	31	8	our	-PRON-	PRP$
cord-006393-jcj9nqfu	31	9	center	center	NN
cord-006393-jcj9nqfu	31	10	is	be	VBZ
cord-006393-jcj9nqfu	31	11	one	one	CD
cord-006393-jcj9nqfu	31	12	in	in	IN
cord-006393-jcj9nqfu	31	13	which	which	WDT
cord-006393-jcj9nqfu	31	14	total	total	JJ
cord-006393-jcj9nqfu	31	15	-	-	HYPH
cord-006393-jcj9nqfu	31	16	body	body	NN
cord-006393-jcj9nqfu	31	17	irradiation	irradiation	NN
cord-006393-jcj9nqfu	31	18	(	(	-LRB-
cord-006393-jcj9nqfu	31	19	TBI	TBI	NNP
cord-006393-jcj9nqfu	31	20	)	)	-RRB-
cord-006393-jcj9nqfu	31	21	is	be	VBZ
cord-006393-jcj9nqfu	31	22	replaced	replace	VBN
cord-006393-jcj9nqfu	31	23	by	by	IN
cord-006393-jcj9nqfu	31	24	a	a	DT
cord-006393-jcj9nqfu	31	25	seemingly	seemingly	RB
cord-006393-jcj9nqfu	31	26	less	less	RBR
cord-006393-jcj9nqfu	31	27	toxic	toxic	JJ
cord-006393-jcj9nqfu	31	28	agent	agent	NN
cord-006393-jcj9nqfu	31	29	such	such	JJ
cord-006393-jcj9nqfu	31	30	as	as	IN
cord-006393-jcj9nqfu	31	31	busulfan	busulfan	NNP
cord-006393-jcj9nqfu	31	32	(	(	-LRB-
cord-006393-jcj9nqfu	31	33	1	1	CD
cord-006393-jcj9nqfu	31	34	)	)	-RRB-
cord-006393-jcj9nqfu	31	35	.	.	.
cord-006393-jcj9nqfu	32	1	Such	such	PDT
cord-006393-jcj9nqfu	32	2	a	a	DT
cord-006393-jcj9nqfu	32	3	regimen	regimen	NN
cord-006393-jcj9nqfu	32	4	permits	permit	VBZ
cord-006393-jcj9nqfu	32	5	a	a	DT
cord-006393-jcj9nqfu	32	6	very	very	RB
cord-006393-jcj9nqfu	32	7	short	short	JJ
cord-006393-jcj9nqfu	32	8	period	period	NN
cord-006393-jcj9nqfu	32	9	of	of	IN
cord-006393-jcj9nqfu	32	10	aplasia	aplasia	NNP
cord-006393-jcj9nqfu	32	11	(	(	-LRB-
cord-006393-jcj9nqfu	32	12	for	for	IN
cord-006393-jcj9nqfu	32	13	only	only	RB
cord-006393-jcj9nqfu	32	14	5	5	CD
cord-006393-jcj9nqfu	32	15	to	to	TO
cord-006393-jcj9nqfu	32	16	7	7	CD
cord-006393-jcj9nqfu	32	17	days	day	NNS
cord-006393-jcj9nqfu	32	18	)	)	-RRB-
cord-006393-jcj9nqfu	32	19	,	,	,
cord-006393-jcj9nqfu	32	20	which	which	WDT
cord-006393-jcj9nqfu	32	21	markedly	markedly	RB
cord-006393-jcj9nqfu	32	22	reduces	reduce	VBZ
cord-006393-jcj9nqfu	32	23	the	the	DT
cord-006393-jcj9nqfu	32	24	danger	danger	NN
cord-006393-jcj9nqfu	32	25	to	to	IN
cord-006393-jcj9nqfu	32	26	the	the	DT
cord-006393-jcj9nqfu	32	27	patient	patient	NN
cord-006393-jcj9nqfu	32	28	.	.	.
cord-006393-jcj9nqfu	33	1	Second	second	RB
cord-006393-jcj9nqfu	33	2	,	,	,
cord-006393-jcj9nqfu	33	3	one	one	PRP
cord-006393-jcj9nqfu	33	4	could	could	MD
cord-006393-jcj9nqfu	33	5	try	try	VB
cord-006393-jcj9nqfu	33	6	to	to	TO
cord-006393-jcj9nqfu	33	7	reduce	reduce	VB
cord-006393-jcj9nqfu	33	8	the	the	DT
cord-006393-jcj9nqfu	33	9	patient	patient	NN
cord-006393-jcj9nqfu	33	10	's	's	POS
cord-006393-jcj9nqfu	33	11	own	own	JJ
cord-006393-jcj9nqfu	33	12	microflora	microflora	NN
cord-006393-jcj9nqfu	33	13	reservoirs	reservoir	NNS
cord-006393-jcj9nqfu	33	14	by	by	IN
cord-006393-jcj9nqfu	33	15	providing	provide	VBG
cord-006393-jcj9nqfu	33	16	a	a	DT
cord-006393-jcj9nqfu	33	17	gnotobiotic	gnotobiotic	JJ
cord-006393-jcj9nqfu	33	18	,	,	,
cord-006393-jcj9nqfu	33	19	highly	highly	RB
cord-006393-jcj9nqfu	33	20	restricted	restrict	VBN
cord-006393-jcj9nqfu	33	21	environment	environment	NN
cord-006393-jcj9nqfu	33	22	.	.	.
cord-006393-jcj9nqfu	34	1	It	-PRON-	PRP
cord-006393-jcj9nqfu	34	2	has	have	VBZ
cord-006393-jcj9nqfu	34	3	been	be	VBN
cord-006393-jcj9nqfu	34	4	shown	show	VBN
cord-006393-jcj9nqfu	34	5	that	that	IN
cord-006393-jcj9nqfu	34	6	patients	patient	NNS
cord-006393-jcj9nqfu	34	7	with	with	IN
cord-006393-jcj9nqfu	34	8	aplastic	aplastic	JJ
cord-006393-jcj9nqfu	34	9	anemia	anemia	NN
cord-006393-jcj9nqfu	34	10	who	who	WP
cord-006393-jcj9nqfu	34	11	were	be	VBD
cord-006393-jcj9nqfu	34	12	placed	place	VBN
cord-006393-jcj9nqfu	34	13	in	in	IN
cord-006393-jcj9nqfu	34	14	such	such	PDT
cord-006393-jcj9nqfu	34	15	an	an	DT
cord-006393-jcj9nqfu	34	16	environment	environment	NN
cord-006393-jcj9nqfu	34	17	had	have	VBD
cord-006393-jcj9nqfu	34	18	a	a	DT
cord-006393-jcj9nqfu	34	19	significantly	significantly	RB
cord-006393-jcj9nqfu	34	20	increased	increase	VBN
cord-006393-jcj9nqfu	34	21	probability	probability	NN
cord-006393-jcj9nqfu	34	22	of	of	IN
cord-006393-jcj9nqfu	34	23	survival	survival	NN
cord-006393-jcj9nqfu	34	24	following	follow	VBG
cord-006393-jcj9nqfu	34	25	bone	bone	NN
cord-006393-jcj9nqfu	34	26	marrow	marrow	NN
cord-006393-jcj9nqfu	34	27	transplantation	transplantation	NN
cord-006393-jcj9nqfu	34	28	(	(	-LRB-
cord-006393-jcj9nqfu	34	29	2	2	CD
cord-006393-jcj9nqfu	34	30	)	)	-RRB-
cord-006393-jcj9nqfu	34	31	.	.	.
cord-006393-jcj9nqfu	35	1	Third	third	RB
cord-006393-jcj9nqfu	35	2	,	,	,
cord-006393-jcj9nqfu	35	3	one	one	PRP
cord-006393-jcj9nqfu	35	4	could	could	MD
cord-006393-jcj9nqfu	35	5	try	try	VB
cord-006393-jcj9nqfu	35	6	to	to	TO
cord-006393-jcj9nqfu	35	7	bolster	bolster	VB
cord-006393-jcj9nqfu	35	8	the	the	DT
cord-006393-jcj9nqfu	35	9	humoral	humoral	JJ
cord-006393-jcj9nqfu	35	10	immunity	immunity	NN
cord-006393-jcj9nqfu	35	11	by	by	IN
cord-006393-jcj9nqfu	35	12	passively	passively	RB
cord-006393-jcj9nqfu	35	13	administering	administer	VBG
cord-006393-jcj9nqfu	35	14	antibodies	antibody	NNS
cord-006393-jcj9nqfu	35	15	against	against	IN
cord-006393-jcj9nqfu	35	16	the	the	DT
cord-006393-jcj9nqfu	35	17	relevant	relevant	JJ
cord-006393-jcj9nqfu	35	18	microorganisms	microorganism	NNS
cord-006393-jcj9nqfu	35	19	.	.	.
cord-006393-jcj9nqfu	36	1	Commercially	commercially	RB
cord-006393-jcj9nqfu	36	2	available	available	JJ
cord-006393-jcj9nqfu	36	3	immune	immune	JJ
cord-006393-jcj9nqfu	36	4	globulin	globulin	NN
cord-006393-jcj9nqfu	36	5	preparations	preparation	NNS
cord-006393-jcj9nqfu	36	6	do	do	VBP
cord-006393-jcj9nqfu	36	7	indeed	indeed	RB
cord-006393-jcj9nqfu	36	8	contain	contain	VB
cord-006393-jcj9nqfu	36	9	antibodies	antibody	NNS
cord-006393-jcj9nqfu	36	10	against	against	IN
cord-006393-jcj9nqfu	36	11	a	a	DT
cord-006393-jcj9nqfu	36	12	wide	wide	JJ
cord-006393-jcj9nqfu	36	13	range	range	NN
cord-006393-jcj9nqfu	36	14	of	of	IN
cord-006393-jcj9nqfu	36	15	pathogens	pathogen	NNS
cord-006393-jcj9nqfu	36	16	and	and	CC
cord-006393-jcj9nqfu	36	17	toxins	toxin	NNS
cord-006393-jcj9nqfu	36	18	,	,	,
cord-006393-jcj9nqfu	36	19	in	in	IN
cord-006393-jcj9nqfu	36	20	fact	fact	NN
cord-006393-jcj9nqfu	36	21	against	against	IN
cord-006393-jcj9nqfu	36	22	virtually	virtually	RB
cord-006393-jcj9nqfu	36	23	all	all	PDT
cord-006393-jcj9nqfu	36	24	the	the	DT
cord-006393-jcj9nqfu	36	25	pathogenic	pathogenic	JJ
cord-006393-jcj9nqfu	36	26	organisms	organism	NNS
cord-006393-jcj9nqfu	36	27	that	that	WDT
cord-006393-jcj9nqfu	36	28	are	be	VBP
cord-006393-jcj9nqfu	36	29	important	important	JJ
cord-006393-jcj9nqfu	36	30	for	for	IN
cord-006393-jcj9nqfu	36	31	infections	infection	NNS
cord-006393-jcj9nqfu	36	32	in	in	IN
cord-006393-jcj9nqfu	36	33	the	the	DT
cord-006393-jcj9nqfu	36	34	transplant	transplant	NN
cord-006393-jcj9nqfu	36	35	setting	setting	NN
cord-006393-jcj9nqfu	36	36	.	.	.
cord-006393-jcj9nqfu	37	1	The	the	DT
cord-006393-jcj9nqfu	37	2	activation	activation	NN
cord-006393-jcj9nqfu	37	3	of	of	IN
cord-006393-jcj9nqfu	37	4	the	the	DT
cord-006393-jcj9nqfu	37	5	complement	complement	JJ
cord-006393-jcj9nqfu	37	6	system	system	NN
cord-006393-jcj9nqfu	37	7	by	by	IN
cord-006393-jcj9nqfu	37	8	the	the	DT
cord-006393-jcj9nqfu	37	9	administration	administration	NN
cord-006393-jcj9nqfu	37	10	of	of	IN
cord-006393-jcj9nqfu	37	11	immune	immune	JJ
cord-006393-jcj9nqfu	37	12	globulins	globulin	NNS
cord-006393-jcj9nqfu	37	13	will	will	MD
cord-006393-jcj9nqfu	37	14	lead	lead	VB
cord-006393-jcj9nqfu	37	15	to	to	IN
cord-006393-jcj9nqfu	37	16	increased	increase	VBN
cord-006393-jcj9nqfu	37	17	phagocytosis	phagocytosis	NN
cord-006393-jcj9nqfu	37	18	and	and	CC
cord-006393-jcj9nqfu	37	19	an	an	DT
cord-006393-jcj9nqfu	37	20	increased	increase	VBN
cord-006393-jcj9nqfu	37	21	granulocytochemotaxis	granulocytochemotaxis	NN
cord-006393-jcj9nqfu	37	22	.	.	.
cord-006393-jcj9nqfu	38	1	Immune	immune	JJ
cord-006393-jcj9nqfu	38	2	globulins	globulin	NNS
cord-006393-jcj9nqfu	38	3	may	may	MD
cord-006393-jcj9nqfu	38	4	also	also	RB
cord-006393-jcj9nqfu	38	5	prevent	prevent	VB
cord-006393-jcj9nqfu	38	6	bacterial	bacterial	JJ
cord-006393-jcj9nqfu	38	7	attachment	attachment	NN
cord-006393-jcj9nqfu	38	8	on	on	IN
cord-006393-jcj9nqfu	38	9	the	the	DT
cord-006393-jcj9nqfu	38	10	mucosal	mucosal	JJ
cord-006393-jcj9nqfu	38	11	surfaces	surface	NNS
cord-006393-jcj9nqfu	38	12	because	because	IN
cord-006393-jcj9nqfu	38	13	the	the	DT
cord-006393-jcj9nqfu	38	14	receptor	receptor	NN
cord-006393-jcj9nqfu	38	15	sites	site	NNS
cord-006393-jcj9nqfu	38	16	will	will	MD
cord-006393-jcj9nqfu	38	17	be	be	VB
cord-006393-jcj9nqfu	38	18	occupied	occupy	VBN
cord-006393-jcj9nqfu	38	19	by	by	IN
cord-006393-jcj9nqfu	38	20	the	the	DT
cord-006393-jcj9nqfu	38	21	infused	infuse	VBN
cord-006393-jcj9nqfu	38	22	antibodies	antibody	NNS
cord-006393-jcj9nqfu	38	23	.	.	.
cord-006393-jcj9nqfu	39	1	Furthermore	furthermore	RB
cord-006393-jcj9nqfu	39	2	,	,	,
cord-006393-jcj9nqfu	39	3	some	some	DT
cord-006393-jcj9nqfu	39	4	reasonably	reasonably	RB
cord-006393-jcj9nqfu	39	5	wellcontrolled	wellcontrolled	JJ
cord-006393-jcj9nqfu	39	6	studies	study	NNS
cord-006393-jcj9nqfu	39	7	have	have	VBP
cord-006393-jcj9nqfu	39	8	shown	show	VBN
cord-006393-jcj9nqfu	39	9	that	that	IN
cord-006393-jcj9nqfu	39	10	passive	passive	JJ
cord-006393-jcj9nqfu	39	11	immune	immune	JJ
cord-006393-jcj9nqfu	39	12	globulin	globulin	NN
cord-006393-jcj9nqfu	39	13	therapy	therapy	NN
cord-006393-jcj9nqfu	39	14	is	be	VBZ
cord-006393-jcj9nqfu	39	15	effective	effective	JJ
cord-006393-jcj9nqfu	39	16	for	for	IN
cord-006393-jcj9nqfu	39	17	burn	burn	NN
cord-006393-jcj9nqfu	39	18	patients	patient	NNS
cord-006393-jcj9nqfu	39	19	as	as	RB
cord-006393-jcj9nqfu	39	20	well	well	RB
cord-006393-jcj9nqfu	39	21	as	as	IN
cord-006393-jcj9nqfu	39	22	for	for	IN
cord-006393-jcj9nqfu	39	23	trauma	trauma	NN
cord-006393-jcj9nqfu	39	24	patients	patient	NNS
cord-006393-jcj9nqfu	39	25	(	(	-LRB-
cord-006393-jcj9nqfu	39	26	3	3	CD
cord-006393-jcj9nqfu	39	27	,	,	,
cord-006393-jcj9nqfu	39	28	4	4	CD
cord-006393-jcj9nqfu	39	29	)	)	-RRB-
cord-006393-jcj9nqfu	39	30	.	.	.
cord-006393-jcj9nqfu	40	1	In	in	IN
cord-006393-jcj9nqfu	40	2	our	-PRON-	PRP$
cord-006393-jcj9nqfu	40	3	own	own	JJ
cord-006393-jcj9nqfu	40	4	program	program	NN
cord-006393-jcj9nqfu	40	5	we	-PRON-	PRP
cord-006393-jcj9nqfu	40	6	have	have	VBP
cord-006393-jcj9nqfu	40	7	tried	try	VBN
cord-006393-jcj9nqfu	40	8	to	to	TO
cord-006393-jcj9nqfu	40	9	utilize	utilize	VB
cord-006393-jcj9nqfu	40	10	all	all	PDT
cord-006393-jcj9nqfu	40	11	the	the	DT
cord-006393-jcj9nqfu	40	12	accepted	accept	VBN
cord-006393-jcj9nqfu	40	13	measures	measure	NNS
cord-006393-jcj9nqfu	40	14	for	for	IN
cord-006393-jcj9nqfu	40	15	infectious	infectious	JJ
cord-006393-jcj9nqfu	40	16	prophylaxis	prophylaxis	NN
cord-006393-jcj9nqfu	40	17	.	.	.
cord-006393-jcj9nqfu	41	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	41	2	studied	study	VBD
cord-006393-jcj9nqfu	41	3	110	110	CD
cord-006393-jcj9nqfu	41	4	consecutive	consecutive	JJ
cord-006393-jcj9nqfu	41	5	transplant	transplant	NN
cord-006393-jcj9nqfu	41	6	patients	patient	NNS
cord-006393-jcj9nqfu	41	7	for	for	IN
cord-006393-jcj9nqfu	41	8	whom	whom	WP
cord-006393-jcj9nqfu	41	9	we	-PRON-	PRP
cord-006393-jcj9nqfu	41	10	substituted	substitute	VBD
cord-006393-jcj9nqfu	41	11	busulfan	busulfan	NN
cord-006393-jcj9nqfu	41	12	in	in	IN
cord-006393-jcj9nqfu	41	13	place	place	NN
cord-006393-jcj9nqfu	41	14	of	of	IN
cord-006393-jcj9nqfu	41	15	TBI	TBI	NNP
cord-006393-jcj9nqfu	41	16	.	.	.
cord-006393-jcj9nqfu	42	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	42	2	used	use	VBD
cord-006393-jcj9nqfu	42	3	selective	selective	JJ
cord-006393-jcj9nqfu	42	4	body	body	NN
cord-006393-jcj9nqfu	42	5	decontamination	decontamination	NN
cord-006393-jcj9nqfu	42	6	in	in	IN
cord-006393-jcj9nqfu	42	7	an	an	DT
cord-006393-jcj9nqfu	42	8	ultraclean	ultraclean	JJ
cord-006393-jcj9nqfu	42	9	environment	environment	NN
cord-006393-jcj9nqfu	42	10	and	and	CC
cord-006393-jcj9nqfu	42	11	administered	administer	VBD
cord-006393-jcj9nqfu	42	12	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	42	13	at	at	IN
cord-006393-jcj9nqfu	42	14	a	a	DT
cord-006393-jcj9nqfu	42	15	dose	dose	NN
cord-006393-jcj9nqfu	42	16	of	of	IN
cord-006393-jcj9nqfu	42	17	500	500	CD
cord-006393-jcj9nqfu	42	18	mg	mg	NNP
cord-006393-jcj9nqfu	42	19	/	/	SYM
cord-006393-jcj9nqfu	42	20	kg	kg	NN
cord-006393-jcj9nqfu	42	21	every	every	DT
cord-006393-jcj9nqfu	42	22	2	2	CD
cord-006393-jcj9nqfu	42	23	weeks	week	NNS
cord-006393-jcj9nqfu	42	24	for	for	IN
cord-006393-jcj9nqfu	42	25	a	a	DT
cord-006393-jcj9nqfu	42	26	total	total	NN
cord-006393-jcj9nqfu	42	27	of	of	IN
cord-006393-jcj9nqfu	42	28	4	4	CD
cord-006393-jcj9nqfu	42	29	months	month	NNS
cord-006393-jcj9nqfu	42	30	.	.	.
cord-006393-jcj9nqfu	43	1	With	with	IN
cord-006393-jcj9nqfu	43	2	this	this	DT
cord-006393-jcj9nqfu	43	3	regimen	regimen	NN
cord-006393-jcj9nqfu	43	4	the	the	DT
cord-006393-jcj9nqfu	43	5	incidence	incidence	NN
cord-006393-jcj9nqfu	43	6	of	of	IN
cord-006393-jcj9nqfu	43	7	bacteremia	bacteremia	NN
cord-006393-jcj9nqfu	43	8	was	be	VBD
cord-006393-jcj9nqfu	43	9	only	only	RB
cord-006393-jcj9nqfu	43	10	2.7	2.7	CD
cord-006393-jcj9nqfu	43	11	%	%	NN
cord-006393-jcj9nqfu	43	12	and	and	CC
cord-006393-jcj9nqfu	43	13	almost	almost	RB
cord-006393-jcj9nqfu	43	14	half	half	NN
cord-006393-jcj9nqfu	43	15	of	of	IN
cord-006393-jcj9nqfu	43	16	the	the	DT
cord-006393-jcj9nqfu	43	17	patients	patient	NNS
cord-006393-jcj9nqfu	43	18	developed	develop	VBD
cord-006393-jcj9nqfu	43	19	no	no	DT
cord-006393-jcj9nqfu	43	20	fever	fever	NN
cord-006393-jcj9nqfu	43	21	during	during	IN
cord-006393-jcj9nqfu	43	22	aplasia	aplasia	NNP
cord-006393-jcj9nqfu	43	23	.	.	.
cord-006393-jcj9nqfu	44	1	Unfortunately	unfortunately	RB
cord-006393-jcj9nqfu	44	2	,	,	,
cord-006393-jcj9nqfu	44	3	this	this	DT
cord-006393-jcj9nqfu	44	4	study	study	NN
cord-006393-jcj9nqfu	44	5	was	be	VBD
cord-006393-jcj9nqfu	44	6	not	not	RB
cord-006393-jcj9nqfu	44	7	a	a	DT
cord-006393-jcj9nqfu	44	8	controlled	control	VBN
cord-006393-jcj9nqfu	44	9	one	one	CD
cord-006393-jcj9nqfu	44	10	and	and	CC
cord-006393-jcj9nqfu	44	11	the	the	DT
cord-006393-jcj9nqfu	44	12	important	important	JJ
cord-006393-jcj9nqfu	44	13	question	question	NN
cord-006393-jcj9nqfu	44	14	if	if	IN
cord-006393-jcj9nqfu	44	15	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	44	16	given	give	VBN
cord-006393-jcj9nqfu	44	17	systemically	systemically	RB
cord-006393-jcj9nqfu	44	18	wilt	wilt	VBP
cord-006393-jcj9nqfu	44	19	reduce	reduce	VB
cord-006393-jcj9nqfu	44	20	infectious	infectious	JJ
cord-006393-jcj9nqfu	44	21	complications	complication	NNS
cord-006393-jcj9nqfu	44	22	during	during	IN
cord-006393-jcj9nqfu	44	23	aplasia	aplasia	NNP
cord-006393-jcj9nqfu	44	24	remains	remain	VBZ
cord-006393-jcj9nqfu	44	25	unanswered	unanswered	JJ
cord-006393-jcj9nqfu	44	26	.	.	.
cord-006393-jcj9nqfu	45	1	Several	several	JJ
cord-006393-jcj9nqfu	45	2	placebo	placebo	NN
cord-006393-jcj9nqfu	45	3	-	-	HYPH
cord-006393-jcj9nqfu	45	4	controlled	control	VBN
cord-006393-jcj9nqfu	45	5	trials	trial	NNS
cord-006393-jcj9nqfu	45	6	are	be	VBP
cord-006393-jcj9nqfu	45	7	under	under	IN
cord-006393-jcj9nqfu	45	8	way	way	NN
cord-006393-jcj9nqfu	45	9	in	in	IN
cord-006393-jcj9nqfu	45	10	a	a	DT
cord-006393-jcj9nqfu	45	11	number	number	NN
cord-006393-jcj9nqfu	45	12	of	of	IN
cord-006393-jcj9nqfu	45	13	transplant	transplant	NN
cord-006393-jcj9nqfu	45	14	centers	center	NNS
cord-006393-jcj9nqfu	45	15	to	to	TO
cord-006393-jcj9nqfu	45	16	resolve	resolve	VB
cord-006393-jcj9nqfu	45	17	this	this	DT
cord-006393-jcj9nqfu	45	18	matter	matter	NN
cord-006393-jcj9nqfu	45	19	.	.	.
cord-006393-jcj9nqfu	46	1	From	from	IN
cord-006393-jcj9nqfu	46	2	the	the	DT
cord-006393-jcj9nqfu	46	3	viewpoint	viewpoint	NN
cord-006393-jcj9nqfu	46	4	of	of	IN
cord-006393-jcj9nqfu	46	5	the	the	DT
cord-006393-jcj9nqfu	46	6	immunobiologist	immunobiologist	NN
cord-006393-jcj9nqfu	46	7	,	,	,
cord-006393-jcj9nqfu	46	8	phase	phase	NN
cord-006393-jcj9nqfu	46	9	II	II	NNP
cord-006393-jcj9nqfu	46	10	,	,	,
cord-006393-jcj9nqfu	46	11	the	the	DT
cord-006393-jcj9nqfu	46	12	phase	phase	NN
cord-006393-jcj9nqfu	46	13	early	early	RB
cord-006393-jcj9nqfu	46	14	after	after	IN
cord-006393-jcj9nqfu	46	15	marrow	marrow	NN
cord-006393-jcj9nqfu	46	16	engraftment	engraftment	NN
cord-006393-jcj9nqfu	46	17	,	,	,
cord-006393-jcj9nqfu	46	18	is	be	VBZ
cord-006393-jcj9nqfu	46	19	the	the	DT
cord-006393-jcj9nqfu	46	20	more	more	RBR
cord-006393-jcj9nqfu	46	21	important	important	JJ
cord-006393-jcj9nqfu	46	22	period	period	NN
cord-006393-jcj9nqfu	46	23	.	.	.
cord-006393-jcj9nqfu	47	1	A	a	DT
cord-006393-jcj9nqfu	47	2	number	number	NN
cord-006393-jcj9nqfu	47	3	of	of	IN
cord-006393-jcj9nqfu	47	4	critical	critical	JJ
cord-006393-jcj9nqfu	47	5	immune	immune	JJ
cord-006393-jcj9nqfu	47	6	events	event	NNS
cord-006393-jcj9nqfu	47	7	take	take	VBP
cord-006393-jcj9nqfu	47	8	place	place	NN
cord-006393-jcj9nqfu	47	9	in	in	IN
cord-006393-jcj9nqfu	47	10	this	this	DT
cord-006393-jcj9nqfu	47	11	second	second	JJ
cord-006393-jcj9nqfu	47	12	phase	phase	NN
cord-006393-jcj9nqfu	47	13	.	.	.
cord-006393-jcj9nqfu	48	1	By	by	IN
cord-006393-jcj9nqfu	48	2	this	this	DT
cord-006393-jcj9nqfu	48	3	time	time	NN
cord-006393-jcj9nqfu	48	4	host	host	NN
cord-006393-jcj9nqfu	48	5	B	b	NN
cord-006393-jcj9nqfu	48	6	-	-	HYPH
cord-006393-jcj9nqfu	48	7	cell	cell	NN
cord-006393-jcj9nqfu	48	8	immunity	immunity	NN
cord-006393-jcj9nqfu	48	9	has	have	VBZ
cord-006393-jcj9nqfu	48	10	disappeared	disappear	VBN
cord-006393-jcj9nqfu	48	11	completely	completely	RB
cord-006393-jcj9nqfu	48	12	but	but	CC
cord-006393-jcj9nqfu	48	13	donor	donor	NN
cord-006393-jcj9nqfu	48	14	B	b	NN
cord-006393-jcj9nqfu	48	15	-	-	HYPH
cord-006393-jcj9nqfu	48	16	cell	cell	NN
cord-006393-jcj9nqfu	48	17	immunity	immunity	NN
cord-006393-jcj9nqfu	48	18	has	have	VBZ
cord-006393-jcj9nqfu	48	19	not	not	RB
cord-006393-jcj9nqfu	48	20	yet	yet	RB
cord-006393-jcj9nqfu	48	21	been	be	VBN
cord-006393-jcj9nqfu	48	22	reestablished	reestablish	VBN
cord-006393-jcj9nqfu	48	23	.	.	.
cord-006393-jcj9nqfu	49	1	Adoptive	adoptive	JJ
cord-006393-jcj9nqfu	49	2	T	t	NN
cord-006393-jcj9nqfu	49	3	-	-	HYPH
cord-006393-jcj9nqfu	49	4	cell	cell	NN
cord-006393-jcj9nqfu	49	5	donor	donor	NN
cord-006393-jcj9nqfu	49	6	immunity	immunity	NN
cord-006393-jcj9nqfu	49	7	(	(	-LRB-
cord-006393-jcj9nqfu	49	8	due	due	IN
cord-006393-jcj9nqfu	49	9	to	to	IN
cord-006393-jcj9nqfu	49	10	mature	mature	JJ
cord-006393-jcj9nqfu	49	11	cells	cell	NNS
cord-006393-jcj9nqfu	49	12	that	that	WDT
cord-006393-jcj9nqfu	49	13	were	be	VBD
cord-006393-jcj9nqfu	49	14	transferred	transfer	VBN
cord-006393-jcj9nqfu	49	15	with	with	IN
cord-006393-jcj9nqfu	49	16	the	the	DT
cord-006393-jcj9nqfu	49	17	bone	bone	NN
cord-006393-jcj9nqfu	49	18	marrow	marrow	NN
cord-006393-jcj9nqfu	49	19	)	)	-RRB-
cord-006393-jcj9nqfu	49	20	has	have	VBZ
cord-006393-jcj9nqfu	49	21	disappeared	disappear	VBN
cord-006393-jcj9nqfu	49	22	as	as	RB
cord-006393-jcj9nqfu	49	23	well	well	RB
cord-006393-jcj9nqfu	49	24	.	.	.
cord-006393-jcj9nqfu	50	1	The	the	DT
cord-006393-jcj9nqfu	50	2	function	function	NN
cord-006393-jcj9nqfu	50	3	of	of	IN
cord-006393-jcj9nqfu	50	4	the	the	DT
cord-006393-jcj9nqfu	50	5	helper	helper	NN
cord-006393-jcj9nqfu	50	6	T	T	NNP
cord-006393-jcj9nqfu	50	7	cells	cell	NNS
cord-006393-jcj9nqfu	50	8	is	be	VBZ
cord-006393-jcj9nqfu	50	9	markedly	markedly	RB
cord-006393-jcj9nqfu	50	10	impaired	impair	VBN
cord-006393-jcj9nqfu	50	11	,	,	,
cord-006393-jcj9nqfu	50	12	either	either	CC
cord-006393-jcj9nqfu	50	13	because	because	IN
cord-006393-jcj9nqfu	50	14	the	the	DT
cord-006393-jcj9nqfu	50	15	stem	stem	NN
cord-006393-jcj9nqfu	50	16	cells	cell	NNS
cord-006393-jcj9nqfu	50	17	have	have	VBP
cord-006393-jcj9nqfu	50	18	not	not	RB
cord-006393-jcj9nqfu	50	19	yet	yet	RB
cord-006393-jcj9nqfu	50	20	developed	develop	VBN
cord-006393-jcj9nqfu	50	21	into	into	IN
cord-006393-jcj9nqfu	50	22	the	the	DT
cord-006393-jcj9nqfu	50	23	appropriate	appropriate	JJ
cord-006393-jcj9nqfu	50	24	mature	mature	NN
cord-006393-jcj9nqfu	50	25	T	t	NN
cord-006393-jcj9nqfu	50	26	cells	cell	NNS
cord-006393-jcj9nqfu	50	27	or	or	CC
cord-006393-jcj9nqfu	50	28	because	because	IN
cord-006393-jcj9nqfu	50	29	the	the	DT
cord-006393-jcj9nqfu	50	30	patients	patient	NNS
cord-006393-jcj9nqfu	50	31	are	be	VBP
cord-006393-jcj9nqfu	50	32	receiving	receive	VBG
cord-006393-jcj9nqfu	50	33	immunosuppressive	immunosuppressive	JJ
cord-006393-jcj9nqfu	50	34	agents	agent	NNS
cord-006393-jcj9nqfu	50	35	.	.	.
cord-006393-jcj9nqfu	51	1	The	the	DT
cord-006393-jcj9nqfu	51	2	cytotoxic	cytotoxic	JJ
cord-006393-jcj9nqfu	51	3	effector	effector	NN
cord-006393-jcj9nqfu	51	4	function	function	NN
cord-006393-jcj9nqfu	51	5	is	be	VBZ
cord-006393-jcj9nqfu	51	6	also	also	RB
cord-006393-jcj9nqfu	51	7	impaired	impair	VBN
cord-006393-jcj9nqfu	51	8	in	in	IN
cord-006393-jcj9nqfu	51	9	these	these	DT
cord-006393-jcj9nqfu	51	10	patients	patient	NNS
cord-006393-jcj9nqfu	51	11	.	.	.
cord-006393-jcj9nqfu	52	1	In	in	IN
cord-006393-jcj9nqfu	52	2	addition	addition	NN
cord-006393-jcj9nqfu	52	3	to	to	IN
cord-006393-jcj9nqfu	52	4	these	these	DT
cord-006393-jcj9nqfu	52	5	difficulties	difficulty	NNS
cord-006393-jcj9nqfu	52	6	,	,	,
cord-006393-jcj9nqfu	52	7	the	the	DT
cord-006393-jcj9nqfu	52	8	donor	donor	NN
cord-006393-jcj9nqfu	52	9	immune	immune	NN
cord-006393-jcj9nqfu	52	10	system	system	NN
cord-006393-jcj9nqfu	52	11	must	must	MD
cord-006393-jcj9nqfu	52	12	reorient	reorient	VB
cord-006393-jcj9nqfu	52	13	itself	-PRON-	PRP
cord-006393-jcj9nqfu	52	14	in	in	IN
cord-006393-jcj9nqfu	52	15	a	a	DT
cord-006393-jcj9nqfu	52	16	different	different	JJ
cord-006393-jcj9nqfu	52	17	MHC	MHC	NNP
cord-006393-jcj9nqfu	52	18	-	-	HYPH
cord-006393-jcj9nqfu	52	19	restriction	restriction	NN
cord-006393-jcj9nqfu	52	20	setting	setting	NN
cord-006393-jcj9nqfu	52	21	.	.	.
cord-006393-jcj9nqfu	53	1	Furthermore	furthermore	RB
cord-006393-jcj9nqfu	53	2	,	,	,
cord-006393-jcj9nqfu	53	3	nonspecific	nonspecific	JJ
cord-006393-jcj9nqfu	53	4	suppressor	suppressor	NN
cord-006393-jcj9nqfu	53	5	cells	cell	NNS
cord-006393-jcj9nqfu	53	6	will	will	MD
cord-006393-jcj9nqfu	53	7	appear	appear	VB
cord-006393-jcj9nqfu	53	8	30	30	CD
cord-006393-jcj9nqfu	53	9	to	to	TO
cord-006393-jcj9nqfu	53	10	50	50	CD
cord-006393-jcj9nqfu	53	11	days	day	NNS
cord-006393-jcj9nqfu	53	12	after	after	IN
cord-006393-jcj9nqfu	53	13	transplantation	transplantation	NN
cord-006393-jcj9nqfu	53	14	,	,	,
cord-006393-jcj9nqfu	53	15	resulting	result	VBG
cord-006393-jcj9nqfu	53	16	in	in	IN
cord-006393-jcj9nqfu	53	17	a	a	DT
cord-006393-jcj9nqfu	53	18	global	global	JJ
cord-006393-jcj9nqfu	53	19	impairment	impairment	NN
cord-006393-jcj9nqfu	53	20	of	of	IN
cord-006393-jcj9nqfu	53	21	the	the	DT
cord-006393-jcj9nqfu	53	22	immune	immune	JJ
cord-006393-jcj9nqfu	53	23	defense	defense	NN
cord-006393-jcj9nqfu	53	24	system	system	NN
cord-006393-jcj9nqfu	53	25	.	.	.
cord-006393-jcj9nqfu	54	1	Acute	acute	JJ
cord-006393-jcj9nqfu	54	2	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	54	3	might	may	MD
cord-006393-jcj9nqfu	54	4	be	be	VB
cord-006393-jcj9nqfu	54	5	present	present	JJ
cord-006393-jcj9nqfu	54	6	,	,	,
cord-006393-jcj9nqfu	54	7	markedly	markedly	RB
cord-006393-jcj9nqfu	54	8	worsening	worsen	VBG
cord-006393-jcj9nqfu	54	9	the	the	DT
cord-006393-jcj9nqfu	54	10	already	already	RB
cord-006393-jcj9nqfu	54	11	present	present	JJ
cord-006393-jcj9nqfu	54	12	immune	immune	JJ
cord-006393-jcj9nqfu	54	13	defect	defect	NN
cord-006393-jcj9nqfu	54	14	in	in	IN
cord-006393-jcj9nqfu	54	15	the	the	DT
cord-006393-jcj9nqfu	54	16	second	second	JJ
cord-006393-jcj9nqfu	54	17	phase	phase	NN
cord-006393-jcj9nqfu	54	18	of	of	IN
cord-006393-jcj9nqfu	54	19	transplantation	transplantation	NN
cord-006393-jcj9nqfu	54	20	.	.	.
cord-006393-jcj9nqfu	55	1	An	an	DT
cord-006393-jcj9nqfu	55	2	oversimplified	oversimplified	JJ
cord-006393-jcj9nqfu	55	3	definition	definition	NN
cord-006393-jcj9nqfu	55	4	of	of	IN
cord-006393-jcj9nqfu	55	5	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	55	6	describes	describe	VBZ
cord-006393-jcj9nqfu	55	7	it	-PRON-	PRP
cord-006393-jcj9nqfu	55	8	as	as	IN
cord-006393-jcj9nqfu	55	9	an	an	DT
cord-006393-jcj9nqfu	55	10	immune	immune	JJ
cord-006393-jcj9nqfu	55	11	attack	attack	NN
cord-006393-jcj9nqfu	55	12	by	by	IN
cord-006393-jcj9nqfu	55	13	donor	donor	NN
cord-006393-jcj9nqfu	55	14	T	t	NN
cord-006393-jcj9nqfu	55	15	lymphocytes	lymphocyte	NNS
cord-006393-jcj9nqfu	55	16	on	on	IN
cord-006393-jcj9nqfu	55	17	certain	certain	JJ
cord-006393-jcj9nqfu	55	18	host	host	NN
cord-006393-jcj9nqfu	55	19	target	target	NN
cord-006393-jcj9nqfu	55	20	cells	cell	NNS
cord-006393-jcj9nqfu	55	21	in	in	IN
cord-006393-jcj9nqfu	55	22	the	the	DT
cord-006393-jcj9nqfu	55	23	gastrointestinal	gastrointestinal	JJ
cord-006393-jcj9nqfu	55	24	tract	tract	NN
cord-006393-jcj9nqfu	55	25	,	,	,
cord-006393-jcj9nqfu	55	26	the	the	DT
cord-006393-jcj9nqfu	55	27	liver	liver	NN
cord-006393-jcj9nqfu	55	28	,	,	,
cord-006393-jcj9nqfu	55	29	and	and	CC
cord-006393-jcj9nqfu	55	30	particularly	particularly	RB
cord-006393-jcj9nqfu	55	31	,	,	,
cord-006393-jcj9nqfu	55	32	the	the	DT
cord-006393-jcj9nqfu	55	33	skin	skin	NN
cord-006393-jcj9nqfu	55	34	.	.	.
cord-006393-jcj9nqfu	56	1	The	the	DT
cord-006393-jcj9nqfu	56	2	resultant	resultant	JJ
cord-006393-jcj9nqfu	56	3	cutaneous	cutaneous	JJ
cord-006393-jcj9nqfu	56	4	disease	disease	NN
cord-006393-jcj9nqfu	56	5	is	be	VBZ
cord-006393-jcj9nqfu	56	6	characterized	characterize	VBN
cord-006393-jcj9nqfu	56	7	by	by	IN
cord-006393-jcj9nqfu	56	8	discoloration	discoloration	NN
cord-006393-jcj9nqfu	56	9	and	and	CC
cord-006393-jcj9nqfu	56	10	desquamation	desquamation	NN
cord-006393-jcj9nqfu	56	11	followed	follow	VBN
cord-006393-jcj9nqfu	56	12	by	by	IN
cord-006393-jcj9nqfu	56	13	severe	severe	JJ
cord-006393-jcj9nqfu	56	14	erythema	erythema	NN
cord-006393-jcj9nqfu	56	15	together	together	RB
cord-006393-jcj9nqfu	56	16	with	with	IN
cord-006393-jcj9nqfu	56	17	epidermal	epidermal	JJ
cord-006393-jcj9nqfu	56	18	lysis	lysis	NN
cord-006393-jcj9nqfu	56	19	in	in	IN
cord-006393-jcj9nqfu	56	20	which	which	WDT
cord-006393-jcj9nqfu	56	21	the	the	DT
cord-006393-jcj9nqfu	56	22	entire	entire	JJ
cord-006393-jcj9nqfu	56	23	integument	integument	NN
cord-006393-jcj9nqfu	56	24	is	be	VBZ
cord-006393-jcj9nqfu	56	25	affected	affect	VBN
cord-006393-jcj9nqfu	56	26	.	.	.
cord-006393-jcj9nqfu	57	1	A	a	DT
cord-006393-jcj9nqfu	57	2	number	number	NN
cord-006393-jcj9nqfu	57	3	of	of	IN
cord-006393-jcj9nqfu	57	4	infectious	infectious	JJ
cord-006393-jcj9nqfu	57	5	complications	complication	NNS
cord-006393-jcj9nqfu	57	6	are	be	VBP
cord-006393-jcj9nqfu	57	7	associated	associate	VBN
cord-006393-jcj9nqfu	57	8	with	with	IN
cord-006393-jcj9nqfu	57	9	acute	acute	JJ
cord-006393-jcj9nqfu	57	10	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	57	11	,	,	,
cord-006393-jcj9nqfu	57	12	especially	especially	RB
cord-006393-jcj9nqfu	57	13	those	those	DT
cord-006393-jcj9nqfu	57	14	due	due	JJ
cord-006393-jcj9nqfu	57	15	to	to	IN
cord-006393-jcj9nqfu	57	16	resistant	resistant	JJ
cord-006393-jcj9nqfu	57	17	gram	gram	NN
cord-006393-jcj9nqfu	57	18	-	-	HYPH
cord-006393-jcj9nqfu	57	19	negative	negative	JJ
cord-006393-jcj9nqfu	57	20	bacteria	bacteria	NNS
cord-006393-jcj9nqfu	57	21	,	,	,
cord-006393-jcj9nqfu	57	22	but	but	CC
cord-006393-jcj9nqfu	57	23	also	also	RB
cord-006393-jcj9nqfu	57	24	Candida	Candida	NNP
cord-006393-jcj9nqfu	57	25	infections	infection	NNS
cord-006393-jcj9nqfu	57	26	and	and	CC
cord-006393-jcj9nqfu	57	27	gram	gram	NN
cord-006393-jcj9nqfu	57	28	-	-	HYPH
cord-006393-jcj9nqfu	57	29	positive	positive	JJ
cord-006393-jcj9nqfu	57	30	infections	infection	NNS
cord-006393-jcj9nqfu	57	31	caused	cause	VBN
cord-006393-jcj9nqfu	57	32	by	by	IN
cord-006393-jcj9nqfu	57	33	Corynebacteria	Corynebacteria	NNP
cord-006393-jcj9nqfu	57	34	.	.	.
cord-006393-jcj9nqfu	58	1	Interstitial	interstitial	JJ
cord-006393-jcj9nqfu	58	2	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	58	3	,	,	,
cord-006393-jcj9nqfu	58	4	a	a	DT
cord-006393-jcj9nqfu	58	5	very	very	RB
cord-006393-jcj9nqfu	58	6	important	important	JJ
cord-006393-jcj9nqfu	58	7	infection	infection	NN
cord-006393-jcj9nqfu	58	8	which	which	WDT
cord-006393-jcj9nqfu	58	9	is	be	VBZ
cord-006393-jcj9nqfu	58	10	often	often	RB
cord-006393-jcj9nqfu	58	11	associated	associate	VBN
cord-006393-jcj9nqfu	58	12	with	with	IN
cord-006393-jcj9nqfu	58	13	acute	acute	JJ
cord-006393-jcj9nqfu	58	14	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	58	15	,	,	,
cord-006393-jcj9nqfu	58	16	is	be	VBZ
cord-006393-jcj9nqfu	58	17	discussed	discuss	VBN
cord-006393-jcj9nqfu	58	18	shortly	shortly	RB
cord-006393-jcj9nqfu	58	19	.	.	.
cord-006393-jcj9nqfu	59	1	There	there	EX
cord-006393-jcj9nqfu	59	2	is	be	VBZ
cord-006393-jcj9nqfu	59	3	an	an	DT
cord-006393-jcj9nqfu	59	4	intricate	intricate	JJ
cord-006393-jcj9nqfu	59	5	relationship	relationship	NN
cord-006393-jcj9nqfu	59	6	between	between	IN
cord-006393-jcj9nqfu	59	7	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	59	8	and	and	CC
cord-006393-jcj9nqfu	59	9	infections	infection	NNS
cord-006393-jcj9nqfu	59	10	,	,	,
cord-006393-jcj9nqfu	59	11	Germ	germ	NN
cord-006393-jcj9nqfu	59	12	-	-	HYPH
cord-006393-jcj9nqfu	59	13	free	free	JJ
cord-006393-jcj9nqfu	59	14	rodents	rodent	NNS
cord-006393-jcj9nqfu	59	15	which	which	WDT
cord-006393-jcj9nqfu	59	16	are	be	VBP
cord-006393-jcj9nqfu	59	17	transplanted	transplant	VBN
cord-006393-jcj9nqfu	59	18	in	in	IN
cord-006393-jcj9nqfu	59	19	a	a	DT
cord-006393-jcj9nqfu	59	20	germ	germ	NN
cord-006393-jcj9nqfu	59	21	-	-	HYPH
cord-006393-jcj9nqfu	59	22	free	free	JJ
cord-006393-jcj9nqfu	59	23	environment	environment	NN
cord-006393-jcj9nqfu	59	24	will	will	MD
cord-006393-jcj9nqfu	59	25	not	not	RB
cord-006393-jcj9nqfu	59	26	develop	develop	VB
cord-006393-jcj9nqfu	59	27	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	59	28	even	even	RB
cord-006393-jcj9nqfu	59	29	if	if	IN
cord-006393-jcj9nqfu	59	30	they	-PRON-	PRP
cord-006393-jcj9nqfu	59	31	receive	receive	VBP
cord-006393-jcj9nqfu	59	32	a	a	DT
cord-006393-jcj9nqfu	59	33	mismatched	mismatched	JJ
cord-006393-jcj9nqfu	59	34	transplant	transplant	NN
cord-006393-jcj9nqfu	59	35	.	.	.
cord-006393-jcj9nqfu	60	1	Conversely	conversely	RB
cord-006393-jcj9nqfu	60	2	,	,	,
cord-006393-jcj9nqfu	60	3	intentional	intentional	JJ
cord-006393-jcj9nqfu	60	4	contamination	contamination	NN
cord-006393-jcj9nqfu	60	5	of	of	IN
cord-006393-jcj9nqfu	60	6	these	these	DT
cord-006393-jcj9nqfu	60	7	chimeric	chimeric	JJ
cord-006393-jcj9nqfu	60	8	animals	animal	NNS
cord-006393-jcj9nqfu	60	9	will	will	MD
cord-006393-jcj9nqfu	60	10	cause	cause	VB
cord-006393-jcj9nqfu	60	11	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	60	12	(	(	-LRB-
cord-006393-jcj9nqfu	60	13	5	5	CD
cord-006393-jcj9nqfu	60	14	)	)	-RRB-
cord-006393-jcj9nqfu	60	15	.	.	.
cord-006393-jcj9nqfu	61	1	Patients	patient	NNS
cord-006393-jcj9nqfu	61	2	in	in	IN
cord-006393-jcj9nqfu	61	3	germ	germ	NN
cord-006393-jcj9nqfu	61	4	-	-	HYPH
cord-006393-jcj9nqfu	61	5	free	free	JJ
cord-006393-jcj9nqfu	61	6	environments	environment	NNS
cord-006393-jcj9nqfu	61	7	have	have	VBP
cord-006393-jcj9nqfu	61	8	a	a	DT
cord-006393-jcj9nqfu	61	9	reduced	reduce	VBN
cord-006393-jcj9nqfu	61	10	incidence	incidence	NN
cord-006393-jcj9nqfu	61	11	of	of	IN
cord-006393-jcj9nqfu	61	12	severe	severe	JJ
cord-006393-jcj9nqfu	61	13	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	61	14	.	.	.
cord-006393-jcj9nqfu	62	1	Furthermore	furthermore	RB
cord-006393-jcj9nqfu	62	2	,	,	,
cord-006393-jcj9nqfu	62	3	cutaneous	cutaneous	JJ
cord-006393-jcj9nqfu	62	4	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	62	5	will	will	MD
cord-006393-jcj9nqfu	62	6	develop	develop	VB
cord-006393-jcj9nqfu	62	7	in	in	IN
cord-006393-jcj9nqfu	62	8	areas	area	NNS
cord-006393-jcj9nqfu	62	9	which	which	WDT
cord-006393-jcj9nqfu	62	10	have	have	VBP
cord-006393-jcj9nqfu	62	11	tissue	tissue	NN
cord-006393-jcj9nqfu	62	12	damage	damage	NN
cord-006393-jcj9nqfu	62	13	,	,	,
cord-006393-jcj9nqfu	62	14	especially	especially	RB
cord-006393-jcj9nqfu	62	15	if	if	IN
cord-006393-jcj9nqfu	62	16	this	this	DT
cord-006393-jcj9nqfu	62	17	damage	damage	NN
cord-006393-jcj9nqfu	62	18	is	be	VBZ
cord-006393-jcj9nqfu	62	19	caused	cause	VBN
cord-006393-jcj9nqfu	62	20	by	by	IN
cord-006393-jcj9nqfu	62	21	a	a	DT
cord-006393-jcj9nqfu	62	22	virus	virus	NN
cord-006393-jcj9nqfu	62	23	.	.	.
cord-006393-jcj9nqfu	63	1	Finally	finally	RB
cord-006393-jcj9nqfu	63	2	,	,	,
cord-006393-jcj9nqfu	63	3	viral	viral	JJ
cord-006393-jcj9nqfu	63	4	infections	infection	NNS
cord-006393-jcj9nqfu	63	5	are	be	VBP
cord-006393-jcj9nqfu	63	6	known	know	VBN
cord-006393-jcj9nqfu	63	7	to	to	TO
cord-006393-jcj9nqfu	63	8	trigger	trigger	VB
cord-006393-jcj9nqfu	63	9	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	63	10	in	in	IN
cord-006393-jcj9nqfu	63	11	rats	rat	NNS
cord-006393-jcj9nqfu	63	12	(	(	-LRB-
cord-006393-jcj9nqfu	63	13	6	6	CD
cord-006393-jcj9nqfu	63	14	)	)	-RRB-
cord-006393-jcj9nqfu	63	15	.	.	.
cord-006393-jcj9nqfu	64	1	Could	Could	MD
cord-006393-jcj9nqfu	64	2	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	64	3	have	have	VB
cord-006393-jcj9nqfu	64	4	a	a	DT
cord-006393-jcj9nqfu	64	5	role	role	NN
cord-006393-jcj9nqfu	64	6	in	in	IN
cord-006393-jcj9nqfu	64	7	preventing	prevent	VBG
cord-006393-jcj9nqfu	64	8	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	64	9	?	?	.
cord-006393-jcj9nqfu	65	1	Animal	animal	NN
cord-006393-jcj9nqfu	65	2	studies	study	NNS
cord-006393-jcj9nqfu	65	3	,	,	,
cord-006393-jcj9nqfu	65	4	including	include	VBG
cord-006393-jcj9nqfu	65	5	some	some	DT
cord-006393-jcj9nqfu	65	6	from	from	IN
cord-006393-jcj9nqfu	65	7	our	-PRON-	PRP$
cord-006393-jcj9nqfu	65	8	laboratory	laboratory	NN
cord-006393-jcj9nqfu	65	9	,	,	,
cord-006393-jcj9nqfu	65	10	indicate	indicate	VBP
cord-006393-jcj9nqfu	65	11	that	that	IN
cord-006393-jcj9nqfu	65	12	when	when	WRB
cord-006393-jcj9nqfu	65	13	antibody	antibody	NN
cord-006393-jcj9nqfu	65	14	against	against	IN
cord-006393-jcj9nqfu	65	15	Escherichia	Escherichia	NNP
cord-006393-jcj9nqfu	65	16	coli	coli	NNS
cord-006393-jcj9nqfu	65	17	is	be	VBZ
cord-006393-jcj9nqfu	65	18	given	give	VBN
cord-006393-jcj9nqfu	65	19	systemically	systemically	RB
cord-006393-jcj9nqfu	65	20	to	to	IN
cord-006393-jcj9nqfu	65	21	rats	rat	NNS
cord-006393-jcj9nqfu	65	22	,	,	,
cord-006393-jcj9nqfu	65	23	it	-PRON-	PRP
cord-006393-jcj9nqfu	65	24	will	will	MD
cord-006393-jcj9nqfu	65	25	reduce	reduce	VB
cord-006393-jcj9nqfu	65	26	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	65	27	in	in	IN
cord-006393-jcj9nqfu	65	28	matched	match	VBN
cord-006393-jcj9nqfu	65	29	bone	bone	NN
cord-006393-jcj9nqfu	65	30	marrow	marrow	NN
cord-006393-jcj9nqfu	65	31	transplants	transplant	NNS
cord-006393-jcj9nqfu	65	32	.	.	.
cord-006393-jcj9nqfu	66	1	This	this	DT
cord-006393-jcj9nqfu	66	2	suggests	suggest	VBZ
cord-006393-jcj9nqfu	66	3	that	that	IN
cord-006393-jcj9nqfu	66	4	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	66	5	might	may	MD
cord-006393-jcj9nqfu	66	6	have	have	VB
cord-006393-jcj9nqfu	66	7	some	some	DT
cord-006393-jcj9nqfu	66	8	influence	influence	NN
cord-006393-jcj9nqfu	66	9	on	on	IN
cord-006393-jcj9nqfu	66	10	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	66	11	.	.	.
cord-006393-jcj9nqfu	67	1	It	-PRON-	PRP
cord-006393-jcj9nqfu	67	2	is	be	VBZ
cord-006393-jcj9nqfu	67	3	possible	possible	JJ
cord-006393-jcj9nqfu	67	4	that	that	IN
cord-006393-jcj9nqfu	67	5	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	67	6	could	could	MD
cord-006393-jcj9nqfu	67	7	act	act	VB
cord-006393-jcj9nqfu	67	8	as	as	IN
cord-006393-jcj9nqfu	67	9	an	an	DT
cord-006393-jcj9nqfu	67	10	immune	immune	JJ
cord-006393-jcj9nqfu	67	11	modulator	modulator	NN
cord-006393-jcj9nqfu	67	12	.	.	.
cord-006393-jcj9nqfu	68	1	An	an	DT
cord-006393-jcj9nqfu	68	2	Fcdependent	Fcdependent	NNP
cord-006393-jcj9nqfu	68	3	blockade	blockade	NN
cord-006393-jcj9nqfu	68	4	of	of	IN
cord-006393-jcj9nqfu	68	5	reticuloendothelial	reticuloendothelial	JJ
cord-006393-jcj9nqfu	68	6	structures	structure	NNS
cord-006393-jcj9nqfu	68	7	by	by	IN
cord-006393-jcj9nqfu	68	8	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	68	9	has	have	VBZ
cord-006393-jcj9nqfu	68	10	been	be	VBN
cord-006393-jcj9nqfu	68	11	described	describe	VBN
cord-006393-jcj9nqfu	68	12	and	and	CC
cord-006393-jcj9nqfu	68	13	studies	study	NNS
cord-006393-jcj9nqfu	68	14	in	in	IN
cord-006393-jcj9nqfu	68	15	animal	animal	NN
cord-006393-jcj9nqfu	68	16	models	model	NNS
cord-006393-jcj9nqfu	68	17	have	have	VBP
cord-006393-jcj9nqfu	68	18	shown	show	VBN
cord-006393-jcj9nqfu	68	19	that	that	IN
cord-006393-jcj9nqfu	68	20	immune	immune	JJ
cord-006393-jcj9nqfu	68	21	globulins	globulin	NNS
cord-006393-jcj9nqfu	68	22	can	can	MD
cord-006393-jcj9nqfu	68	23	induce	induce	VB
cord-006393-jcj9nqfu	68	24	antiidiotypic	antiidiotypic	JJ
cord-006393-jcj9nqfu	68	25	regulation	regulation	NN
cord-006393-jcj9nqfu	68	26	.	.	.
cord-006393-jcj9nqfu	69	1	Also	also	RB
cord-006393-jcj9nqfu	69	2	on	on	IN
cord-006393-jcj9nqfu	69	3	the	the	DT
cord-006393-jcj9nqfu	69	4	basis	basis	NN
cord-006393-jcj9nqfu	69	5	of	of	IN
cord-006393-jcj9nqfu	69	6	animal	animal	NN
cord-006393-jcj9nqfu	69	7	models	model	NNS
cord-006393-jcj9nqfu	69	8	,	,	,
cord-006393-jcj9nqfu	69	9	we	-PRON-	PRP
cord-006393-jcj9nqfu	69	10	know	know	VBP
cord-006393-jcj9nqfu	69	11	that	that	IN
cord-006393-jcj9nqfu	69	12	suppressorcell	suppressorcell	JJ
cord-006393-jcj9nqfu	69	13	function	function	NN
cord-006393-jcj9nqfu	69	14	can	can	MD
cord-006393-jcj9nqfu	69	15	be	be	VB
cord-006393-jcj9nqfu	69	16	restored	restore	VBN
cord-006393-jcj9nqfu	69	17	with	with	IN
cord-006393-jcj9nqfu	69	18	the	the	DT
cord-006393-jcj9nqfu	69	19	use	use	NN
cord-006393-jcj9nqfu	69	20	of	of	IN
cord-006393-jcj9nqfu	69	21	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	69	22	.	.	.
cord-006393-jcj9nqfu	70	1	Since	since	IN
cord-006393-jcj9nqfu	70	2	specific	specific	JJ
cord-006393-jcj9nqfu	70	3	suppressor	suppressor	NN
cord-006393-jcj9nqfu	70	4	cells	cell	NNS
cord-006393-jcj9nqfu	70	5	are	be	VBP
cord-006393-jcj9nqfu	70	6	important	important	JJ
cord-006393-jcj9nqfu	70	7	in	in	IN
cord-006393-jcj9nqfu	70	8	counteracting	counteract	VBG
cord-006393-jcj9nqfu	70	9	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	70	10	,	,	,
cord-006393-jcj9nqfu	70	11	this	this	DT
cord-006393-jcj9nqfu	70	12	is	be	VBZ
cord-006393-jcj9nqfu	70	13	another	another	DT
cord-006393-jcj9nqfu	70	14	instance	instance	NN
cord-006393-jcj9nqfu	70	15	in	in	IN
cord-006393-jcj9nqfu	70	16	which	which	WDT
cord-006393-jcj9nqfu	70	17	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	70	18	may	may	MD
cord-006393-jcj9nqfu	70	19	play	play	VB
cord-006393-jcj9nqfu	70	20	a	a	DT
cord-006393-jcj9nqfu	70	21	role	role	NN
cord-006393-jcj9nqfu	70	22	,	,	,
cord-006393-jcj9nqfu	70	23	at	at	IN
cord-006393-jcj9nqfu	70	24	least	least	JJS
cord-006393-jcj9nqfu	70	25	in	in	IN
cord-006393-jcj9nqfu	70	26	theory	theory	NN
cord-006393-jcj9nqfu	70	27	.	.	.
cord-006393-jcj9nqfu	71	1	The	the	DT
cord-006393-jcj9nqfu	71	2	most	most	RBS
cord-006393-jcj9nqfu	71	3	important	important	JJ
cord-006393-jcj9nqfu	71	4	effect	effect	NN
cord-006393-jcj9nqfu	71	5	of	of	IN
cord-006393-jcj9nqfu	71	6	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	71	7	,	,	,
cord-006393-jcj9nqfu	71	8	however	however	RB
cord-006393-jcj9nqfu	71	9	,	,	,
cord-006393-jcj9nqfu	71	10	might	may	MD
cord-006393-jcj9nqfu	71	11	be	be	VB
cord-006393-jcj9nqfu	71	12	an	an	DT
cord-006393-jcj9nqfu	71	13	indirect	indirect	JJ
cord-006393-jcj9nqfu	71	14	one	one	NN
cord-006393-jcj9nqfu	71	15	by	by	IN
cord-006393-jcj9nqfu	71	16	which	which	WDT
cord-006393-jcj9nqfu	71	17	prevention	prevention	NN
cord-006393-jcj9nqfu	71	18	of	of	IN
cord-006393-jcj9nqfu	71	19	infections	infection	NNS
cord-006393-jcj9nqfu	71	20	will	will	MD
cord-006393-jcj9nqfu	71	21	,	,	,
cord-006393-jcj9nqfu	71	22	in	in	IN
cord-006393-jcj9nqfu	71	23	turn	turn	NN
cord-006393-jcj9nqfu	71	24	,	,	,
cord-006393-jcj9nqfu	71	25	avert	avert	VB
cord-006393-jcj9nqfu	71	26	the	the	DT
cord-006393-jcj9nqfu	71	27	trigger	trigger	NN
cord-006393-jcj9nqfu	71	28	for	for	IN
cord-006393-jcj9nqfu	71	29	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	71	30	.	.	.
cord-006393-jcj9nqfu	72	1	Although	although	IN
cord-006393-jcj9nqfu	72	2	at	at	IN
cord-006393-jcj9nqfu	72	3	the	the	DT
cord-006393-jcj9nqfu	72	4	present	present	JJ
cord-006393-jcj9nqfu	72	5	time	time	NN
cord-006393-jcj9nqfu	72	6	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	72	7	is	be	VBZ
cord-006393-jcj9nqfu	72	8	no	no	RB
cord-006393-jcj9nqfu	72	9	longer	long	RBR
cord-006393-jcj9nqfu	72	10	a	a	DT
cord-006393-jcj9nqfu	72	11	major	major	JJ
cord-006393-jcj9nqfu	72	12	problem	problem	NN
cord-006393-jcj9nqfu	72	13	in	in	IN
cord-006393-jcj9nqfu	72	14	most	most	JJS
cord-006393-jcj9nqfu	72	15	transplant	transplant	NN
cord-006393-jcj9nqfu	72	16	programs	program	NNS
cord-006393-jcj9nqfu	72	17	,	,	,
cord-006393-jcj9nqfu	72	18	GVHDassociated	gvhdassociate	VBD
cord-006393-jcj9nqfu	72	19	viral	viral	JJ
cord-006393-jcj9nqfu	72	20	infections	infection	NNS
cord-006393-jcj9nqfu	72	21	are	be	VBP
cord-006393-jcj9nqfu	72	22	still	still	RB
cord-006393-jcj9nqfu	72	23	of	of	IN
cord-006393-jcj9nqfu	72	24	great	great	JJ
cord-006393-jcj9nqfu	72	25	importance	importance	NN
cord-006393-jcj9nqfu	72	26	.	.	.
cord-006393-jcj9nqfu	73	1	The	the	DT
cord-006393-jcj9nqfu	73	2	two	two	CD
cord-006393-jcj9nqfu	73	3	major	major	JJ
cord-006393-jcj9nqfu	73	4	viral	viral	JJ
cord-006393-jcj9nqfu	73	5	infections	infection	NNS
cord-006393-jcj9nqfu	73	6	in	in	IN
cord-006393-jcj9nqfu	73	7	phase	phase	NN
cord-006393-jcj9nqfu	73	8	1I	1i	CD
cord-006393-jcj9nqfu	73	9	express	express	VBP
cord-006393-jcj9nqfu	73	10	themselves	-PRON-	PRP
cord-006393-jcj9nqfu	73	11	either	either	CC
cord-006393-jcj9nqfu	73	12	as	as	IN
cord-006393-jcj9nqfu	73	13	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	73	14	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	73	15	or	or	CC
cord-006393-jcj9nqfu	73	16	as	as	IN
cord-006393-jcj9nqfu	73	17	a	a	DT
cord-006393-jcj9nqfu	73	18	hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	73	19	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	73	20	not	not	RB
cord-006393-jcj9nqfu	73	21	unlike	unlike	IN
cord-006393-jcj9nqfu	73	22	the	the	DT
cord-006393-jcj9nqfu	73	23	necrotizing	necrotize	VBG
cord-006393-jcj9nqfu	73	24	enterocolitis	enterocolitis	NN
cord-006393-jcj9nqfu	73	25	in	in	IN
cord-006393-jcj9nqfu	73	26	the	the	DT
cord-006393-jcj9nqfu	73	27	pediatric	pediatric	JJ
cord-006393-jcj9nqfu	73	28	population	population	NN
cord-006393-jcj9nqfu	73	29	which	which	WDT
cord-006393-jcj9nqfu	73	30	is	be	VBZ
cord-006393-jcj9nqfu	73	31	described	describe	VBN
cord-006393-jcj9nqfu	73	32	elsewhere	elsewhere	RB
cord-006393-jcj9nqfu	73	33	in	in	IN
cord-006393-jcj9nqfu	73	34	this	this	DT
cord-006393-jcj9nqfu	73	35	issue	issue	NN
cord-006393-jcj9nqfu	73	36	.	.	.
cord-006393-jcj9nqfu	74	1	The	the	DT
cord-006393-jcj9nqfu	74	2	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	74	3	infiltrate	infiltrate	NN
cord-006393-jcj9nqfu	74	4	of	of	IN
cord-006393-jcj9nqfu	74	5	the	the	DT
cord-006393-jcj9nqfu	74	6	early	early	JJ
cord-006393-jcj9nqfu	74	7	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	74	8	quickly	quickly	RB
cord-006393-jcj9nqfu	74	9	spreads	spread	VBZ
cord-006393-jcj9nqfu	74	10	over	over	IN
cord-006393-jcj9nqfu	74	11	both	both	DT
cord-006393-jcj9nqfu	74	12	lungs	lung	NNS
cord-006393-jcj9nqfu	74	13	,	,	,
cord-006393-jcj9nqfu	74	14	often	often	RB
cord-006393-jcj9nqfu	74	15	resulting	result	VBG
cord-006393-jcj9nqfu	74	16	in	in	IN
cord-006393-jcj9nqfu	74	17	a	a	DT
cord-006393-jcj9nqfu	74	18	complete	complete	JJ
cord-006393-jcj9nqfu	74	19	whitening	whitening	NN
cord-006393-jcj9nqfu	75	1	~f	~f	NNP
cord-006393-jcj9nqfu	75	2	the	the	DT
cord-006393-jcj9nqfu	75	3	lungs	lung	NNS
cord-006393-jcj9nqfu	75	4	which	which	WDT
cord-006393-jcj9nqfu	75	5	is	be	VBZ
cord-006393-jcj9nqfu	75	6	accompanied	accompany	VBN
cord-006393-jcj9nqfu	75	7	by	by	IN
cord-006393-jcj9nqfu	75	8	severe	severe	JJ
cord-006393-jcj9nqfu	75	9	adult	adult	NN
cord-006393-jcj9nqfu	75	10	respiratory	respiratory	JJ
cord-006393-jcj9nqfu	75	11	disease	disease	NN
cord-006393-jcj9nqfu	75	12	syndrome	syndrome	NN
cord-006393-jcj9nqfu	75	13	(	(	-LRB-
cord-006393-jcj9nqfu	75	14	ARDS	ARDS	NNP
cord-006393-jcj9nqfu	75	15	)	)	-RRB-
cord-006393-jcj9nqfu	75	16	.	.	.
cord-006393-jcj9nqfu	76	1	In	in	IN
cord-006393-jcj9nqfu	76	2	at	at	RB
cord-006393-jcj9nqfu	76	3	least	least	JJS
cord-006393-jcj9nqfu	76	4	half	half	PDT
cord-006393-jcj9nqfu	76	5	the	the	DT
cord-006393-jcj9nqfu	76	6	cases	case	NNS
cord-006393-jcj9nqfu	76	7	,	,	,
cord-006393-jcj9nqfu	76	8	cytomegalovirus	cytomegalovirus	NNP
cord-006393-jcj9nqfu	76	9	(	(	-LRB-
cord-006393-jcj9nqfu	76	10	CMV	CMV	NNP
cord-006393-jcj9nqfu	76	11	)	)	-RRB-
cord-006393-jcj9nqfu	76	12	is	be	VBZ
cord-006393-jcj9nqfu	76	13	associated	associate	VBN
cord-006393-jcj9nqfu	76	14	with	with	IN
cord-006393-jcj9nqfu	76	15	ARDS	ARDS	NNP
cord-006393-jcj9nqfu	76	16	.	.	.
cord-006393-jcj9nqfu	77	1	The	the	DT
cord-006393-jcj9nqfu	77	2	incidence	incidence	NN
cord-006393-jcj9nqfu	77	3	of	of	IN
cord-006393-jcj9nqfu	77	4	this	this	DT
cord-006393-jcj9nqfu	77	5	disease	disease	NN
cord-006393-jcj9nqfu	77	6	varies	vary	VBZ
cord-006393-jcj9nqfu	77	7	between	between	IN
cord-006393-jcj9nqfu	77	8	15	15	CD
cord-006393-jcj9nqfu	77	9	and	and	CC
cord-006393-jcj9nqfu	77	10	40	40	CD
cord-006393-jcj9nqfu	77	11	%	%	NN
cord-006393-jcj9nqfu	77	12	,	,	,
cord-006393-jcj9nqfu	77	13	with	with	IN
cord-006393-jcj9nqfu	77	14	CMV	CMV	NNP
cord-006393-jcj9nqfu	77	15	being	be	VBG
cord-006393-jcj9nqfu	77	16	responsible	responsible	JJ
cord-006393-jcj9nqfu	77	17	for	for	IN
cord-006393-jcj9nqfu	77	18	about	about	IN
cord-006393-jcj9nqfu	77	19	half	half	NN
cord-006393-jcj9nqfu	77	20	of	of	IN
cord-006393-jcj9nqfu	77	21	the	the	DT
cord-006393-jcj9nqfu	77	22	cases	case	NNS
cord-006393-jcj9nqfu	77	23	.	.	.
cord-006393-jcj9nqfu	78	1	When	when	WRB
cord-006393-jcj9nqfu	78	2	CMV	CMV	NNP
cord-006393-jcj9nqfu	78	3	is	be	VBZ
cord-006393-jcj9nqfu	78	4	the	the	DT
cord-006393-jcj9nqfu	78	5	agent	agent	NN
cord-006393-jcj9nqfu	78	6	,	,	,
cord-006393-jcj9nqfu	78	7	mortality	mortality	NN
cord-006393-jcj9nqfu	78	8	can	can	MD
cord-006393-jcj9nqfu	78	9	range	range	VB
cord-006393-jcj9nqfu	78	10	from	from	IN
cord-006393-jcj9nqfu	78	11	85	85	CD
cord-006393-jcj9nqfu	78	12	to	to	IN
cord-006393-jcj9nqfu	78	13	as	as	RB
cord-006393-jcj9nqfu	78	14	much	much	JJ
cord-006393-jcj9nqfu	78	15	as	as	IN
cord-006393-jcj9nqfu	78	16	100	100	CD
cord-006393-jcj9nqfu	78	17	%	%	NN
cord-006393-jcj9nqfu	78	18	.	.	.
cord-006393-jcj9nqfu	79	1	There	there	EX
cord-006393-jcj9nqfu	79	2	are	be	VBP
cord-006393-jcj9nqfu	79	3	several	several	JJ
cord-006393-jcj9nqfu	79	4	risk	risk	NN
cord-006393-jcj9nqfu	79	5	factors	factor	NNS
cord-006393-jcj9nqfu	79	6	for	for	IN
cord-006393-jcj9nqfu	79	7	the	the	DT
cord-006393-jcj9nqfu	79	8	development	development	NN
cord-006393-jcj9nqfu	79	9	of	of	IN
cord-006393-jcj9nqfu	79	10	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	79	11	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	79	12	such	such	JJ
cord-006393-jcj9nqfu	79	13	as	as	IN
cord-006393-jcj9nqfu	79	14	TBI	TBI	NNP
cord-006393-jcj9nqfu	79	15	(	(	-LRB-
cord-006393-jcj9nqfu	79	16	if	if	IN
cord-006393-jcj9nqfu	79	17	the	the	DT
cord-006393-jcj9nqfu	79	18	lung	lung	NN
cord-006393-jcj9nqfu	79	19	dose	dose	NN
cord-006393-jcj9nqfu	79	20	exceeds	exceed	VBZ
cord-006393-jcj9nqfu	79	21	600	600	CD
cord-006393-jcj9nqfu	79	22	rads	rad	NNS
cord-006393-jcj9nqfu	79	23	)	)	-RRB-
cord-006393-jcj9nqfu	79	24	,	,	,
cord-006393-jcj9nqfu	79	25	acute	acute	JJ
cord-006393-jcj9nqfu	79	26	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	79	27	,	,	,
cord-006393-jcj9nqfu	79	28	increased	increase	VBN
cord-006393-jcj9nqfu	79	29	age	age	NN
cord-006393-jcj9nqfu	79	30	of	of	IN
cord-006393-jcj9nqfu	79	31	the	the	DT
cord-006393-jcj9nqfu	79	32	patient	patient	NN
cord-006393-jcj9nqfu	79	33	,	,	,
cord-006393-jcj9nqfu	79	34	CMV	CMV	NNP
cord-006393-jcj9nqfu	79	35	seropositivity	seropositivity	NN
cord-006393-jcj9nqfu	79	36	of	of	IN
cord-006393-jcj9nqfu	79	37	the	the	DT
cord-006393-jcj9nqfu	79	38	patient	patient	NN
cord-006393-jcj9nqfu	79	39	before	before	IN
cord-006393-jcj9nqfu	79	40	the	the	DT
cord-006393-jcj9nqfu	79	41	transplant	transplant	NN
cord-006393-jcj9nqfu	79	42	,	,	,
cord-006393-jcj9nqfu	79	43	transfusion	transfusion	NN
cord-006393-jcj9nqfu	79	44	of	of	IN
cord-006393-jcj9nqfu	79	45	blood	blood	NN
cord-006393-jcj9nqfu	79	46	products	product	NNS
cord-006393-jcj9nqfu	79	47	from	from	IN
cord-006393-jcj9nqfu	79	48	CMV	CMV	NNP
cord-006393-jcj9nqfu	79	49	-	-	HYPH
cord-006393-jcj9nqfu	79	50	positive	positive	JJ
cord-006393-jcj9nqfu	79	51	donors	donor	NNS
cord-006393-jcj9nqfu	79	52	,	,	,
cord-006393-jcj9nqfu	79	53	inability	inability	NN
cord-006393-jcj9nqfu	79	54	to	to	TO
cord-006393-jcj9nqfu	79	55	generate	generate	VB
cord-006393-jcj9nqfu	79	56	an	an	DT
cord-006393-jcj9nqfu	79	57	antiviral	antiviral	JJ
cord-006393-jcj9nqfu	79	58	cytotoxicity	cytotoxicity	NN
cord-006393-jcj9nqfu	79	59	(	(	-LRB-
cord-006393-jcj9nqfu	79	60	which	which	WDT
cord-006393-jcj9nqfu	79	61	is	be	VBZ
cord-006393-jcj9nqfu	79	62	very	very	RB
cord-006393-jcj9nqfu	79	63	common	common	JJ
cord-006393-jcj9nqfu	79	64	in	in	IN
cord-006393-jcj9nqfu	79	65	the	the	DT
cord-006393-jcj9nqfu	79	66	postengraftment	postengraftment	NN
cord-006393-jcj9nqfu	79	67	phase	phase	NN
cord-006393-jcj9nqfu	79	68	)	)	-RRB-
cord-006393-jcj9nqfu	79	69	,	,	,
cord-006393-jcj9nqfu	79	70	and	and	CC
cord-006393-jcj9nqfu	79	71	inability	inability	NN
cord-006393-jcj9nqfu	79	72	to	to	TO
cord-006393-jcj9nqfu	79	73	mount	mount	VB
cord-006393-jcj9nqfu	79	74	a	a	DT
cord-006393-jcj9nqfu	79	75	humoral	humoral	JJ
cord-006393-jcj9nqfu	79	76	antibody	antibody	NN
cord-006393-jcj9nqfu	79	77	response	response	NN
cord-006393-jcj9nqfu	79	78	.	.	.
cord-006393-jcj9nqfu	80	1	The	the	DT
cord-006393-jcj9nqfu	80	2	latter	latter	JJ
cord-006393-jcj9nqfu	80	3	defect	defect	NN
cord-006393-jcj9nqfu	80	4	is	be	VBZ
cord-006393-jcj9nqfu	80	5	quite	quite	RB
cord-006393-jcj9nqfu	80	6	important	important	JJ
cord-006393-jcj9nqfu	80	7	and	and	CC
cord-006393-jcj9nqfu	80	8	suggests	suggest	VBZ
cord-006393-jcj9nqfu	80	9	a	a	DT
cord-006393-jcj9nqfu	80	10	potential	potential	JJ
cord-006393-jcj9nqfu	80	11	rote	rote	NN
cord-006393-jcj9nqfu	80	12	for	for	IN
cord-006393-jcj9nqfu	80	13	passive	passive	JJ
cord-006393-jcj9nqfu	80	14	therapy	therapy	NN
cord-006393-jcj9nqfu	80	15	with	with	IN
cord-006393-jcj9nqfu	80	16	antibodies	antibody	NNS
cord-006393-jcj9nqfu	80	17	.	.	.
cord-006393-jcj9nqfu	81	1	Historically	historically	RB
cord-006393-jcj9nqfu	81	2	bone	bone	NN
cord-006393-jcj9nqfu	81	3	marrow	marrow	NN
cord-006393-jcj9nqfu	81	4	transplant	transplant	NN
cord-006393-jcj9nqfu	81	5	recipients	recipient	NNS
cord-006393-jcj9nqfu	81	6	who	who	WP
cord-006393-jcj9nqfu	81	7	have	have	VBP
cord-006393-jcj9nqfu	81	8	high	high	JJ
cord-006393-jcj9nqfu	81	9	titers	titer	NNS
cord-006393-jcj9nqfu	81	10	of	of	IN
cord-006393-jcj9nqfu	81	11	complement	complement	NN
cord-006393-jcj9nqfu	81	12	-	-	HYPH
cord-006393-jcj9nqfu	81	13	fixing	fix	VBG
cord-006393-jcj9nqfu	81	14	antibodies	antibody	NNS
cord-006393-jcj9nqfu	81	15	to	to	IN
cord-006393-jcj9nqfu	81	16	CMV	CMV	NNP
cord-006393-jcj9nqfu	81	17	prior	prior	RB
cord-006393-jcj9nqfu	81	18	to	to	IN
cord-006393-jcj9nqfu	81	19	transplant	transplant	NN
cord-006393-jcj9nqfu	81	20	have	have	VBP
cord-006393-jcj9nqfu	81	21	had	have	VBN
cord-006393-jcj9nqfu	81	22	a	a	DT
cord-006393-jcj9nqfu	81	23	better	well	JJR
cord-006393-jcj9nqfu	81	24	prognosis	prognosis	NN
cord-006393-jcj9nqfu	81	25	for	for	IN
cord-006393-jcj9nqfu	81	26	overcoming	overcome	VBG
cord-006393-jcj9nqfu	81	27	such	such	PDT
cord-006393-jcj9nqfu	81	28	a	a	DT
cord-006393-jcj9nqfu	81	29	severe	severe	JJ
cord-006393-jcj9nqfu	81	30	viral	viral	JJ
cord-006393-jcj9nqfu	81	31	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	81	32	.	.	.
cord-006393-jcj9nqfu	82	1	In	in	IN
cord-006393-jcj9nqfu	82	2	the	the	DT
cord-006393-jcj9nqfu	82	3	murine	murine	JJ
cord-006393-jcj9nqfu	82	4	model	model	NN
cord-006393-jcj9nqfu	82	5	,	,	,
cord-006393-jcj9nqfu	82	6	it	-PRON-	PRP
cord-006393-jcj9nqfu	82	7	could	could	MD
cord-006393-jcj9nqfu	82	8	be	be	VB
cord-006393-jcj9nqfu	82	9	shown	show	VBN
cord-006393-jcj9nqfu	82	10	that	that	IN
cord-006393-jcj9nqfu	82	11	passive	passive	JJ
cord-006393-jcj9nqfu	82	12	immunization	immunization	NN
cord-006393-jcj9nqfu	82	13	can	can	MD
cord-006393-jcj9nqfu	82	14	modify	modify	VB
cord-006393-jcj9nqfu	82	15	CMV	CMV	NNP
cord-006393-jcj9nqfu	82	16	infection	infection	NN
cord-006393-jcj9nqfu	82	17	.	.	.
cord-006393-jcj9nqfu	83	1	Several	several	JJ
cord-006393-jcj9nqfu	83	2	studies	study	NNS
cord-006393-jcj9nqfu	83	3	have	have	VBP
cord-006393-jcj9nqfu	83	4	been	be	VBN
cord-006393-jcj9nqfu	83	5	carried	carry	VBN
cord-006393-jcj9nqfu	83	6	out	out	RP
cord-006393-jcj9nqfu	83	7	to	to	TO
cord-006393-jcj9nqfu	83	8	see	see	VB
cord-006393-jcj9nqfu	83	9	if	if	IN
cord-006393-jcj9nqfu	83	10	passive	passive	JJ
cord-006393-jcj9nqfu	83	11	immunization	immunization	NN
cord-006393-jcj9nqfu	83	12	with	with	IN
cord-006393-jcj9nqfu	83	13	antibodies	antibody	NNS
cord-006393-jcj9nqfu	83	14	against	against	IN
cord-006393-jcj9nqfu	83	15	CMV	CMV	NNP
cord-006393-jcj9nqfu	83	16	would	would	MD
cord-006393-jcj9nqfu	83	17	prevent	prevent	VB
cord-006393-jcj9nqfu	83	18	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	83	19	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	83	20	.	.	.
cord-006393-jcj9nqfu	84	1	Investigators	investigator	NNS
cord-006393-jcj9nqfu	84	2	from	from	IN
cord-006393-jcj9nqfu	84	3	UCLA	UCLA	NNP
cord-006393-jcj9nqfu	84	4	,	,	,
cord-006393-jcj9nqfu	84	5	Minnesota	Minnesota	NNP
cord-006393-jcj9nqfu	84	6	,	,	,
cord-006393-jcj9nqfu	84	7	and	and	CC
cord-006393-jcj9nqfu	84	8	Sloan	Sloan	NNP
cord-006393-jcj9nqfu	84	9	-	-	HYPH
cord-006393-jcj9nqfu	84	10	Kettering	Kettering	NNP
cord-006393-jcj9nqfu	84	11	all	all	DT
cord-006393-jcj9nqfu	84	12	showed	show	VBD
cord-006393-jcj9nqfu	84	13	,	,	,
cord-006393-jcj9nqfu	84	14	in	in	IN
cord-006393-jcj9nqfu	84	15	reasonably	reasonably	RB
cord-006393-jcj9nqfu	84	16	well	well	RB
cord-006393-jcj9nqfu	84	17	-	-	HYPH
cord-006393-jcj9nqfu	84	18	controlled	control	VBN
cord-006393-jcj9nqfu	84	19	studies	study	NNS
cord-006393-jcj9nqfu	84	20	,	,	,
cord-006393-jcj9nqfu	84	21	that	that	IN
cord-006393-jcj9nqfu	84	22	the	the	DT
cord-006393-jcj9nqfu	84	23	incidence	incidence	NN
cord-006393-jcj9nqfu	84	24	of	of	IN
cord-006393-jcj9nqfu	84	25	CMV	CMV	NNP
cord-006393-jcj9nqfu	84	26	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	84	27	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	84	28	was	be	VBD
cord-006393-jcj9nqfu	84	29	reduced	reduce	VBN
cord-006393-jcj9nqfu	84	30	in	in	IN
cord-006393-jcj9nqfu	84	31	patients	patient	NNS
cord-006393-jcj9nqfu	84	32	given	give	VBN
cord-006393-jcj9nqfu	84	33	high	high	JJ
cord-006393-jcj9nqfu	84	34	-	-	HYPH
cord-006393-jcj9nqfu	84	35	titered	titered	JJ
cord-006393-jcj9nqfu	84	36	antibody	antibody	NN
cord-006393-jcj9nqfu	84	37	preparations	preparation	NNS
cord-006393-jcj9nqfu	84	38	compared	compare	VBN
cord-006393-jcj9nqfu	84	39	to	to	IN
cord-006393-jcj9nqfu	84	40	that	that	DT
cord-006393-jcj9nqfu	84	41	in	in	IN
cord-006393-jcj9nqfu	84	42	the	the	DT
cord-006393-jcj9nqfu	84	43	control	control	NN
cord-006393-jcj9nqfu	84	44	group	group	NN
cord-006393-jcj9nqfu	84	45	.	.	.
cord-006393-jcj9nqfu	85	1	This	this	DT
cord-006393-jcj9nqfu	85	2	finding	finding	NN
cord-006393-jcj9nqfu	85	3	triggered	trigger	VBD
cord-006393-jcj9nqfu	85	4	numerous	numerous	JJ
cord-006393-jcj9nqfu	85	5	other	other	JJ
cord-006393-jcj9nqfu	85	6	studies	study	NNS
cord-006393-jcj9nqfu	85	7	,	,	,
cord-006393-jcj9nqfu	85	8	mostly	mostly	RB
cord-006393-jcj9nqfu	85	9	uncontrolled	uncontrolled	JJ
cord-006393-jcj9nqfu	85	10	,	,	,
cord-006393-jcj9nqfu	85	11	which	which	WDT
cord-006393-jcj9nqfu	85	12	can	can	MD
cord-006393-jcj9nqfu	85	13	be	be	VB
cord-006393-jcj9nqfu	85	14	summarized	summarize	VBN
cord-006393-jcj9nqfu	85	15	as	as	IN
cord-006393-jcj9nqfu	85	16	follows	follow	VBZ
cord-006393-jcj9nqfu	85	17	.	.	.
cord-006393-jcj9nqfu	86	1	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	86	2	is	be	VBZ
cord-006393-jcj9nqfu	86	3	effective	effective	JJ
cord-006393-jcj9nqfu	86	4	in	in	IN
cord-006393-jcj9nqfu	86	5	preventing	prevent	VBG
cord-006393-jcj9nqfu	86	6	CMV	CMV	NNP
cord-006393-jcj9nqfu	86	7	infections	infection	NNS
cord-006393-jcj9nqfu	86	8	in	in	IN
cord-006393-jcj9nqfu	86	9	CMV	CMV	NNP
cord-006393-jcj9nqfu	86	10	-	-	HYPH
cord-006393-jcj9nqfu	86	11	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	86	12	recipients	recipient	NNS
cord-006393-jcj9nqfu	86	13	who	who	WP
cord-006393-jcj9nqfu	86	14	receive	receive	VBP
cord-006393-jcj9nqfu	86	15	CMVseronegative	cmvseronegative	JJ
cord-006393-jcj9nqfu	86	16	grafts	graft	NNS
cord-006393-jcj9nqfu	86	17	.	.	.
cord-006393-jcj9nqfu	87	1	It	-PRON-	PRP
cord-006393-jcj9nqfu	87	2	is	be	VBZ
cord-006393-jcj9nqfu	87	3	likely	likely	JJ
cord-006393-jcj9nqfu	87	4	to	to	TO
cord-006393-jcj9nqfu	87	5	be	be	VB
cord-006393-jcj9nqfu	87	6	ineffective	ineffective	JJ
cord-006393-jcj9nqfu	87	7	in	in	IN
cord-006393-jcj9nqfu	87	8	preventing	prevent	VBG
cord-006393-jcj9nqfu	87	9	the	the	DT
cord-006393-jcj9nqfu	87	10	development	development	NN
cord-006393-jcj9nqfu	87	11	of	of	IN
cord-006393-jcj9nqfu	87	12	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	87	13	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	87	14	in	in	IN
cord-006393-jcj9nqfu	87	15	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	87	16	recipients	recipient	NNS
cord-006393-jcj9nqfu	87	17	who	who	WP
cord-006393-jcj9nqfu	87	18	receive	receive	VBP
cord-006393-jcj9nqfu	87	19	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	87	20	grafts	graft	NNS
cord-006393-jcj9nqfu	87	21	.	.	.
cord-006393-jcj9nqfu	88	1	Furthermore	furthermore	RB
cord-006393-jcj9nqfu	88	2	,	,	,
cord-006393-jcj9nqfu	88	3	it	-PRON-	PRP
cord-006393-jcj9nqfu	88	4	is	be	VBZ
cord-006393-jcj9nqfu	88	5	likely	likely	JJ
cord-006393-jcj9nqfu	88	6	to	to	TO
cord-006393-jcj9nqfu	88	7	be	be	VB
cord-006393-jcj9nqfu	88	8	ineffective	ineffective	JJ
cord-006393-jcj9nqfu	88	9	in	in	IN
cord-006393-jcj9nqfu	88	10	CMV	CMV	NNP
cord-006393-jcj9nqfu	88	11	-	-	HYPH
cord-006393-jcj9nqfu	88	12	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	88	13	recipients	recipient	NNS
cord-006393-jcj9nqfu	88	14	who	who	WP
cord-006393-jcj9nqfu	88	15	receive	receive	VBP
cord-006393-jcj9nqfu	88	16	CMV	CMV	NNP
cord-006393-jcj9nqfu	88	17	-	-	HYPH
cord-006393-jcj9nqfu	88	18	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	88	19	blood	blood	NN
cord-006393-jcj9nqfu	88	20	products	product	NNS
cord-006393-jcj9nqfu	88	21	;	;	:
cord-006393-jcj9nqfu	88	22	however	however	RB
cord-006393-jcj9nqfu	88	23	,	,	,
cord-006393-jcj9nqfu	88	24	the	the	DT
cord-006393-jcj9nqfu	88	25	latter	latter	JJ
cord-006393-jcj9nqfu	88	26	statement	statement	NN
cord-006393-jcj9nqfu	88	27	is	be	VBZ
cord-006393-jcj9nqfu	88	28	not	not	RB
cord-006393-jcj9nqfu	88	29	fully	fully	RB
cord-006393-jcj9nqfu	88	30	substantiated	substantiate	VBN
cord-006393-jcj9nqfu	88	31	and	and	CC
cord-006393-jcj9nqfu	88	32	a	a	DT
cord-006393-jcj9nqfu	88	33	number	number	NN
cord-006393-jcj9nqfu	88	34	of	of	IN
cord-006393-jcj9nqfu	88	35	studies	study	NNS
cord-006393-jcj9nqfu	88	36	are	be	VBP
cord-006393-jcj9nqfu	88	37	in	in	IN
cord-006393-jcj9nqfu	88	38	progress	progress	NN
cord-006393-jcj9nqfu	88	39	to	to	TO
cord-006393-jcj9nqfu	88	40	delineate	delineate	VB
cord-006393-jcj9nqfu	88	41	that	that	DT
cord-006393-jcj9nqfu	88	42	point	point	NN
cord-006393-jcj9nqfu	88	43	.	.	.
cord-006393-jcj9nqfu	89	1	It	-PRON-	PRP
cord-006393-jcj9nqfu	89	2	is	be	VBZ
cord-006393-jcj9nqfu	89	3	likely	likely	JJ
cord-006393-jcj9nqfu	89	4	that	that	IN
cord-006393-jcj9nqfu	89	5	immunoglobulin	immunoglobulin	NN
cord-006393-jcj9nqfu	89	6	is	be	VBZ
cord-006393-jcj9nqfu	89	7	ineffective	ineffective	JJ
cord-006393-jcj9nqfu	89	8	in	in	IN
cord-006393-jcj9nqfu	89	9	CMV	CMV	NNP
cord-006393-jcj9nqfu	89	10	-	-	HYPH
cord-006393-jcj9nqfu	89	11	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	89	12	recipients	recipient	NNS
cord-006393-jcj9nqfu	89	13	who	who	WP
cord-006393-jcj9nqfu	89	14	receive	receive	VBP
cord-006393-jcj9nqfu	89	15	either	either	CC
cord-006393-jcj9nqfu	89	16	CMV	CMV	NNP
cord-006393-jcj9nqfu	89	17	-	-	HYPH
cord-006393-jcj9nqfu	89	18	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	89	19	or	or	CC
cord-006393-jcj9nqfu	89	20	CMV	CMV	NNP
cord-006393-jcj9nqfu	89	21	-	-	HYPH
cord-006393-jcj9nqfu	89	22	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	89	23	blood	blood	NN
cord-006393-jcj9nqfu	89	24	products	product	NNS
cord-006393-jcj9nqfu	89	25	.	.	.
cord-006393-jcj9nqfu	90	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	90	2	conducted	conduct	VBD
cord-006393-jcj9nqfu	90	3	our	-PRON-	PRP$
cord-006393-jcj9nqfu	90	4	own	own	JJ
cord-006393-jcj9nqfu	90	5	trial	trial	NN
cord-006393-jcj9nqfu	90	6	with	with	IN
cord-006393-jcj9nqfu	90	7	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	90	8	in	in	IN
cord-006393-jcj9nqfu	90	9	which	which	WDT
cord-006393-jcj9nqfu	90	10	119	119	CD
cord-006393-jcj9nqfu	90	11	patients	patient	NNS
cord-006393-jcj9nqfu	90	12	were	be	VBD
cord-006393-jcj9nqfu	90	13	enrolled	enrol	VBN
cord-006393-jcj9nqfu	90	14	(	(	-LRB-
cord-006393-jcj9nqfu	90	15	7	7	CD
cord-006393-jcj9nqfu	90	16	)	)	-RRB-
cord-006393-jcj9nqfu	90	17	.	.	.
cord-006393-jcj9nqfu	91	1	Slightly	slightly	RB
cord-006393-jcj9nqfu	91	2	more	more	JJR
cord-006393-jcj9nqfu	91	3	than	than	IN
cord-006393-jcj9nqfu	91	4	half	half	NN
cord-006393-jcj9nqfu	91	5	of	of	IN
cord-006393-jcj9nqfu	91	6	the	the	DT
cord-006393-jcj9nqfu	91	7	patients	patient	NNS
cord-006393-jcj9nqfu	91	8	were	be	VBD
cord-006393-jcj9nqfu	91	9	CMV	CMV	NNP
cord-006393-jcj9nqfu	91	10	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	91	11	.	.	.
cord-006393-jcj9nqfu	92	1	The	the	DT
cord-006393-jcj9nqfu	92	2	median	median	JJ
cord-006393-jcj9nqfu	92	3	observation	observation	NN
cord-006393-jcj9nqfu	92	4	time	time	NN
cord-006393-jcj9nqfu	92	5	was	be	VBD
cord-006393-jcj9nqfu	92	6	29	29	CD
cord-006393-jcj9nqfu	92	7	months	month	NNS
cord-006393-jcj9nqfu	92	8	.	.	.
cord-006393-jcj9nqfu	93	1	All	all	PDT
cord-006393-jcj9nqfu	93	2	the	the	DT
cord-006393-jcj9nqfu	93	3	patients	patient	NNS
cord-006393-jcj9nqfu	93	4	received	receive	VBD
cord-006393-jcj9nqfu	93	5	CMV	CMV	NNP
cord-006393-jcj9nqfu	93	6	-	-	HYPH
cord-006393-jcj9nqfu	93	7	negative	negative	JJ
cord-006393-jcj9nqfu	93	8	blood	blood	NN
cord-006393-jcj9nqfu	93	9	products	product	NNS
cord-006393-jcj9nqfu	93	10	and	and	CC
cord-006393-jcj9nqfu	93	11	were	be	VBD
cord-006393-jcj9nqfu	93	12	given	give	VBN
cord-006393-jcj9nqfu	93	13	500	500	CD
cord-006393-jcj9nqfu	93	14	mg	mg	NNP
cord-006393-jcj9nqfu	93	15	/	/	SYM
cord-006393-jcj9nqfu	93	16	kg	kg	NNS
cord-006393-jcj9nqfu	93	17	of	of	IN
cord-006393-jcj9nqfu	93	18	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	93	19	every	every	DT
cord-006393-jcj9nqfu	93	20	2	2	CD
cord-006393-jcj9nqfu	93	21	weeks	week	NNS
cord-006393-jcj9nqfu	93	22	for	for	IN
cord-006393-jcj9nqfu	93	23	eight	eight	CD
cord-006393-jcj9nqfu	93	24	administrations	administration	NNS
cord-006393-jcj9nqfu	93	25	.	.	.
cord-006393-jcj9nqfu	94	1	There	there	EX
cord-006393-jcj9nqfu	94	2	were	be	VBD
cord-006393-jcj9nqfu	94	3	no	no	DT
cord-006393-jcj9nqfu	94	4	CMV	CMV	NNP
cord-006393-jcj9nqfu	94	5	infections	infection	NNS
cord-006393-jcj9nqfu	94	6	and	and	CC
cord-006393-jcj9nqfu	94	7	there	there	EX
cord-006393-jcj9nqfu	94	8	was	be	VBD
cord-006393-jcj9nqfu	94	9	no	no	DT
cord-006393-jcj9nqfu	94	10	CMV	CMV	NNP
cord-006393-jcj9nqfu	94	11	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	94	12	in	in	IN
cord-006393-jcj9nqfu	94	13	the	the	DT
cord-006393-jcj9nqfu	94	14	first	first	JJ
cord-006393-jcj9nqfu	94	15	group	group	NN
cord-006393-jcj9nqfu	94	16	of	of	IN
cord-006393-jcj9nqfu	94	17	57	57	CD
cord-006393-jcj9nqfu	94	18	patients	patient	NNS
cord-006393-jcj9nqfu	94	19	,	,	,
cord-006393-jcj9nqfu	94	20	who	who	WP
cord-006393-jcj9nqfu	94	21	were	be	VBD
cord-006393-jcj9nqfu	94	22	CMV	CMV	NNP
cord-006393-jcj9nqfu	94	23	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	94	24	and	and	CC
cord-006393-jcj9nqfu	94	25	had	have	VBD
cord-006393-jcj9nqfu	94	26	received	receive	VBN
cord-006393-jcj9nqfu	94	27	a	a	DT
cord-006393-jcj9nqfu	94	28	graft	graft	NN
cord-006393-jcj9nqfu	94	29	from	from	IN
cord-006393-jcj9nqfu	94	30	a	a	DT
cord-006393-jcj9nqfu	94	31	CMVseronegative	cmvseronegative	JJ
cord-006393-jcj9nqfu	94	32	donor	donor	NN
cord-006393-jcj9nqfu	94	33	.	.	.
cord-006393-jcj9nqfu	95	1	In	in	IN
cord-006393-jcj9nqfu	95	2	the	the	DT
cord-006393-jcj9nqfu	95	3	next	next	JJ
cord-006393-jcj9nqfu	95	4	group	group	NN
cord-006393-jcj9nqfu	95	5	of	of	IN
cord-006393-jcj9nqfu	95	6	CMVseronegative	CMVseronegative	NNP
cord-006393-jcj9nqfu	95	7	recipients	recipient	NNS
cord-006393-jcj9nqfu	95	8	,	,	,
cord-006393-jcj9nqfu	95	9	who	who	WP
cord-006393-jcj9nqfu	95	10	were	be	VBD
cord-006393-jcj9nqfu	95	11	given	give	VBN
cord-006393-jcj9nqfu	95	12	a	a	DT
cord-006393-jcj9nqfu	95	13	graft	graft	NN
cord-006393-jcj9nqfu	95	14	from	from	IN
cord-006393-jcj9nqfu	95	15	a	a	DT
cord-006393-jcj9nqfu	95	16	CMV	CMV	NNP
cord-006393-jcj9nqfu	95	17	-	-	HYPH
cord-006393-jcj9nqfu	95	18	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	95	19	donor	donor	NN
cord-006393-jcj9nqfu	95	20	,	,	,
cord-006393-jcj9nqfu	95	21	3	3	CD
cord-006393-jcj9nqfu	95	22	of	of	IN
cord-006393-jcj9nqfu	95	23	12	12	CD
cord-006393-jcj9nqfu	95	24	patients	patient	NNS
cord-006393-jcj9nqfu	95	25	developed	develop	VBN
cord-006393-jcj9nqfu	95	26	viremia	viremia	NN
cord-006393-jcj9nqfu	95	27	or	or	CC
cord-006393-jcj9nqfu	95	28	viruria	viruria	NN
cord-006393-jcj9nqfu	95	29	but	but	CC
cord-006393-jcj9nqfu	95	30	none	none	NN
cord-006393-jcj9nqfu	95	31	of	of	IN
cord-006393-jcj9nqfu	95	32	them	-PRON-	PRP
cord-006393-jcj9nqfu	95	33	developed	develop	VBD
cord-006393-jcj9nqfu	95	34	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	95	35	.	.	.
cord-006393-jcj9nqfu	96	1	The	the	DT
cord-006393-jcj9nqfu	96	2	low	low	JJ
cord-006393-jcj9nqfu	96	3	incidence	incidence	NN
cord-006393-jcj9nqfu	96	4	of	of	IN
cord-006393-jcj9nqfu	96	5	CMV	CMV	NNP
cord-006393-jcj9nqfu	96	6	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	96	7	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	96	8	in	in	IN
cord-006393-jcj9nqfu	96	9	this	this	DT
cord-006393-jcj9nqfu	96	10	group	group	NN
cord-006393-jcj9nqfu	96	11	indicated	indicate	VBD
cord-006393-jcj9nqfu	96	12	that	that	IN
cord-006393-jcj9nqfu	96	13	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	96	14	might	may	MD
cord-006393-jcj9nqfu	96	15	be	be	VB
cord-006393-jcj9nqfu	96	16	effective	effective	JJ
cord-006393-jcj9nqfu	96	17	in	in	IN
cord-006393-jcj9nqfu	96	18	the	the	DT
cord-006393-jcj9nqfu	96	19	CMV	CMV	NNP
cord-006393-jcj9nqfu	96	20	-	-	HYPH
cord-006393-jcj9nqfu	96	21	seronegative	seronegative	JJ
cord-006393-jcj9nqfu	96	22	patient	patient	NN
cord-006393-jcj9nqfu	96	23	even	even	RB
cord-006393-jcj9nqfu	96	24	when	when	WRB
cord-006393-jcj9nqfu	96	25	receiving	receive	VBG
cord-006393-jcj9nqfu	96	26	a	a	DT
cord-006393-jcj9nqfu	96	27	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	96	28	donor	donor	NN
cord-006393-jcj9nqfu	96	29	graft	graft	NN
cord-006393-jcj9nqfu	96	30	.	.	.
cord-006393-jcj9nqfu	97	1	Unfortunately	unfortunately	RB
cord-006393-jcj9nqfu	97	2	,	,	,
cord-006393-jcj9nqfu	97	3	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	97	4	was	be	VBD
cord-006393-jcj9nqfu	97	5	largely	largely	RB
cord-006393-jcj9nqfu	97	6	ineffective	ineffective	JJ
cord-006393-jcj9nqfu	97	7	in	in	IN
cord-006393-jcj9nqfu	97	8	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	97	9	patients	patient	NNS
cord-006393-jcj9nqfu	97	10	.	.	.
cord-006393-jcj9nqfu	98	1	Of	of	IN
cord-006393-jcj9nqfu	98	2	the	the	DT
cord-006393-jcj9nqfu	98	3	50	50	CD
cord-006393-jcj9nqfu	98	4	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	98	5	recipients	recipient	NNS
cord-006393-jcj9nqfu	98	6	,	,	,
cord-006393-jcj9nqfu	98	7	33	33	CD
cord-006393-jcj9nqfu	98	8	(	(	-LRB-
cord-006393-jcj9nqfu	98	9	66	66	CD
cord-006393-jcj9nqfu	98	10	%	%	NN
cord-006393-jcj9nqfu	98	11	)	)	-RRB-
cord-006393-jcj9nqfu	98	12	developed	develop	VBD
cord-006393-jcj9nqfu	98	13	a	a	DT
cord-006393-jcj9nqfu	98	14	positive	positive	JJ
cord-006393-jcj9nqfu	98	15	CMV	CMV	NNP
cord-006393-jcj9nqfu	98	16	culture	culture	NN
cord-006393-jcj9nqfu	98	17	and	and	CC
cord-006393-jcj9nqfu	98	18	8	8	CD
cord-006393-jcj9nqfu	98	19	developed	develop	VBD
cord-006393-jcj9nqfu	98	20	CMV	CMV	NNP
cord-006393-jcj9nqfu	98	21	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	98	22	,	,	,
cord-006393-jcj9nqfu	98	23	which	which	WDT
cord-006393-jcj9nqfu	98	24	was	be	VBD
cord-006393-jcj9nqfu	98	25	fatal	fatal	JJ
cord-006393-jcj9nqfu	98	26	in	in	IN
cord-006393-jcj9nqfu	98	27	6	6	CD
cord-006393-jcj9nqfu	98	28	cases	case	NNS
cord-006393-jcj9nqfu	98	29	.	.	.
cord-006393-jcj9nqfu	99	1	When	when	WRB
cord-006393-jcj9nqfu	99	2	all	all	DT
cord-006393-jcj9nqfu	99	3	groups	group	NNS
cord-006393-jcj9nqfu	99	4	are	be	VBP
cord-006393-jcj9nqfu	99	5	combined	combine	VBN
cord-006393-jcj9nqfu	99	6	the	the	DT
cord-006393-jcj9nqfu	99	7	overall	overall	JJ
cord-006393-jcj9nqfu	99	8	effect	effect	NN
cord-006393-jcj9nqfu	99	9	of	of	IN
cord-006393-jcj9nqfu	99	10	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	99	11	appears	appear	VBZ
cord-006393-jcj9nqfu	99	12	impressive	impressive	JJ
cord-006393-jcj9nqfu	99	13	:	:	:
cord-006393-jcj9nqfu	99	14	a	a	DT
cord-006393-jcj9nqfu	99	15	13	13	CD
cord-006393-jcj9nqfu	99	16	%	%	NN
cord-006393-jcj9nqfu	99	17	incidence	incidence	NN
cord-006393-jcj9nqfu	99	18	of	of	IN
cord-006393-jcj9nqfu	99	19	CMV	CMV	NNP
cord-006393-jcj9nqfu	99	20	infection	infection	NN
cord-006393-jcj9nqfu	99	21	and	and	CC
cord-006393-jcj9nqfu	99	22	a	a	DT
cord-006393-jcj9nqfu	99	23	7	7	CD
cord-006393-jcj9nqfu	99	24	%	%	NN
cord-006393-jcj9nqfu	99	25	incidence	incidence	NN
cord-006393-jcj9nqfu	99	26	of	of	IN
cord-006393-jcj9nqfu	99	27	CMV	CMV	NNP
cord-006393-jcj9nqfu	99	28	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	99	29	,	,	,
cord-006393-jcj9nqfu	99	30	suggesting	suggest	VBG
cord-006393-jcj9nqfu	99	31	that	that	IN
cord-006393-jcj9nqfu	99	32	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	99	33	was	be	VBD
cord-006393-jcj9nqfu	99	34	able	able	JJ
cord-006393-jcj9nqfu	99	35	to	to	TO
cord-006393-jcj9nqfu	99	36	reduce	reduce	VB
cord-006393-jcj9nqfu	99	37	the	the	DT
cord-006393-jcj9nqfu	99	38	incidence	incidence	NN
cord-006393-jcj9nqfu	99	39	of	of	IN
cord-006393-jcj9nqfu	99	40	CMV	CMV	NNP
cord-006393-jcj9nqfu	99	41	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	99	42	,	,	,
cord-006393-jcj9nqfu	99	43	perhaps	perhaps	RB
cord-006393-jcj9nqfu	99	44	even	even	RB
cord-006393-jcj9nqfu	99	45	in	in	IN
cord-006393-jcj9nqfu	99	46	CMV	CMV	NNP
cord-006393-jcj9nqfu	99	47	-	-	HYPH
cord-006393-jcj9nqfu	99	48	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	99	49	patients	patient	NNS
cord-006393-jcj9nqfu	99	50	.	.	.
cord-006393-jcj9nqfu	100	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	100	2	tried	try	VBD
cord-006393-jcj9nqfu	100	3	to	to	TO
cord-006393-jcj9nqfu	100	4	obtain	obtain	VB
cord-006393-jcj9nqfu	100	5	more	more	RBR
cord-006393-jcj9nqfu	100	6	definitive	definitive	JJ
cord-006393-jcj9nqfu	100	7	information	information	NN
cord-006393-jcj9nqfu	100	8	about	about	IN
cord-006393-jcj9nqfu	100	9	the	the	DT
cord-006393-jcj9nqfu	100	10	role	role	NN
cord-006393-jcj9nqfu	100	11	of	of	IN
cord-006393-jcj9nqfu	100	12	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	100	13	in	in	IN
cord-006393-jcj9nqfu	100	14	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	100	15	recipients	recipient	NNS
cord-006393-jcj9nqfu	100	16	.	.	.
cord-006393-jcj9nqfu	101	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	101	2	were	be	VBD
cord-006393-jcj9nqfu	101	3	unwilling	unwilling	JJ
cord-006393-jcj9nqfu	101	4	to	to	TO
cord-006393-jcj9nqfu	101	5	do	do	VB
cord-006393-jcj9nqfu	101	6	a	a	DT
cord-006393-jcj9nqfu	101	7	randomized	randomized	JJ
cord-006393-jcj9nqfu	101	8	,	,	,
cord-006393-jcj9nqfu	101	9	placebocontrolled	placebocontrolled	JJ
cord-006393-jcj9nqfu	101	10	study	study	NN
cord-006393-jcj9nqfu	101	11	since	since	IN
cord-006393-jcj9nqfu	101	12	we	-PRON-	PRP
cord-006393-jcj9nqfu	101	13	had	have	VBD
cord-006393-jcj9nqfu	101	14	ethical	ethical	JJ
cord-006393-jcj9nqfu	101	15	problems	problem	NNS
cord-006393-jcj9nqfu	101	16	with	with	IN
cord-006393-jcj9nqfu	101	17	not	not	RB
cord-006393-jcj9nqfu	101	18	treating	treat	VBG
cord-006393-jcj9nqfu	101	19	all	all	PDT
cord-006393-jcj9nqfu	101	20	our	-PRON-	PRP$
cord-006393-jcj9nqfu	101	21	patients	patient	NNS
cord-006393-jcj9nqfu	101	22	with	with	IN
cord-006393-jcj9nqfu	101	23	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	101	24	.	.	.
cord-006393-jcj9nqfu	102	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	102	2	speculated	speculate	VBD
cord-006393-jcj9nqfu	102	3	that	that	IN
cord-006393-jcj9nqfu	102	4	if	if	IN
cord-006393-jcj9nqfu	102	5	we	-PRON-	PRP
cord-006393-jcj9nqfu	102	6	were	be	VBD
cord-006393-jcj9nqfu	102	7	to	to	TO
cord-006393-jcj9nqfu	102	8	give	give	VB
cord-006393-jcj9nqfu	102	9	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	102	10	to	to	IN
cord-006393-jcj9nqfu	102	11	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	102	12	patients	patient	NNS
cord-006393-jcj9nqfu	102	13	in	in	IN
cord-006393-jcj9nqfu	102	14	higher	high	JJR
cord-006393-jcj9nqfu	102	15	doses	dose	NNS
cord-006393-jcj9nqfu	102	16	and	and	CC
cord-006393-jcj9nqfu	102	17	more	more	RBR
cord-006393-jcj9nqfu	102	18	frequently	frequently	RB
cord-006393-jcj9nqfu	102	19	,	,	,
cord-006393-jcj9nqfu	102	20	we	-PRON-	PRP
cord-006393-jcj9nqfu	102	21	might	may	MD
cord-006393-jcj9nqfu	102	22	prevent	prevent	VB
cord-006393-jcj9nqfu	102	23	not	not	RB
cord-006393-jcj9nqfu	102	24	only	only	RB
cord-006393-jcj9nqfu	102	25	CMV	CMV	NNP
cord-006393-jcj9nqfu	102	26	excretion	excretion	NN
cord-006393-jcj9nqfu	102	27	(	(	-LRB-
cord-006393-jcj9nqfu	102	28	such	such	JJ
cord-006393-jcj9nqfu	102	29	as	as	IN
cord-006393-jcj9nqfu	102	30	viremia	viremia	NN
cord-006393-jcj9nqfu	102	31	or	or	CC
cord-006393-jcj9nqfu	102	32	viruria	viruria	NNP
cord-006393-jcj9nqfu	102	33	)	)	-RRB-
cord-006393-jcj9nqfu	102	34	but	but	CC
cord-006393-jcj9nqfu	102	35	also	also	RB
cord-006393-jcj9nqfu	102	36	the	the	DT
cord-006393-jcj9nqfu	102	37	development	development	NN
cord-006393-jcj9nqfu	102	38	of	of	IN
cord-006393-jcj9nqfu	102	39	CMV	CMV	NNP
cord-006393-jcj9nqfu	102	40	infection	infection	NN
cord-006393-jcj9nqfu	102	41	.	.	.
cord-006393-jcj9nqfu	103	1	For	for	IN
cord-006393-jcj9nqfu	103	2	these	these	DT
cord-006393-jcj9nqfu	103	3	reasons	reason	NNS
cord-006393-jcj9nqfu	103	4	we	-PRON-	PRP
cord-006393-jcj9nqfu	103	5	limited	limit	VBD
cord-006393-jcj9nqfu	103	6	our	-PRON-	PRP$
cord-006393-jcj9nqfu	103	7	study	study	NN
cord-006393-jcj9nqfu	103	8	to	to	IN
cord-006393-jcj9nqfu	103	9	CMV	CMV	NNP
cord-006393-jcj9nqfu	103	10	-	-	HYPH
cord-006393-jcj9nqfu	103	11	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	103	12	recipients	recipient	NNS
cord-006393-jcj9nqfu	103	13	and	and	CC
cord-006393-jcj9nqfu	103	14	stratified	stratify	VBD
cord-006393-jcj9nqfu	103	15	them	-PRON-	PRP
cord-006393-jcj9nqfu	103	16	between	between	IN
cord-006393-jcj9nqfu	103	17	two	two	CD
cord-006393-jcj9nqfu	103	18	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	103	19	schedules	schedule	NNS
cord-006393-jcj9nqfu	103	20	,	,	,
cord-006393-jcj9nqfu	103	21	giving	give	VBG
cord-006393-jcj9nqfu	103	22	either	either	CC
cord-006393-jcj9nqfu	103	23	500	500	CD
cord-006393-jcj9nqfu	103	24	mg	mg	NN
cord-006393-jcj9nqfu	103	25	/	/	SYM
cord-006393-jcj9nqfu	103	26	kg	kg	NN
cord-006393-jcj9nqfu	103	27	every	every	DT
cord-006393-jcj9nqfu	103	28	2	2	CD
cord-006393-jcj9nqfu	103	29	weeks	week	NNS
cord-006393-jcj9nqfu	103	30	for	for	IN
cord-006393-jcj9nqfu	103	31	4	4	CD
cord-006393-jcj9nqfu	103	32	months	month	NNS
cord-006393-jcj9nqfu	103	33	or	or	CC
cord-006393-jcj9nqfu	103	34	500	500	CD
cord-006393-jcj9nqfu	103	35	mg	mg	NNP
cord-006393-jcj9nqfu	103	36	/	/	SYM
cord-006393-jcj9nqfu	103	37	kg	kg	NN
cord-006393-jcj9nqfu	103	38	every	every	DT
cord-006393-jcj9nqfu	103	39	week	week	NN
cord-006393-jcj9nqfu	103	40	for	for	IN
cord-006393-jcj9nqfu	103	41	4	4	CD
cord-006393-jcj9nqfu	103	42	months	month	NNS
cord-006393-jcj9nqfu	103	43	.	.	.
cord-006393-jcj9nqfu	104	1	If	if	IN
cord-006393-jcj9nqfu	104	2	patients	patient	NNS
cord-006393-jcj9nqfu	104	3	became	become	VBD
cord-006393-jcj9nqfu	104	4	excretors	excretor	NNS
cord-006393-jcj9nqfu	104	5	of	of	IN
cord-006393-jcj9nqfu	104	6	the	the	DT
cord-006393-jcj9nqfu	104	7	virus	virus	NN
cord-006393-jcj9nqfu	104	8	,	,	,
cord-006393-jcj9nqfu	104	9	they	-PRON-	PRP
cord-006393-jcj9nqfu	104	10	received	receive	VBD
cord-006393-jcj9nqfu	104	11	a	a	DT
cord-006393-jcj9nqfu	104	12	dose	dose	NN
cord-006393-jcj9nqfu	104	13	of	of	IN
cord-006393-jcj9nqfu	104	14	500	500	CD
cord-006393-jcj9nqfu	104	15	mg	mg	NNP
cord-006393-jcj9nqfu	104	16	/	/	SYM
cord-006393-jcj9nqfu	104	17	kg	kg	NNP
cord-006393-jcj9nqfu	104	18	daily	daily	RB
cord-006393-jcj9nqfu	104	19	for	for	IN
cord-006393-jcj9nqfu	104	20	10	10	CD
cord-006393-jcj9nqfu	104	21	days	day	NNS
cord-006393-jcj9nqfu	104	22	.	.	.
cord-006393-jcj9nqfu	105	1	There	there	EX
cord-006393-jcj9nqfu	105	2	were	be	VBD
cord-006393-jcj9nqfu	105	3	24	24	CD
cord-006393-jcj9nqfu	105	4	patients	patient	NNS
cord-006393-jcj9nqfu	105	5	in	in	IN
cord-006393-jcj9nqfu	105	6	the	the	DT
cord-006393-jcj9nqfu	105	7	standard	standard	JJ
cord-006393-jcj9nqfu	105	8	group	group	NN
cord-006393-jcj9nqfu	105	9	and	and	CC
cord-006393-jcj9nqfu	105	10	22	22	CD
cord-006393-jcj9nqfu	105	11	in	in	IN
cord-006393-jcj9nqfu	105	12	the	the	DT
cord-006393-jcj9nqfu	105	13	high	high	JJ
cord-006393-jcj9nqfu	105	14	-	-	HYPH
cord-006393-jcj9nqfu	105	15	dose	dose	NN
cord-006393-jcj9nqfu	105	16	group	group	NN
cord-006393-jcj9nqfu	105	17	.	.	.
cord-006393-jcj9nqfu	106	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	106	2	observed	observe	VBD
cord-006393-jcj9nqfu	106	3	no	no	DT
cord-006393-jcj9nqfu	106	4	difference	difference	NN
cord-006393-jcj9nqfu	106	5	in	in	IN
cord-006393-jcj9nqfu	106	6	the	the	DT
cord-006393-jcj9nqfu	106	7	number	number	NN
cord-006393-jcj9nqfu	106	8	of	of	IN
cord-006393-jcj9nqfu	106	9	patients	patient	NNS
cord-006393-jcj9nqfu	106	10	who	who	WP
cord-006393-jcj9nqfu	106	11	became	become	VBD
cord-006393-jcj9nqfu	106	12	excretors--15	excretors--15	JJ
cord-006393-jcj9nqfu	106	13	in	in	IN
cord-006393-jcj9nqfu	106	14	the	the	DT
cord-006393-jcj9nqfu	106	15	standard	standard	JJ
cord-006393-jcj9nqfu	106	16	-	-	HYPH
cord-006393-jcj9nqfu	106	17	dose	dose	NN
cord-006393-jcj9nqfu	106	18	group	group	NN
cord-006393-jcj9nqfu	106	19	and	and	CC
cord-006393-jcj9nqfu	106	20	17	17	CD
cord-006393-jcj9nqfu	106	21	in	in	IN
cord-006393-jcj9nqfu	106	22	the	the	DT
cord-006393-jcj9nqfu	106	23	high	high	JJ
cord-006393-jcj9nqfu	106	24	-	-	HYPH
cord-006393-jcj9nqfu	106	25	dose	dose	NN
cord-006393-jcj9nqfu	106	26	group	group	NN
cord-006393-jcj9nqfu	106	27	.	.	.
cord-006393-jcj9nqfu	107	1	There	there	EX
cord-006393-jcj9nqfu	107	2	was	be	VBD
cord-006393-jcj9nqfu	107	3	no	no	DT
cord-006393-jcj9nqfu	107	4	difference	difference	NN
cord-006393-jcj9nqfu	107	5	in	in	IN
cord-006393-jcj9nqfu	107	6	the	the	DT
cord-006393-jcj9nqfu	107	7	number	number	NN
cord-006393-jcj9nqfu	107	8	of	of	IN
cord-006393-jcj9nqfu	107	9	patients	patient	NNS
cord-006393-jcj9nqfu	107	10	that	that	WDT
cord-006393-jcj9nqfu	107	11	developed	develop	VBD
cord-006393-jcj9nqfu	107	12	systemic	systemic	JJ
cord-006393-jcj9nqfu	107	13	disease	disease	NN
cord-006393-jcj9nqfu	107	14	or	or	CC
cord-006393-jcj9nqfu	107	15	in	in	IN
cord-006393-jcj9nqfu	107	16	the	the	DT
cord-006393-jcj9nqfu	107	17	number	number	NN
cord-006393-jcj9nqfu	107	18	of	of	IN
cord-006393-jcj9nqfu	107	19	fatalities	fatality	NNS
cord-006393-jcj9nqfu	107	20	observed	observe	VBD
cord-006393-jcj9nqfu	107	21	.	.	.
cord-006393-jcj9nqfu	108	1	Thus	thus	RB
cord-006393-jcj9nqfu	108	2	,	,	,
cord-006393-jcj9nqfu	108	3	a	a	DT
cord-006393-jcj9nqfu	108	4	higher	high	JJR
cord-006393-jcj9nqfu	108	5	dose	dose	NN
cord-006393-jcj9nqfu	108	6	of	of	IN
cord-006393-jcj9nqfu	108	7	antibody	antibody	NN
cord-006393-jcj9nqfu	108	8	does	do	VBZ
cord-006393-jcj9nqfu	108	9	not	not	RB
cord-006393-jcj9nqfu	108	10	appear	appear	VB
cord-006393-jcj9nqfu	108	11	to	to	TO
cord-006393-jcj9nqfu	108	12	be	be	VB
cord-006393-jcj9nqfu	108	13	more	more	RBR
cord-006393-jcj9nqfu	108	14	beneficial	beneficial	JJ
cord-006393-jcj9nqfu	108	15	than	than	IN
cord-006393-jcj9nqfu	108	16	a	a	DT
cord-006393-jcj9nqfu	108	17	lower	low	JJR
cord-006393-jcj9nqfu	108	18	dose	dose	NN
cord-006393-jcj9nqfu	108	19	in	in	IN
cord-006393-jcj9nqfu	108	20	preventing	prevent	VBG
cord-006393-jcj9nqfu	108	21	CMV	CMV	NNP
cord-006393-jcj9nqfu	108	22	disease	disease	NN
cord-006393-jcj9nqfu	108	23	.	.	.
cord-006393-jcj9nqfu	109	1	New	new	JJ
cord-006393-jcj9nqfu	109	2	strategies	strategy	NNS
cord-006393-jcj9nqfu	109	3	need	need	VBP
cord-006393-jcj9nqfu	109	4	to	to	TO
cord-006393-jcj9nqfu	109	5	be	be	VB
cord-006393-jcj9nqfu	109	6	developed	develop	VBN
cord-006393-jcj9nqfu	109	7	to	to	TO
cord-006393-jcj9nqfu	109	8	overcome	overcome	VB
cord-006393-jcj9nqfu	109	9	the	the	DT
cord-006393-jcj9nqfu	109	10	severe	severe	JJ
cord-006393-jcj9nqfu	109	11	problem	problem	NN
cord-006393-jcj9nqfu	109	12	presented	present	VBN
cord-006393-jcj9nqfu	109	13	by	by	IN
cord-006393-jcj9nqfu	109	14	the	the	DT
cord-006393-jcj9nqfu	109	15	CMV	CMV	NNP
cord-006393-jcj9nqfu	109	16	-	-	HYPH
cord-006393-jcj9nqfu	109	17	seropositive	seropositive	JJ
cord-006393-jcj9nqfu	109	18	patient	patient	NN
cord-006393-jcj9nqfu	109	19	.	.	.
cord-006393-jcj9nqfu	110	1	The	the	DT
cord-006393-jcj9nqfu	110	2	treatment	treatment	NN
cord-006393-jcj9nqfu	110	3	of	of	IN
cord-006393-jcj9nqfu	110	4	established	establish	VBN
cord-006393-jcj9nqfu	110	5	CMV	CMV	NNP
cord-006393-jcj9nqfu	110	6	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	110	7	is	be	VBZ
cord-006393-jcj9nqfu	110	8	not	not	RB
cord-006393-jcj9nqfu	110	9	very	very	RB
cord-006393-jcj9nqfu	110	10	effective	effective	JJ
cord-006393-jcj9nqfu	110	11	.	.	.
cord-006393-jcj9nqfu	111	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	111	2	have	have	VBP
cord-006393-jcj9nqfu	111	3	learned	learn	VBN
cord-006393-jcj9nqfu	111	4	that	that	IN
cord-006393-jcj9nqfu	111	5	ARA	ARA	NNP
cord-006393-jcj9nqfu	111	6	-	-	HYPH
cord-006393-jcj9nqfu	111	7	A	A	NNP
cord-006393-jcj9nqfu	111	8	,	,	,
cord-006393-jcj9nqfu	111	9	acyclovir	acyclovir	NN
cord-006393-jcj9nqfu	111	10	,	,	,
cord-006393-jcj9nqfu	111	11	and	and	CC
cord-006393-jcj9nqfu	111	12	TFT	TFT	NNP
cord-006393-jcj9nqfu	111	13	are	be	VBP
cord-006393-jcj9nqfu	111	14	not	not	RB
cord-006393-jcj9nqfu	111	15	effective	effective	JJ
cord-006393-jcj9nqfu	111	16	in	in	IN
cord-006393-jcj9nqfu	111	17	the	the	DT
cord-006393-jcj9nqfu	111	18	therapy	therapy	NN
cord-006393-jcj9nqfu	111	19	of	of	IN
cord-006393-jcj9nqfu	111	20	this	this	DT
cord-006393-jcj9nqfu	111	21	disease	disease	NN
cord-006393-jcj9nqfu	111	22	,	,	,
cord-006393-jcj9nqfu	111	23	although	although	IN
cord-006393-jcj9nqfu	111	24	acyclovir	acyclovir	NNP
cord-006393-jcj9nqfu	111	25	might	may	MD
cord-006393-jcj9nqfu	111	26	be	be	VB
cord-006393-jcj9nqfu	111	27	effective	effective	JJ
cord-006393-jcj9nqfu	111	28	as	as	IN
cord-006393-jcj9nqfu	111	29	a	a	DT
cord-006393-jcj9nqfu	111	30	preventive	preventive	JJ
cord-006393-jcj9nqfu	111	31	agent	agent	NN
cord-006393-jcj9nqfu	111	32	.	.	.
cord-006393-jcj9nqfu	112	1	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	112	2	alone	alone	RB
cord-006393-jcj9nqfu	112	3	is	be	VBZ
cord-006393-jcj9nqfu	112	4	as	as	RB
cord-006393-jcj9nqfu	112	5	effective	effective	JJ
cord-006393-jcj9nqfu	112	6	as	as	IN
cord-006393-jcj9nqfu	112	7	9(l,3-dihydroxy-2-proxymethyl	9(l,3-dihydroxy-2-proxymethyl	CD
cord-006393-jcj9nqfu	112	8	)	)	-RRB-
cord-006393-jcj9nqfu	112	9	guanine	guanine	NN
cord-006393-jcj9nqfu	112	10	(	(	-LRB-
cord-006393-jcj9nqfu	112	11	DHPG	DHPG	NNP
cord-006393-jcj9nqfu	112	12	)	)	-RRB-
cord-006393-jcj9nqfu	112	13	alone	alone	RB
cord-006393-jcj9nqfu	112	14	in	in	IN
cord-006393-jcj9nqfu	112	15	treating	treat	VBG
cord-006393-jcj9nqfu	112	16	established	establish	VBN
cord-006393-jcj9nqfu	112	17	CMV	CMV	NNP
cord-006393-jcj9nqfu	112	18	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	112	19	,	,	,
cord-006393-jcj9nqfu	112	20	but	but	CC
cord-006393-jcj9nqfu	112	21	surprisingly	surprisingly	RB
cord-006393-jcj9nqfu	112	22	,	,	,
cord-006393-jcj9nqfu	112	23	the	the	DT
cord-006393-jcj9nqfu	112	24	combination	combination	NN
cord-006393-jcj9nqfu	112	25	of	of	IN
cord-006393-jcj9nqfu	112	26	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	112	27	and	and	CC
cord-006393-jcj9nqfu	112	28	DHPG	DHPG	NNP
cord-006393-jcj9nqfu	112	29	is	be	VBZ
cord-006393-jcj9nqfu	112	30	quite	quite	RB
cord-006393-jcj9nqfu	112	31	effective	effective	JJ
cord-006393-jcj9nqfu	112	32	,	,	,
cord-006393-jcj9nqfu	112	33	and	and	CC
cord-006393-jcj9nqfu	112	34	in	in	IN
cord-006393-jcj9nqfu	112	35	a	a	DT
cord-006393-jcj9nqfu	112	36	number	number	NN
cord-006393-jcj9nqfu	112	37	of	of	IN
cord-006393-jcj9nqfu	112	38	studies	study	NNS
cord-006393-jcj9nqfu	112	39	it	-PRON-	PRP
cord-006393-jcj9nqfu	112	40	has	have	VBZ
cord-006393-jcj9nqfu	112	41	reduced	reduce	VBN
cord-006393-jcj9nqfu	112	42	the	the	DT
cord-006393-jcj9nqfu	112	43	mortality	mortality	NN
cord-006393-jcj9nqfu	112	44	rate	rate	NN
cord-006393-jcj9nqfu	112	45	from	from	IN
cord-006393-jcj9nqfu	112	46	85	85	CD
cord-006393-jcj9nqfu	112	47	to	to	TO
cord-006393-jcj9nqfu	112	48	50	50	CD
cord-006393-jcj9nqfu	112	49	-	-	SYM
cord-006393-jcj9nqfu	112	50	60	60	CD
cord-006393-jcj9nqfu	112	51	%	%	NN
cord-006393-jcj9nqfu	112	52	(	(	-LRB-
cord-006393-jcj9nqfu	112	53	8	8	CD
cord-006393-jcj9nqfu	112	54	,	,	,
cord-006393-jcj9nqfu	112	55	9	9	CD
cord-006393-jcj9nqfu	112	56	)	)	-RRB-
cord-006393-jcj9nqfu	112	57	.	.	.
cord-006393-jcj9nqfu	113	1	Hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	113	2	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	113	3	is	be	VBZ
cord-006393-jcj9nqfu	113	4	the	the	DT
cord-006393-jcj9nqfu	113	5	other	other	JJ
cord-006393-jcj9nqfu	113	6	major	major	JJ
cord-006393-jcj9nqfu	113	7	viral	viral	JJ
cord-006393-jcj9nqfu	113	8	complication	complication	NN
cord-006393-jcj9nqfu	113	9	in	in	IN
cord-006393-jcj9nqfu	113	10	the	the	DT
cord-006393-jcj9nqfu	113	11	early	early	JJ
cord-006393-jcj9nqfu	113	12	postengraftment	postengraftment	NN
cord-006393-jcj9nqfu	113	13	phase	phase	NN
cord-006393-jcj9nqfu	113	14	(	(	-LRB-
cord-006393-jcj9nqfu	113	15	10	10	CD
cord-006393-jcj9nqfu	113	16	)	)	-RRB-
cord-006393-jcj9nqfu	113	17	.	.	.
cord-006393-jcj9nqfu	114	1	The	the	DT
cord-006393-jcj9nqfu	114	2	mortality	mortality	NN
cord-006393-jcj9nqfu	114	3	is	be	VBZ
cord-006393-jcj9nqfu	114	4	relatively	relatively	RB
cord-006393-jcj9nqfu	114	5	high	high	JJ
cord-006393-jcj9nqfu	114	6	(	(	-LRB-
cord-006393-jcj9nqfu	114	7	29	29	CD
cord-006393-jcj9nqfu	114	8	%	%	NN
cord-006393-jcj9nqfu	114	9	)	)	-RRB-
cord-006393-jcj9nqfu	114	10	even	even	RB
cord-006393-jcj9nqfu	114	11	in	in	IN
cord-006393-jcj9nqfu	114	12	the	the	DT
cord-006393-jcj9nqfu	114	13	absence	absence	NN
cord-006393-jcj9nqfu	114	14	of	of	IN
cord-006393-jcj9nqfu	114	15	acute	acute	JJ
cord-006393-jcj9nqfu	114	16	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	114	17	.	.	.
cord-006393-jcj9nqfu	115	1	A	a	DT
cord-006393-jcj9nqfu	115	2	number	number	NN
cord-006393-jcj9nqfu	115	3	of	of	IN
cord-006393-jcj9nqfu	115	4	viruses	virus	NNS
cord-006393-jcj9nqfu	115	5	(	(	-LRB-
cord-006393-jcj9nqfu	115	6	such	such	JJ
cord-006393-jcj9nqfu	115	7	as	as	IN
cord-006393-jcj9nqfu	115	8	rotavirus	rotavirus	NN
cord-006393-jcj9nqfu	115	9	)	)	-RRB-
cord-006393-jcj9nqfu	115	10	are	be	VBP
cord-006393-jcj9nqfu	115	11	associated	associate	VBN
cord-006393-jcj9nqfu	115	12	with	with	IN
cord-006393-jcj9nqfu	115	13	hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	115	14	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	115	15	,	,	,
cord-006393-jcj9nqfu	115	16	but	but	CC
cord-006393-jcj9nqfu	115	17	recently	recently	RB
cord-006393-jcj9nqfu	115	18	CMV	CMV	NNP
cord-006393-jcj9nqfu	115	19	is	be	VBZ
cord-006393-jcj9nqfu	115	20	becoming	become	VBG
cord-006393-jcj9nqfu	115	21	prevalent	prevalent	JJ
cord-006393-jcj9nqfu	115	22	.	.	.
cord-006393-jcj9nqfu	116	1	About	about	RB
cord-006393-jcj9nqfu	116	2	half	half	NN
cord-006393-jcj9nqfu	116	3	of	of	IN
cord-006393-jcj9nqfu	116	4	the	the	DT
cord-006393-jcj9nqfu	116	5	cases	case	NNS
cord-006393-jcj9nqfu	116	6	of	of	IN
cord-006393-jcj9nqfu	116	7	hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	116	8	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	116	9	in	in	IN
cord-006393-jcj9nqfu	116	10	our	-PRON-	PRP$
cord-006393-jcj9nqfu	116	11	own	own	JJ
cord-006393-jcj9nqfu	116	12	patient	patient	JJ
cord-006393-jcj9nqfu	116	13	population	population	NN
cord-006393-jcj9nqfu	116	14	are	be	VBP
cord-006393-jcj9nqfu	116	15	now	now	RB
cord-006393-jcj9nqfu	116	16	due	due	JJ
cord-006393-jcj9nqfu	116	17	to	to	IN
cord-006393-jcj9nqfu	116	18	CMV	CMV	NNP
cord-006393-jcj9nqfu	116	19	;	;	:
cord-006393-jcj9nqfu	116	20	the	the	DT
cord-006393-jcj9nqfu	116	21	remainder	remainder	NN
cord-006393-jcj9nqfu	116	22	are	be	VBP
cord-006393-jcj9nqfu	116	23	split	split	VBN
cord-006393-jcj9nqfu	116	24	between	between	IN
cord-006393-jcj9nqfu	116	25	rotavirus	rotavirus	NN
cord-006393-jcj9nqfu	116	26	and	and	CC
cord-006393-jcj9nqfu	116	27	adenovirus	adenovirus	NN
cord-006393-jcj9nqfu	116	28	.	.	.
cord-006393-jcj9nqfu	117	1	Effective	effective	JJ
cord-006393-jcj9nqfu	117	2	measures	measure	NNS
cord-006393-jcj9nqfu	117	3	to	to	TO
cord-006393-jcj9nqfu	117	4	prevent	prevent	VB
cord-006393-jcj9nqfu	117	5	this	this	DT
cord-006393-jcj9nqfu	117	6	syndrome	syndrome	NN
cord-006393-jcj9nqfu	117	7	might	may	MD
cord-006393-jcj9nqfu	117	8	include	include	VB
cord-006393-jcj9nqfu	117	9	the	the	DT
cord-006393-jcj9nqfu	117	10	following	follow	VBG
cord-006393-jcj9nqfu	117	11	:	:	:
cord-006393-jcj9nqfu	117	12	strict	strict	JJ
cord-006393-jcj9nqfu	117	13	isolation	isolation	NN
cord-006393-jcj9nqfu	117	14	,	,	,
cord-006393-jcj9nqfu	117	15	effective	effective	JJ
cord-006393-jcj9nqfu	117	16	prevention	prevention	NN
cord-006393-jcj9nqfu	117	17	of	of	IN
cord-006393-jcj9nqfu	117	18	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	117	19	(	(	-LRB-
cord-006393-jcj9nqfu	117	20	since	since	IN
cord-006393-jcj9nqfu	117	21	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	117	22	might	may	MD
cord-006393-jcj9nqfu	117	23	well	well	RB
cord-006393-jcj9nqfu	117	24	set	set	VB
cord-006393-jcj9nqfu	117	25	the	the	DT
cord-006393-jcj9nqfu	117	26	stage	stage	NN
cord-006393-jcj9nqfu	117	27	for	for	IN
cord-006393-jcj9nqfu	117	28	hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	117	29	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	117	30	)	)	-RRB-
cord-006393-jcj9nqfu	117	31	,	,	,
cord-006393-jcj9nqfu	117	32	and	and	CC
cord-006393-jcj9nqfu	117	33	possibly	possibly	RB
cord-006393-jcj9nqfu	117	34	therapy	therapy	NN
cord-006393-jcj9nqfu	117	35	with	with	IN
cord-006393-jcj9nqfu	117	36	orally	orally	RB
cord-006393-jcj9nqfu	117	37	administered	administer	VBN
cord-006393-jcj9nqfu	117	38	immune	immune	JJ
cord-006393-jcj9nqfu	117	39	globulin	globulin	NN
cord-006393-jcj9nqfu	117	40	.	.	.
cord-006393-jcj9nqfu	118	1	There	there	EX
cord-006393-jcj9nqfu	118	2	might	may	MD
cord-006393-jcj9nqfu	118	3	be	be	VB
cord-006393-jcj9nqfu	118	4	a	a	DT
cord-006393-jcj9nqfu	118	5	rationale	rationale	NN
cord-006393-jcj9nqfu	118	6	for	for	IN
cord-006393-jcj9nqfu	118	7	such	such	PDT
cord-006393-jcj9nqfu	118	8	a	a	DT
cord-006393-jcj9nqfu	118	9	therapy	therapy	NN
cord-006393-jcj9nqfu	118	10	if	if	IN
cord-006393-jcj9nqfu	118	11	we	-PRON-	PRP
cord-006393-jcj9nqfu	118	12	consider	consider	VBP
cord-006393-jcj9nqfu	118	13	that	that	IN
cord-006393-jcj9nqfu	118	14	the	the	DT
cord-006393-jcj9nqfu	118	15	gastrointestinal	gastrointestinal	JJ
cord-006393-jcj9nqfu	118	16	tract	tract	NN
cord-006393-jcj9nqfu	118	17	is	be	VBZ
cord-006393-jcj9nqfu	118	18	severely	severely	RB
cord-006393-jcj9nqfu	118	19	injured	injure	VBN
cord-006393-jcj9nqfu	118	20	after	after	IN
cord-006393-jcj9nqfu	118	21	transplantation	transplantation	NN
cord-006393-jcj9nqfu	118	22	.	.	.
cord-006393-jcj9nqfu	119	1	The	the	DT
cord-006393-jcj9nqfu	119	2	preparative	preparative	JJ
cord-006393-jcj9nqfu	119	3	therapy	therapy	NN
cord-006393-jcj9nqfu	119	4	as	as	RB
cord-006393-jcj9nqfu	119	5	well	well	RB
cord-006393-jcj9nqfu	119	6	as	as	IN
cord-006393-jcj9nqfu	119	7	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	119	8	have	have	VBP
cord-006393-jcj9nqfu	119	9	caused	cause	VBN
cord-006393-jcj9nqfu	119	10	severe	severe	JJ
cord-006393-jcj9nqfu	119	11	mucosal	mucosal	JJ
cord-006393-jcj9nqfu	119	12	injury	injury	NN
cord-006393-jcj9nqfu	119	13	.	.	.
cord-006393-jcj9nqfu	120	1	The	the	DT
cord-006393-jcj9nqfu	120	2	Peyer	Peyer	NNP
cord-006393-jcj9nqfu	120	3	's	's	POS
cord-006393-jcj9nqfu	120	4	patches	patch	NNS
cord-006393-jcj9nqfu	120	5	and	and	CC
cord-006393-jcj9nqfu	120	6	other	other	JJ
cord-006393-jcj9nqfu	120	7	gutassociated	gutassociate	VBN
cord-006393-jcj9nqfu	120	8	lymphoid	lymphoid	JJ
cord-006393-jcj9nqfu	120	9	tissues	tissue	NNS
cord-006393-jcj9nqfu	120	10	have	have	VBP
cord-006393-jcj9nqfu	120	11	been	be	VBN
cord-006393-jcj9nqfu	120	12	destroyed	destroy	VBN
cord-006393-jcj9nqfu	120	13	and	and	CC
cord-006393-jcj9nqfu	120	14	must	must	MD
cord-006393-jcj9nqfu	120	15	be	be	VB
cord-006393-jcj9nqfu	120	16	rebuilt	rebuild	VBN
cord-006393-jcj9nqfu	120	17	.	.	.
cord-006393-jcj9nqfu	121	1	In	in	IN
cord-006393-jcj9nqfu	121	2	the	the	DT
cord-006393-jcj9nqfu	121	3	lamina	lamina	NNP
cord-006393-jcj9nqfu	121	4	propria	propria	NNP
cord-006393-jcj9nqfu	121	5	IgA	IgA	NNP
cord-006393-jcj9nqfu	121	6	-	-	HYPH
cord-006393-jcj9nqfu	121	7	and	and	CC
cord-006393-jcj9nqfu	121	8	IgM	IgM	NNP
cord-006393-jcj9nqfu	121	9	-	-	HYPH
cord-006393-jcj9nqfu	121	10	producing	produce	VBG
cord-006393-jcj9nqfu	121	11	plasma	plasma	NN
cord-006393-jcj9nqfu	121	12	cells	cell	NNS
cord-006393-jcj9nqfu	121	13	have	have	VBP
cord-006393-jcj9nqfu	121	14	disappeared	disappear	VBN
cord-006393-jcj9nqfu	121	15	.	.	.
cord-006393-jcj9nqfu	122	1	Most	most	RBS
cord-006393-jcj9nqfu	122	2	importantly	importantly	RB
cord-006393-jcj9nqfu	122	3	the	the	DT
cord-006393-jcj9nqfu	122	4	degradation	degradation	NN
cord-006393-jcj9nqfu	122	5	of	of	IN
cord-006393-jcj9nqfu	122	6	IgG	igg	NN
cord-006393-jcj9nqfu	122	7	when	when	WRB
cord-006393-jcj9nqfu	122	8	administered	administer	VBN
cord-006393-jcj9nqfu	122	9	orally	orally	RB
cord-006393-jcj9nqfu	122	10	is	be	VBZ
cord-006393-jcj9nqfu	122	11	much	much	RB
cord-006393-jcj9nqfu	122	12	impaired	impaired	JJ
cord-006393-jcj9nqfu	122	13	in	in	IN
cord-006393-jcj9nqfu	122	14	such	such	PDT
cord-006393-jcj9nqfu	122	15	a	a	DT
cord-006393-jcj9nqfu	122	16	devastated	devastated	JJ
cord-006393-jcj9nqfu	122	17	gut	gut	NN
cord-006393-jcj9nqfu	122	18	.	.	.
cord-006393-jcj9nqfu	123	1	It	-PRON-	PRP
cord-006393-jcj9nqfu	123	2	has	have	VBZ
cord-006393-jcj9nqfu	123	3	been	be	VBN
cord-006393-jcj9nqfu	123	4	shown	show	VBN
cord-006393-jcj9nqfu	123	5	that	that	IN
cord-006393-jcj9nqfu	123	6	IgG	IgG	NNP
cord-006393-jcj9nqfu	123	7	antibody	antibody	NN
cord-006393-jcj9nqfu	123	8	survives	survive	VBZ
cord-006393-jcj9nqfu	123	9	passage	passage	NN
cord-006393-jcj9nqfu	123	10	through	through	IN
cord-006393-jcj9nqfu	123	11	the	the	DT
cord-006393-jcj9nqfu	123	12	gastrointestinal	gastrointestinal	JJ
cord-006393-jcj9nqfu	123	13	tract	tract	NN
cord-006393-jcj9nqfu	123	14	and	and	CC
cord-006393-jcj9nqfu	123	15	emerges	emerge	VBZ
cord-006393-jcj9nqfu	123	16	as	as	IN
cord-006393-jcj9nqfu	123	17	an	an	DT
cord-006393-jcj9nqfu	123	18	intact	intact	JJ
cord-006393-jcj9nqfu	123	19	molecule	molecule	NN
cord-006393-jcj9nqfu	123	20	.	.	.
cord-006393-jcj9nqfu	124	1	This	this	DT
cord-006393-jcj9nqfu	124	2	led	lead	VBD
cord-006393-jcj9nqfu	124	3	us	-PRON-	PRP
cord-006393-jcj9nqfu	124	4	to	to	TO
cord-006393-jcj9nqfu	124	5	consider	consider	VB
cord-006393-jcj9nqfu	124	6	administering	administer	VBG
cord-006393-jcj9nqfu	124	7	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	124	8	orally	orally	RB
cord-006393-jcj9nqfu	124	9	to	to	IN
cord-006393-jcj9nqfu	124	10	patients	patient	NNS
cord-006393-jcj9nqfu	124	11	at	at	IN
cord-006393-jcj9nqfu	124	12	risk	risk	NN
cord-006393-jcj9nqfu	124	13	for	for	IN
cord-006393-jcj9nqfu	124	14	hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	124	15	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	124	16	.	.	.
cord-006393-jcj9nqfu	125	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	125	2	conducted	conduct	VBD
cord-006393-jcj9nqfu	125	3	a	a	DT
cord-006393-jcj9nqfu	125	4	pilot	pilot	NN
cord-006393-jcj9nqfu	125	5	trial	trial	NN
cord-006393-jcj9nqfu	125	6	in	in	IN
cord-006393-jcj9nqfu	125	7	which	which	WDT
cord-006393-jcj9nqfu	125	8	30	30	CD
cord-006393-jcj9nqfu	125	9	patients	patient	NNS
cord-006393-jcj9nqfu	125	10	were	be	VBD
cord-006393-jcj9nqfu	125	11	given	give	VBN
cord-006393-jcj9nqfu	125	12	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	125	13	orally	orally	RB
cord-006393-jcj9nqfu	125	14	at	at	IN
cord-006393-jcj9nqfu	125	15	a	a	DT
cord-006393-jcj9nqfu	125	16	dose	dose	NN
cord-006393-jcj9nqfu	125	17	of	of	IN
cord-006393-jcj9nqfu	125	18	50	50	CD
cord-006393-jcj9nqfu	125	19	mg	mg	NNP
cord-006393-jcj9nqfu	125	20	/	/	SYM
cord-006393-jcj9nqfu	125	21	kg	kg	NN
cord-006393-jcj9nqfu	125	22	for	for	IN
cord-006393-jcj9nqfu	125	23	4	4	CD
cord-006393-jcj9nqfu	125	24	weeks	week	NNS
cord-006393-jcj9nqfu	125	25	.	.	.
cord-006393-jcj9nqfu	126	1	Prior	prior	RB
cord-006393-jcj9nqfu	126	2	to	to	IN
cord-006393-jcj9nqfu	126	3	administration	administration	NN
cord-006393-jcj9nqfu	126	4	of	of	IN
cord-006393-jcj9nqfu	126	5	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	126	6	we	-PRON-	PRP
cord-006393-jcj9nqfu	126	7	could	could	MD
cord-006393-jcj9nqfu	126	8	not	not	RB
cord-006393-jcj9nqfu	126	9	demonstrate	demonstrate	VB
cord-006393-jcj9nqfu	126	10	any	any	DT
cord-006393-jcj9nqfu	126	11	IgG	igg	NN
cord-006393-jcj9nqfu	126	12	in	in	IN
cord-006393-jcj9nqfu	126	13	the	the	DT
cord-006393-jcj9nqfu	126	14	stool	stool	NN
cord-006393-jcj9nqfu	126	15	.	.	.
cord-006393-jcj9nqfu	127	1	After	after	IN
cord-006393-jcj9nqfu	127	2	oral	oral	JJ
cord-006393-jcj9nqfu	127	3	administration	administration	NN
cord-006393-jcj9nqfu	127	4	of	of	IN
cord-006393-jcj9nqfu	127	5	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	127	6	,	,	,
cord-006393-jcj9nqfu	127	7	20	20	CD
cord-006393-jcj9nqfu	127	8	of	of	IN
cord-006393-jcj9nqfu	127	9	30	30	CD
cord-006393-jcj9nqfu	127	10	patients	patient	NNS
cord-006393-jcj9nqfu	127	11	had	have	VBD
cord-006393-jcj9nqfu	127	12	considerable	considerable	JJ
cord-006393-jcj9nqfu	127	13	amounts	amount	NNS
cord-006393-jcj9nqfu	127	14	of	of	IN
cord-006393-jcj9nqfu	127	15	IgG	igg	NN
cord-006393-jcj9nqfu	127	16	,	,	,
cord-006393-jcj9nqfu	127	17	up	up	IN
cord-006393-jcj9nqfu	127	18	to	to	TO
cord-006393-jcj9nqfu	127	19	400	400	CD
cord-006393-jcj9nqfu	127	20	mg	mg	NNP
cord-006393-jcj9nqfu	127	21	/	/	SYM
cord-006393-jcj9nqfu	127	22	dl	dl	NNP
cord-006393-jcj9nqfu	127	23	,	,	,
cord-006393-jcj9nqfu	127	24	in	in	IN
cord-006393-jcj9nqfu	127	25	the	the	DT
cord-006393-jcj9nqfu	127	26	stool	stool	NN
cord-006393-jcj9nqfu	127	27	.	.	.
cord-006393-jcj9nqfu	128	1	Eighteen	eighteen	CD
cord-006393-jcj9nqfu	128	2	patients	patient	NNS
cord-006393-jcj9nqfu	128	3	had	have	VBD
cord-006393-jcj9nqfu	128	4	greater	great	JJR
cord-006393-jcj9nqfu	128	5	than	than	IN
cord-006393-jcj9nqfu	128	6	20	20	CD
cord-006393-jcj9nqfu	128	7	mg	mg	NNP
cord-006393-jcj9nqfu	128	8	/	/	SYM
cord-006393-jcj9nqfu	128	9	dl	dl	NN
cord-006393-jcj9nqfu	128	10	.	.	.
cord-006393-jcj9nqfu	129	1	Only	only	RB
cord-006393-jcj9nqfu	129	2	1	1	CD
cord-006393-jcj9nqfu	129	3	of	of	IN
cord-006393-jcj9nqfu	129	4	the	the	DT
cord-006393-jcj9nqfu	129	5	30	30	CD
cord-006393-jcj9nqfu	129	6	patients	patient	NNS
cord-006393-jcj9nqfu	129	7	developed	develop	VBD
cord-006393-jcj9nqfu	129	8	a	a	DT
cord-006393-jcj9nqfu	129	9	positive	positive	JJ
cord-006393-jcj9nqfu	129	10	adenovirus	adenovirus	NN
cord-006393-jcj9nqfu	129	11	culture	culture	NN
cord-006393-jcj9nqfu	129	12	and	and	CC
cord-006393-jcj9nqfu	129	13	12	12	CD
cord-006393-jcj9nqfu	129	14	patients	patient	NNS
cord-006393-jcj9nqfu	129	15	remained	remain	VBD
cord-006393-jcj9nqfu	129	16	afebrile	afebrile	JJ
cord-006393-jcj9nqfu	129	17	(	(	-LRB-
cord-006393-jcj9nqfu	129	18	11	11	CD
cord-006393-jcj9nqfu	129	19	)	)	-RRB-
cord-006393-jcj9nqfu	129	20	.	.	.
cord-006393-jcj9nqfu	130	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	130	2	have	have	VBP
cord-006393-jcj9nqfu	130	3	just	just	RB
cord-006393-jcj9nqfu	130	4	completed	complete	VBN
cord-006393-jcj9nqfu	130	5	a	a	DT
cord-006393-jcj9nqfu	130	6	double	double	JJ
cord-006393-jcj9nqfu	130	7	-	-	HYPH
cord-006393-jcj9nqfu	130	8	blind	blind	JJ
cord-006393-jcj9nqfu	130	9	,	,	,
cord-006393-jcj9nqfu	130	10	randomized	randomized	JJ
cord-006393-jcj9nqfu	130	11	study	study	NN
cord-006393-jcj9nqfu	130	12	comparing	compare	VBG
cord-006393-jcj9nqfu	130	13	orally	orally	RB
cord-006393-jcj9nqfu	130	14	administered	administer	VBN
cord-006393-jcj9nqfu	130	15	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	130	16	to	to	IN
cord-006393-jcj9nqfu	130	17	placebo	placebo	NN
cord-006393-jcj9nqfu	130	18	.	.	.
cord-006393-jcj9nqfu	131	1	Hopefully	hopefully	RB
cord-006393-jcj9nqfu	131	2	,	,	,
cord-006393-jcj9nqfu	131	3	the	the	DT
cord-006393-jcj9nqfu	131	4	analysis	analysis	NN
cord-006393-jcj9nqfu	131	5	of	of	IN
cord-006393-jcj9nqfu	131	6	the	the	DT
cord-006393-jcj9nqfu	131	7	study	study	NN
cord-006393-jcj9nqfu	131	8	will	will	MD
cord-006393-jcj9nqfu	131	9	show	show	VB
cord-006393-jcj9nqfu	131	10	that	that	IN
cord-006393-jcj9nqfu	131	11	the	the	DT
cord-006393-jcj9nqfu	131	12	concept	concept	NN
cord-006393-jcj9nqfu	131	13	of	of	IN
cord-006393-jcj9nqfu	131	14	oral	oral	JJ
cord-006393-jcj9nqfu	131	15	administration	administration	NN
cord-006393-jcj9nqfu	131	16	of	of	IN
cord-006393-jcj9nqfu	131	17	immune	immune	JJ
cord-006393-jcj9nqfu	131	18	globulin	globulin	NN
cord-006393-jcj9nqfu	131	19	has	have	VBZ
cord-006393-jcj9nqfu	131	20	some	some	DT
cord-006393-jcj9nqfu	131	21	merit	merit	NN
cord-006393-jcj9nqfu	131	22	.	.	.
cord-006393-jcj9nqfu	132	1	The	the	DT
cord-006393-jcj9nqfu	132	2	immunobiology	immunobiology	NN
cord-006393-jcj9nqfu	132	3	of	of	IN
cord-006393-jcj9nqfu	132	4	phase	phase	NN
cord-006393-jcj9nqfu	132	5	III	III	NNP
cord-006393-jcj9nqfu	132	6	,	,	,
cord-006393-jcj9nqfu	132	7	the	the	DT
cord-006393-jcj9nqfu	132	8	late	late	JJ
cord-006393-jcj9nqfu	132	9	postengraftment	postengraftment	NN
cord-006393-jcj9nqfu	132	10	phase	phase	NN
cord-006393-jcj9nqfu	132	11	,	,	,
cord-006393-jcj9nqfu	132	12	is	be	VBZ
cord-006393-jcj9nqfu	132	13	characterized	characterize	VBN
cord-006393-jcj9nqfu	132	14	by	by	IN
cord-006393-jcj9nqfu	132	15	a	a	DT
cord-006393-jcj9nqfu	132	16	continuous	continuous	JJ
cord-006393-jcj9nqfu	132	17	impairment	impairment	NN
cord-006393-jcj9nqfu	132	18	of	of	IN
cord-006393-jcj9nqfu	132	19	the	the	DT
cord-006393-jcj9nqfu	132	20	T	T	NNP
cord-006393-jcj9nqfu	132	21	helper	helper	NN
cord-006393-jcj9nqfu	132	22	-	-	HYPH
cord-006393-jcj9nqfu	132	23	cell	cell	NN
cord-006393-jcj9nqfu	132	24	function	function	NN
cord-006393-jcj9nqfu	132	25	,	,	,
cord-006393-jcj9nqfu	132	26	a	a	DT
cord-006393-jcj9nqfu	132	27	continuous	continuous	JJ
cord-006393-jcj9nqfu	132	28	defect	defect	NN
cord-006393-jcj9nqfu	132	29	in	in	IN
cord-006393-jcj9nqfu	132	30	humoral	humoral	JJ
cord-006393-jcj9nqfu	132	31	immunity	immunity	NN
cord-006393-jcj9nqfu	132	32	,	,	,
cord-006393-jcj9nqfu	132	33	and	and	CC
cord-006393-jcj9nqfu	132	34	,	,	,
cord-006393-jcj9nqfu	132	35	in	in	IN
cord-006393-jcj9nqfu	132	36	particular	particular	JJ
cord-006393-jcj9nqfu	132	37	,	,	,
cord-006393-jcj9nqfu	132	38	the	the	DT
cord-006393-jcj9nqfu	132	39	development	development	NN
cord-006393-jcj9nqfu	132	40	of	of	IN
cord-006393-jcj9nqfu	132	41	chronic	chronic	JJ
cord-006393-jcj9nqfu	132	42	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	132	43	.	.	.
cord-006393-jcj9nqfu	133	1	A	a	DT
cord-006393-jcj9nqfu	133	2	number	number	NN
cord-006393-jcj9nqfu	133	3	of	of	IN
cord-006393-jcj9nqfu	133	4	infections	infection	NNS
cord-006393-jcj9nqfu	133	5	are	be	VBP
cord-006393-jcj9nqfu	133	6	seen	see	VBN
cord-006393-jcj9nqfu	133	7	in	in	IN
cord-006393-jcj9nqfu	133	8	this	this	DT
cord-006393-jcj9nqfu	133	9	posttransplant	posttransplant	NN
cord-006393-jcj9nqfu	133	10	phase	phase	NN
cord-006393-jcj9nqfu	133	11	,	,	,
cord-006393-jcj9nqfu	133	12	especially	especially	RB
cord-006393-jcj9nqfu	133	13	sinopulmonary	sinopulmonary	JJ
cord-006393-jcj9nqfu	133	14	infections	infection	NNS
cord-006393-jcj9nqfu	133	15	with	with	IN
cord-006393-jcj9nqfu	133	16	encapsulated	encapsulate	VBN
cord-006393-jcj9nqfu	133	17	organisms	organism	NNS
cord-006393-jcj9nqfu	133	18	such	such	JJ
cord-006393-jcj9nqfu	133	19	as	as	IN
cord-006393-jcj9nqfu	133	20	Streptococcus	streptococcus	NN
cord-006393-jcj9nqfu	133	21	pneumoniae	pneumoniae	NN
cord-006393-jcj9nqfu	133	22	.	.	.
cord-006393-jcj9nqfu	134	1	Initially	initially	RB
cord-006393-jcj9nqfu	134	2	we	-PRON-	PRP
cord-006393-jcj9nqfu	134	3	thought	think	VBD
cord-006393-jcj9nqfu	134	4	that	that	IN
cord-006393-jcj9nqfu	134	5	the	the	DT
cord-006393-jcj9nqfu	134	6	hyposplenism	hyposplenism	NN
cord-006393-jcj9nqfu	134	7	associated	associate	VBN
cord-006393-jcj9nqfu	134	8	with	with	IN
cord-006393-jcj9nqfu	134	9	chronic	chronic	JJ
cord-006393-jcj9nqfu	134	10	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	134	11	was	be	VBD
cord-006393-jcj9nqfu	134	12	responsible	responsible	JJ
cord-006393-jcj9nqfu	134	13	for	for	IN
cord-006393-jcj9nqfu	134	14	these	these	DT
cord-006393-jcj9nqfu	134	15	infections	infection	NNS
cord-006393-jcj9nqfu	134	16	(	(	-LRB-
cord-006393-jcj9nqfu	134	17	12	12	CD
cord-006393-jcj9nqfu	134	18	)	)	-RRB-
cord-006393-jcj9nqfu	134	19	.	.	.
cord-006393-jcj9nqfu	135	1	However	however	RB
cord-006393-jcj9nqfu	135	2	,	,	,
cord-006393-jcj9nqfu	135	3	we	-PRON-	PRP
cord-006393-jcj9nqfu	135	4	considered	consider	VBD
cord-006393-jcj9nqfu	135	5	that	that	IN
cord-006393-jcj9nqfu	135	6	there	there	EX
cord-006393-jcj9nqfu	135	7	might	may	MD
cord-006393-jcj9nqfu	135	8	also	also	RB
cord-006393-jcj9nqfu	135	9	be	be	VB
cord-006393-jcj9nqfu	135	10	an	an	DT
cord-006393-jcj9nqfu	135	11	association	association	NN
cord-006393-jcj9nqfu	135	12	with	with	IN
cord-006393-jcj9nqfu	135	13	an	an	DT
cord-006393-jcj9nqfu	135	14	IgGsubclass	IgGsubclass	NNP
cord-006393-jcj9nqfu	135	15	deficiency	deficiency	NN
cord-006393-jcj9nqfu	135	16	and	and	CC
cord-006393-jcj9nqfu	135	17	we	-PRON-	PRP
cord-006393-jcj9nqfu	135	18	conducted	conduct	VBD
cord-006393-jcj9nqfu	135	19	a	a	DT
cord-006393-jcj9nqfu	135	20	small	small	JJ
cord-006393-jcj9nqfu	135	21	study	study	NN
cord-006393-jcj9nqfu	135	22	.	.	.
cord-006393-jcj9nqfu	136	1	IgG	IgG	NNP
cord-006393-jcj9nqfu	136	2	subclasses	subclass	NNS
cord-006393-jcj9nqfu	136	3	were	be	VBD
cord-006393-jcj9nqfu	136	4	determined	determine	VBN
cord-006393-jcj9nqfu	136	5	in	in	IN
cord-006393-jcj9nqfu	136	6	28	28	CD
cord-006393-jcj9nqfu	136	7	patients	patient	NNS
cord-006393-jcj9nqfu	136	8	.	.	.
cord-006393-jcj9nqfu	137	1	One	one	CD
cord-006393-jcj9nqfu	137	2	group	group	NN
cord-006393-jcj9nqfu	137	3	of	of	IN
cord-006393-jcj9nqfu	137	4	14	14	CD
cord-006393-jcj9nqfu	137	5	patients	patient	NNS
cord-006393-jcj9nqfu	137	6	showed	show	VBD
cord-006393-jcj9nqfu	137	7	a	a	DT
cord-006393-jcj9nqfu	137	8	marked	mark	VBN
cord-006393-jcj9nqfu	137	9	IgG2-subclass	IgG2-subclass	NNP
cord-006393-jcj9nqfu	137	10	deficiency	deficiency	NN
cord-006393-jcj9nqfu	137	11	with	with	IN
cord-006393-jcj9nqfu	137	12	a	a	DT
cord-006393-jcj9nqfu	137	13	very	very	RB
cord-006393-jcj9nqfu	137	14	high	high	JJ
cord-006393-jcj9nqfu	137	15	infection	infection	NN
cord-006393-jcj9nqfu	137	16	rate	rate	NN
cord-006393-jcj9nqfu	137	17	.	.	.
cord-006393-jcj9nqfu	138	1	Twelve	twelve	CD
cord-006393-jcj9nqfu	138	2	of	of	IN
cord-006393-jcj9nqfu	138	3	these	these	DT
cord-006393-jcj9nqfu	138	4	14	14	CD
cord-006393-jcj9nqfu	138	5	patients	patient	NNS
cord-006393-jcj9nqfu	138	6	developed	develop	VBD
cord-006393-jcj9nqfu	138	7	infections	infection	NNS
cord-006393-jcj9nqfu	138	8	with	with	IN
cord-006393-jcj9nqfu	138	9	gram	gram	NN
cord-006393-jcj9nqfu	138	10	-	-	HYPH
cord-006393-jcj9nqfu	138	11	positive	positive	JJ
cord-006393-jcj9nqfu	138	12	organisms	organism	NNS
cord-006393-jcj9nqfu	138	13	.	.	.
cord-006393-jcj9nqfu	139	1	Another	another	DT
cord-006393-jcj9nqfu	139	2	group	group	NN
cord-006393-jcj9nqfu	139	3	of	of	IN
cord-006393-jcj9nqfu	139	4	14	14	CD
cord-006393-jcj9nqfu	139	5	patients	patient	NNS
cord-006393-jcj9nqfu	139	6	with	with	IN
cord-006393-jcj9nqfu	139	7	no	no	DT
cord-006393-jcj9nqfu	139	8	IgG2-subclass	IgG2-subclass	NNP
cord-006393-jcj9nqfu	139	9	deficiency	deficiency	NN
cord-006393-jcj9nqfu	139	10	had	have	VBD
cord-006393-jcj9nqfu	139	11	a	a	DT
cord-006393-jcj9nqfu	139	12	very	very	RB
cord-006393-jcj9nqfu	139	13	low	low	JJ
cord-006393-jcj9nqfu	139	14	infection	infection	NN
cord-006393-jcj9nqfu	139	15	rate	rate	NN
cord-006393-jcj9nqfu	139	16	,	,	,
cord-006393-jcj9nqfu	139	17	with	with	IN
cord-006393-jcj9nqfu	139	18	only	only	RB
cord-006393-jcj9nqfu	139	19	2	2	CD
cord-006393-jcj9nqfu	139	20	of	of	IN
cord-006393-jcj9nqfu	139	21	14	14	CD
cord-006393-jcj9nqfu	139	22	being	be	VBG
cord-006393-jcj9nqfu	139	23	infected	infect	VBN
cord-006393-jcj9nqfu	139	24	.	.	.
cord-006393-jcj9nqfu	140	1	Studying	study	VBG
cord-006393-jcj9nqfu	140	2	these	these	DT
cord-006393-jcj9nqfu	140	3	patients	patient	NNS
cord-006393-jcj9nqfu	140	4	further	far	RBR
cord-006393-jcj9nqfu	140	5	we	-PRON-	PRP
cord-006393-jcj9nqfu	140	6	could	could	MD
cord-006393-jcj9nqfu	140	7	show	show	VB
cord-006393-jcj9nqfu	140	8	that	that	IN
cord-006393-jcj9nqfu	140	9	the	the	DT
cord-006393-jcj9nqfu	140	10	patients	patient	NNS
cord-006393-jcj9nqfu	140	11	continued	continue	VBD
cord-006393-jcj9nqfu	140	12	to	to	TO
cord-006393-jcj9nqfu	140	13	show	show	VB
cord-006393-jcj9nqfu	140	14	subclass	subclass	NN
cord-006393-jcj9nqfu	140	15	deficiency	deficiency	NN
cord-006393-jcj9nqfu	140	16	even	even	RB
cord-006393-jcj9nqfu	140	17	after	after	IN
cord-006393-jcj9nqfu	140	18	they	-PRON-	PRP
cord-006393-jcj9nqfu	140	19	resolved	resolve	VBD
cord-006393-jcj9nqfu	140	20	the	the	DT
cord-006393-jcj9nqfu	140	21	infections	infection	NNS
cord-006393-jcj9nqfu	140	22	.	.	.
cord-006393-jcj9nqfu	141	1	However	however	RB
cord-006393-jcj9nqfu	141	2	,	,	,
cord-006393-jcj9nqfu	141	3	it	-PRON-	PRP
cord-006393-jcj9nqfu	141	4	is	be	VBZ
cord-006393-jcj9nqfu	141	5	not	not	RB
cord-006393-jcj9nqfu	141	6	only	only	RB
cord-006393-jcj9nqfu	141	7	IgG2	igg2	JJ
cord-006393-jcj9nqfu	141	8	but	but	CC
cord-006393-jcj9nqfu	141	9	also	also	RB
cord-006393-jcj9nqfu	142	1	IgG4	igg4	CD
cord-006393-jcj9nqfu	142	2	subclass	subclass	NN
cord-006393-jcj9nqfu	142	3	which	which	WDT
cord-006393-jcj9nqfu	142	4	was	be	VBD
cord-006393-jcj9nqfu	142	5	markedly	markedly	RB
cord-006393-jcj9nqfu	142	6	reduced	reduce	VBN
cord-006393-jcj9nqfu	142	7	(	(	-LRB-
cord-006393-jcj9nqfu	142	8	13	13	CD
cord-006393-jcj9nqfu	142	9	)	)	-RRB-
cord-006393-jcj9nqfu	142	10	.	.	.
cord-006393-jcj9nqfu	143	1	To	to	TO
cord-006393-jcj9nqfu	143	2	prevent	prevent	VB
cord-006393-jcj9nqfu	143	3	these	these	DT
cord-006393-jcj9nqfu	143	4	late	late	JJ
cord-006393-jcj9nqfu	143	5	infections	infection	NNS
cord-006393-jcj9nqfu	143	6	one	one	PRP
cord-006393-jcj9nqfu	143	7	could	could	MD
cord-006393-jcj9nqfu	143	8	maintain	maintain	VB
cord-006393-jcj9nqfu	143	9	coverage	coverage	NN
cord-006393-jcj9nqfu	143	10	against	against	IN
cord-006393-jcj9nqfu	143	11	gram	gram	NN
cord-006393-jcj9nqfu	143	12	-	-	HYPH
cord-006393-jcj9nqfu	143	13	positive	positive	JJ
cord-006393-jcj9nqfu	143	14	organisms	organism	NNS
cord-006393-jcj9nqfu	143	15	beyond	beyond	IN
cord-006393-jcj9nqfu	143	16	day	day	NN
cord-006393-jcj9nqfu	143	17	I00	I00	NNP
cord-006393-jcj9nqfu	143	18	and	and	CC
cord-006393-jcj9nqfu	143	19	should	should	MD
cord-006393-jcj9nqfu	143	20	maintain	maintain	VB
cord-006393-jcj9nqfu	143	21	gram	gram	NN
cord-006393-jcj9nqfu	143	22	-	-	HYPH
cord-006393-jcj9nqfu	143	23	positive	positive	JJ
cord-006393-jcj9nqfu	143	24	coverage	coverage	NN
cord-006393-jcj9nqfu	143	25	for	for	IN
cord-006393-jcj9nqfu	143	26	an	an	DT
cord-006393-jcj9nqfu	143	27	even	even	RB
cord-006393-jcj9nqfu	143	28	longer	long	JJR
cord-006393-jcj9nqfu	143	29	period	period	NN
cord-006393-jcj9nqfu	143	30	in	in	IN
cord-006393-jcj9nqfu	143	31	patients	patient	NNS
cord-006393-jcj9nqfu	143	32	who	who	WP
cord-006393-jcj9nqfu	143	33	demonstrate	demonstrate	VBP
cord-006393-jcj9nqfu	143	34	chronic	chronic	JJ
cord-006393-jcj9nqfu	143	35	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	143	36	.	.	.
cord-006393-jcj9nqfu	144	1	Most	most	RBS
cord-006393-jcj9nqfu	144	2	importantly	importantly	RB
cord-006393-jcj9nqfu	144	3	,	,	,
cord-006393-jcj9nqfu	144	4	one	one	PRP
cord-006393-jcj9nqfu	144	5	should	should	MD
cord-006393-jcj9nqfu	144	6	maintain	maintain	VB
cord-006393-jcj9nqfu	144	7	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	144	8	supplementation	supplementation	NN
cord-006393-jcj9nqfu	144	9	beyond	beyond	IN
cord-006393-jcj9nqfu	144	10	day	day	NN
cord-006393-jcj9nqfu	144	11	120	120	CD
cord-006393-jcj9nqfu	144	12	for	for	IN
cord-006393-jcj9nqfu	144	13	the	the	DT
cord-006393-jcj9nqfu	144	14	first	first	JJ
cord-006393-jcj9nqfu	144	15	year	year	NN
cord-006393-jcj9nqfu	144	16	.	.	.
cord-006393-jcj9nqfu	145	1	In	in	IN
cord-006393-jcj9nqfu	145	2	our	-PRON-	PRP$
cord-006393-jcj9nqfu	145	3	transplant	transplant	NN
cord-006393-jcj9nqfu	145	4	center	center	NN
cord-006393-jcj9nqfu	145	5	we	-PRON-	PRP
cord-006393-jcj9nqfu	145	6	continue	continue	VBP
cord-006393-jcj9nqfu	145	7	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	145	8	supplementation	supplementation	NN
cord-006393-jcj9nqfu	145	9	as	as	RB
cord-006393-jcj9nqfu	145	10	long	long	RB
cord-006393-jcj9nqfu	145	11	as	as	IN
cord-006393-jcj9nqfu	145	12	the	the	DT
cord-006393-jcj9nqfu	145	13	subclass	subclass	NN
cord-006393-jcj9nqfu	145	14	deficiency	deficiency	NN
cord-006393-jcj9nqfu	145	15	persists	persist	VBZ
cord-006393-jcj9nqfu	145	16	,	,	,
cord-006393-jcj9nqfu	145	17	not	not	RB
cord-006393-jcj9nqfu	145	18	unlike	unlike	IN
cord-006393-jcj9nqfu	145	19	a	a	DT
cord-006393-jcj9nqfu	145	20	patient	patient	NN
cord-006393-jcj9nqfu	145	21	with	with	IN
cord-006393-jcj9nqfu	145	22	an	an	DT
cord-006393-jcj9nqfu	145	23	inborn	inborn	JJ
cord-006393-jcj9nqfu	145	24	IgGsubclass	IgGsubclass	NNP
cord-006393-jcj9nqfu	145	25	deficiency	deficiency	NN
cord-006393-jcj9nqfu	145	26	syndrome	syndrome	NN
cord-006393-jcj9nqfu	145	27	.	.	.
cord-006393-jcj9nqfu	146	1	Utilizing	utilize	VBG
cord-006393-jcj9nqfu	146	2	this	this	DT
cord-006393-jcj9nqfu	146	3	strategy	strategy	NN
cord-006393-jcj9nqfu	146	4	one	one	PRP
cord-006393-jcj9nqfu	146	5	can	can	MD
cord-006393-jcj9nqfu	146	6	virtually	virtually	RB
cord-006393-jcj9nqfu	146	7	eliminate	eliminate	VB
cord-006393-jcj9nqfu	146	8	late	late	JJ
cord-006393-jcj9nqfu	146	9	gram	gram	NN
cord-006393-jcj9nqfu	146	10	-	-	HYPH
cord-006393-jcj9nqfu	146	11	positive	positive	JJ
cord-006393-jcj9nqfu	146	12	infections	infection	NNS
cord-006393-jcj9nqfu	146	13	.	.	.
cord-006393-jcj9nqfu	147	1	Since	since	IN
cord-006393-jcj9nqfu	147	2	there	there	EX
cord-006393-jcj9nqfu	147	3	are	be	VBP
cord-006393-jcj9nqfu	147	4	a	a	DT
cord-006393-jcj9nqfu	147	5	number	number	NN
cord-006393-jcj9nqfu	147	6	of	of	IN
cord-006393-jcj9nqfu	147	7	sequential	sequential	JJ
cord-006393-jcj9nqfu	147	8	events	event	NNS
cord-006393-jcj9nqfu	147	9	in	in	IN
cord-006393-jcj9nqfu	147	10	the	the	DT
cord-006393-jcj9nqfu	147	11	immunobiology	immunobiology	NN
cord-006393-jcj9nqfu	147	12	after	after	IN
cord-006393-jcj9nqfu	147	13	transplantation	transplantation	NN
cord-006393-jcj9nqfu	147	14	which	which	WDT
cord-006393-jcj9nqfu	147	15	correlate	correlate	VBP
cord-006393-jcj9nqfu	147	16	with	with	IN
cord-006393-jcj9nqfu	147	17	infectious	infectious	JJ
cord-006393-jcj9nqfu	147	18	patterns	pattern	NNS
cord-006393-jcj9nqfu	147	19	,	,	,
cord-006393-jcj9nqfu	147	20	it	-PRON-	PRP
cord-006393-jcj9nqfu	147	21	should	should	MD
cord-006393-jcj9nqfu	147	22	be	be	VB
cord-006393-jcj9nqfu	147	23	possible	possible	JJ
cord-006393-jcj9nqfu	147	24	to	to	TO
cord-006393-jcj9nqfu	147	25	develop	develop	VB
cord-006393-jcj9nqfu	147	26	rational	rational	JJ
cord-006393-jcj9nqfu	147	27	strategies	strategy	NNS
cord-006393-jcj9nqfu	147	28	to	to	TO
cord-006393-jcj9nqfu	147	29	counteract	counteract	VB
cord-006393-jcj9nqfu	147	30	the	the	DT
cord-006393-jcj9nqfu	147	31	various	various	JJ
cord-006393-jcj9nqfu	147	32	immune	immune	JJ
cord-006393-jcj9nqfu	147	33	defects	defect	NNS
cord-006393-jcj9nqfu	147	34	.	.	.
cord-006393-jcj9nqfu	148	1	The	the	DT
cord-006393-jcj9nqfu	148	2	prophylactic	prophylactic	JJ
cord-006393-jcj9nqfu	148	3	and	and	CC
cord-006393-jcj9nqfu	148	4	therapeutic	therapeutic	JJ
cord-006393-jcj9nqfu	148	5	use	use	NN
cord-006393-jcj9nqfu	148	6	of	of	IN
cord-006393-jcj9nqfu	148	7	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	148	8	might	may	MD
cord-006393-jcj9nqfu	148	9	have	have	VB
cord-006393-jcj9nqfu	148	10	a	a	DT
cord-006393-jcj9nqfu	148	11	central	central	JJ
cord-006393-jcj9nqfu	148	12	role	role	NN
cord-006393-jcj9nqfu	148	13	because	because	IN
cord-006393-jcj9nqfu	148	14	it	-PRON-	PRP
cord-006393-jcj9nqfu	148	15	is	be	VBZ
cord-006393-jcj9nqfu	148	16	likely	likely	JJ
cord-006393-jcj9nqfu	148	17	to	to	TO
cord-006393-jcj9nqfu	148	18	affect	affect	VB
cord-006393-jcj9nqfu	148	19	all	all	DT
cord-006393-jcj9nqfu	148	20	phases	phase	NNS
cord-006393-jcj9nqfu	148	21	of	of	IN
cord-006393-jcj9nqfu	148	22	bone	bone	NN
cord-006393-jcj9nqfu	148	23	marrow	marrow	NN
cord-006393-jcj9nqfu	148	24	transplantation	transplantation	NN
cord-006393-jcj9nqfu	148	25	.	.	.
cord-006393-jcj9nqfu	149	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	149	2	know	know	VBP
cord-006393-jcj9nqfu	149	3	that	that	IN
cord-006393-jcj9nqfu	149	4	immune	immune	JJ
cord-006393-jcj9nqfu	149	5	globulins	globulin	NNS
cord-006393-jcj9nqfu	149	6	have	have	VBP
cord-006393-jcj9nqfu	149	7	a	a	DT
cord-006393-jcj9nqfu	149	8	beneficial	beneficial	JJ
cord-006393-jcj9nqfu	149	9	effect	effect	NN
cord-006393-jcj9nqfu	149	10	in	in	IN
cord-006393-jcj9nqfu	149	11	both	both	CC
cord-006393-jcj9nqfu	149	12	the	the	DT
cord-006393-jcj9nqfu	149	13	prevention	prevention	NN
cord-006393-jcj9nqfu	149	14	and	and	CC
cord-006393-jcj9nqfu	149	15	the	the	DT
cord-006393-jcj9nqfu	149	16	treatment	treatment	NN
cord-006393-jcj9nqfu	149	17	of	of	IN
cord-006393-jcj9nqfu	149	18	viral	viral	JJ
cord-006393-jcj9nqfu	149	19	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	149	20	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	149	21	.	.	.
cord-006393-jcj9nqfu	150	1	It	-PRON-	PRP
cord-006393-jcj9nqfu	150	2	is	be	VBZ
cord-006393-jcj9nqfu	150	3	likely	likely	JJ
cord-006393-jcj9nqfu	150	4	that	that	IN
cord-006393-jcj9nqfu	150	5	immune	immune	JJ
cord-006393-jcj9nqfu	150	6	globulin	globulin	NN
cord-006393-jcj9nqfu	150	7	will	will	MD
cord-006393-jcj9nqfu	150	8	also	also	RB
cord-006393-jcj9nqfu	150	9	have	have	VB
cord-006393-jcj9nqfu	150	10	a	a	DT
cord-006393-jcj9nqfu	150	11	beneficial	beneficial	JJ
cord-006393-jcj9nqfu	150	12	effect	effect	NN
cord-006393-jcj9nqfu	150	13	in	in	IN
cord-006393-jcj9nqfu	150	14	the	the	DT
cord-006393-jcj9nqfu	150	15	prevention	prevention	NN
cord-006393-jcj9nqfu	150	16	of	of	IN
cord-006393-jcj9nqfu	150	17	viral	viral	JJ
cord-006393-jcj9nqfu	150	18	enteritis	enteritis	NN
cord-006393-jcj9nqfu	150	19	and	and	CC
cord-006393-jcj9nqfu	150	20	in	in	IN
cord-006393-jcj9nqfu	150	21	counteracting	counteract	VBG
cord-006393-jcj9nqfu	150	22	late	late	JJ
cord-006393-jcj9nqfu	150	23	subclass	subclass	NN
cord-006393-jcj9nqfu	150	24	deficiency	deficiency	NN
cord-006393-jcj9nqfu	150	25	.	.	.
cord-006393-jcj9nqfu	151	1	There	there	EX
cord-006393-jcj9nqfu	151	2	may	may	MD
cord-006393-jcj9nqfu	151	3	also	also	RB
cord-006393-jcj9nqfu	151	4	be	be	VB
cord-006393-jcj9nqfu	151	5	some	some	DT
cord-006393-jcj9nqfu	151	6	modulating	modulate	VBG
cord-006393-jcj9nqfu	151	7	influence	influence	NN
cord-006393-jcj9nqfu	151	8	on	on	IN
cord-006393-jcj9nqfu	151	9	the	the	DT
cord-006393-jcj9nqfu	151	10	entire	entire	JJ
cord-006393-jcj9nqfu	151	11	immunobiology	immunobiology	NN
cord-006393-jcj9nqfu	151	12	of	of	IN
cord-006393-jcj9nqfu	151	13	bone	bone	NN
cord-006393-jcj9nqfu	151	14	marrow	marrow	NN
cord-006393-jcj9nqfu	151	15	transplantation	transplantation	NN
cord-006393-jcj9nqfu	151	16	.	.	.
cord-006393-jcj9nqfu	152	1	Bone	bone	NN
cord-006393-jcj9nqfu	152	2	marrow	marrow	NN
cord-006393-jcj9nqfu	152	3	transplantation	transplantation	NN
cord-006393-jcj9nqfu	152	4	for	for	IN
cord-006393-jcj9nqfu	152	5	leukemia	leukemia	NN
cord-006393-jcj9nqfu	152	6	following	follow	VBG
cord-006393-jcj9nqfu	152	7	a	a	DT
cord-006393-jcj9nqfu	152	8	new	new	JJ
cord-006393-jcj9nqfu	152	9	busuIfan	busuifan	NN
cord-006393-jcj9nqfu	152	10	and	and	CC
cord-006393-jcj9nqfu	152	11	cyclophosphamide	cyclophosphamide	JJ
cord-006393-jcj9nqfu	152	12	regimen	regimen	NN
cord-006393-jcj9nqfu	152	13	Graft	graft	NN
cord-006393-jcj9nqfu	152	14	versus	versus	IN
cord-006393-jcj9nqfu	152	15	host	host	NN
cord-006393-jcj9nqfu	152	16	disease	disease	NN
cord-006393-jcj9nqfu	152	17	and	and	CC
cord-006393-jcj9nqfu	152	18	survival	survival	NN
cord-006393-jcj9nqfu	152	19	in	in	IN
cord-006393-jcj9nqfu	152	20	patients	patient	NNS
cord-006393-jcj9nqfu	152	21	with	with	IN
cord-006393-jcj9nqfu	152	22	aplastic	aplastic	JJ
cord-006393-jcj9nqfu	152	23	anemia	anemia	NN
cord-006393-jcj9nqfu	152	24	treated	treat	VBN
cord-006393-jcj9nqfu	152	25	by	by	IN
cord-006393-jcj9nqfu	152	26	marrow	marrow	NN
cord-006393-jcj9nqfu	152	27	grafts	graft	NNS
cord-006393-jcj9nqfu	152	28	from	from	IN
cord-006393-jcj9nqfu	152	29	HLA	HLA	NNP
cord-006393-jcj9nqfu	152	30	-	-	HYPH
cord-006393-jcj9nqfu	152	31	identical	identical	JJ
cord-006393-jcj9nqfu	152	32	siblings	sibling	NNS
cord-006393-jcj9nqfu	152	33	:	:	:
cord-006393-jcj9nqfu	152	34	Beneficial	beneficial	JJ
cord-006393-jcj9nqfu	152	35	effect	effect	NN
cord-006393-jcj9nqfu	152	36	of	of	IN
cord-006393-jcj9nqfu	152	37	a	a	DT
cord-006393-jcj9nqfu	152	38	protective	protective	JJ
cord-006393-jcj9nqfu	152	39	environment	environment	NN
cord-006393-jcj9nqfu	152	40	Clinical	clinical	JJ
cord-006393-jcj9nqfu	152	41	Use	Use	NNP
cord-006393-jcj9nqfu	152	42	of	of	IN
cord-006393-jcj9nqfu	152	43	Intravenous	Intravenous	NNP
cord-006393-jcj9nqfu	152	44	Immunoglobulins	Immunoglobulins	NNP
cord-006393-jcj9nqfu	152	45	Antibody	Antibody	NNP
cord-006393-jcj9nqfu	152	46	therapy	therapy	NN
cord-006393-jcj9nqfu	152	47	in	in	IN
cord-006393-jcj9nqfu	152	48	gram	gram	JJ
cord-006393-jcj9nqfu	152	49	-	-	HYPH
cord-006393-jcj9nqfu	152	50	negative	negative	JJ
cord-006393-jcj9nqfu	152	51	bacterial	bacterial	JJ
cord-006393-jcj9nqfu	152	52	disease	disease	NN
cord-006393-jcj9nqfu	153	1	The	the	DT
cord-006393-jcj9nqfu	153	2	role	role	NN
cord-006393-jcj9nqfu	153	3	of	of	IN
cord-006393-jcj9nqfu	153	4	microflora	microflora	NN
cord-006393-jcj9nqfu	153	5	in	in	IN
cord-006393-jcj9nqfu	153	6	development	development	NN
cord-006393-jcj9nqfu	153	7	of	of	IN
cord-006393-jcj9nqfu	153	8	graft	graft	NN
cord-006393-jcj9nqfu	153	9	versus	versus	IN
cord-006393-jcj9nqfu	153	10	host	host	NN
cord-006393-jcj9nqfu	153	11	disease	disease	NN
cord-006393-jcj9nqfu	153	12	Graftvs	Graftvs	NNP
cord-006393-jcj9nqfu	153	13	-	-	HYPH
cord-006393-jcj9nqfu	153	14	host	host	NN
cord-006393-jcj9nqfu	153	15	disease	disease	NN
cord-006393-jcj9nqfu	153	16	and	and	CC
cord-006393-jcj9nqfu	153	17	sialodacryoadenitis	sialodacryoadenitis	JJ
cord-006393-jcj9nqfu	153	18	viral	viral	JJ
cord-006393-jcj9nqfu	153	19	infection	infection	NN
cord-006393-jcj9nqfu	153	20	in	in	IN
cord-006393-jcj9nqfu	153	21	bone	bone	NN
cord-006393-jcj9nqfu	153	22	marrow	marrow	NN
cord-006393-jcj9nqfu	153	23	transplanted	transplant	VBD
cord-006393-jcj9nqfu	153	24	rats	rat	NNS
cord-006393-jcj9nqfu	153	25	Cytomegalovirus	Cytomegalovirus	NNP
cord-006393-jcj9nqfu	153	26	(	(	-LRB-
cord-006393-jcj9nqfu	153	27	CMV	CMV	NNP
cord-006393-jcj9nqfu	153	28	)	)	-RRB-
cord-006393-jcj9nqfu	153	29	infection	infection	NN
cord-006393-jcj9nqfu	153	30	in	in	IN
cord-006393-jcj9nqfu	153	31	bone	bone	NN
cord-006393-jcj9nqfu	153	32	marrow	marrow	NN
cord-006393-jcj9nqfu	153	33	transplant	transplant	NN
cord-006393-jcj9nqfu	153	34	recipients	recipient	NNS
cord-006393-jcj9nqfu	153	35	:	:	:
cord-006393-jcj9nqfu	154	1	Use	use	NN
cord-006393-jcj9nqfu	154	2	of	of	IN
cord-006393-jcj9nqfu	154	3	intravenous	intravenous	JJ
cord-006393-jcj9nqfu	154	4	gammaglobulin	gammaglobulin	NN
cord-006393-jcj9nqfu	154	5	as	as	IN
cord-006393-jcj9nqfu	154	6	prophylactic	prophylactic	JJ
cord-006393-jcj9nqfu	154	7	and	and	CC
cord-006393-jcj9nqfu	154	8	therapeutic	therapeutic	JJ
cord-006393-jcj9nqfu	154	9	agents	agent	NNS
cord-006393-jcj9nqfu	154	10	Successful	successful	JJ
cord-006393-jcj9nqfu	154	11	treatment	treatment	NN
cord-006393-jcj9nqfu	154	12	of	of	IN
cord-006393-jcj9nqfu	154	13	serious	serious	JJ
cord-006393-jcj9nqfu	154	14	cytomegalovirus	cytomegalovirus	NN
cord-006393-jcj9nqfu	154	15	disease	disease	NN
cord-006393-jcj9nqfu	154	16	with	with	IN
cord-006393-jcj9nqfu	154	17	9(1,3-dihydroxy-2-propoxymethyl	9(1,3-dihydroxy-2-propoxymethyl	CD
cord-006393-jcj9nqfu	154	18	)	)	-RRB-
cord-006393-jcj9nqfu	154	19	guanine	guanine	NN
cord-006393-jcj9nqfu	154	20	in	in	IN
cord-006393-jcj9nqfu	154	21	bone	bone	NN
cord-006393-jcj9nqfu	154	22	marrow	marrow	NN
cord-006393-jcj9nqfu	154	23	transplant	transplant	NN
cord-006393-jcj9nqfu	154	24	(	(	-LRB-
cord-006393-jcj9nqfu	154	25	BMT	BMT	NNP
cord-006393-jcj9nqfu	154	26	)	)	-RRB-
cord-006393-jcj9nqfu	154	27	patients	patient	NNS
cord-006393-jcj9nqfu	155	1	The	the	DT
cord-006393-jcj9nqfu	155	2	diagnostic	diagnostic	JJ
cord-006393-jcj9nqfu	155	3	,	,	,
cord-006393-jcj9nqfu	155	4	prophylactic	prophylactic	JJ
cord-006393-jcj9nqfu	155	5	and	and	CC
cord-006393-jcj9nqfu	155	6	therapeutic	therapeutic	JJ
cord-006393-jcj9nqfu	155	7	uses	use	NNS
cord-006393-jcj9nqfu	155	8	of	of	IN
cord-006393-jcj9nqfu	155	9	monoclonal	monoclonal	JJ
cord-006393-jcj9nqfu	155	10	antibodies	antibody	NNS
cord-006393-jcj9nqfu	155	11	to	to	IN
cord-006393-jcj9nqfu	155	12	human	human	JJ
cord-006393-jcj9nqfu	155	13	cytomegalovirus	cytomegalovirus	NN
cord-006393-jcj9nqfu	155	14	Infectious	infectious	JJ
cord-006393-jcj9nqfu	155	15	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	155	16	in	in	IN
cord-006393-jcj9nqfu	155	17	bone	bone	NN
cord-006393-jcj9nqfu	155	18	marrow	marrow	NN
cord-006393-jcj9nqfu	155	19	transplant	transplant	NN
cord-006393-jcj9nqfu	155	20	recipients	recipient	NNS
cord-006393-jcj9nqfu	155	21	Oral	oral	JJ
cord-006393-jcj9nqfu	155	22	administration	administration	NN
cord-006393-jcj9nqfu	155	23	of	of	IN
cord-006393-jcj9nqfu	155	24	IgG	IgG	NNP
cord-006393-jcj9nqfu	155	25	in	in	IN
cord-006393-jcj9nqfu	155	26	marrow	marrow	NN
cord-006393-jcj9nqfu	155	27	transplant	transplant	NN
cord-006393-jcj9nqfu	155	28	recipients	recipient	NNS
cord-006393-jcj9nqfu	155	29	Functional	functional	JJ
cord-006393-jcj9nqfu	155	30	asplenia	asplenia	NN
cord-006393-jcj9nqfu	155	31	in	in	IN
cord-006393-jcj9nqfu	155	32	patients	patient	NNS
cord-006393-jcj9nqfu	155	33	with	with	IN
cord-006393-jcj9nqfu	155	34	chronic	chronic	JJ
cord-006393-jcj9nqfu	155	35	graftversus	graftversus	NN
cord-006393-jcj9nqfu	155	36	-	-	HYPH
cord-006393-jcj9nqfu	155	37	host	host	NN
cord-006393-jcj9nqfu	155	38	disease	disease	NN
cord-006393-jcj9nqfu	155	39	:	:	:
cord-006393-jcj9nqfu	155	40	Concise	concise	JJ
cord-006393-jcj9nqfu	155	41	communication	communication	NN
cord-006393-jcj9nqfu	155	42	IgG	igg	NN
cord-006393-jcj9nqfu	155	43	subclass	subclass	NN
cord-006393-jcj9nqfu	155	44	deficiency	deficiency	NN
cord-006393-jcj9nqfu	155	45	and	and	CC
cord-006393-jcj9nqfu	155	46	pneumococcal	pneumococcal	JJ
cord-006393-jcj9nqfu	155	47	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	155	48	following	follow	VBG
cord-006393-jcj9nqfu	155	49	allogeneic	allogeneic	IN
cord-006393-jcj9nqfu	155	50	marrow	marrow	NN
cord-006393-jcj9nqfu	155	51	transplantation	transplantation	NN
cord-006393-jcj9nqfu	155	52	Dr.	Dr.	NNP
cord-006393-jcj9nqfu	155	53	Gulati	Gulati	NNP
cord-006393-jcj9nqfu	155	54	:	:	:
cord-006393-jcj9nqfu	155	55	What	what	WP
cord-006393-jcj9nqfu	155	56	has	have	VBZ
cord-006393-jcj9nqfu	155	57	been	be	VBN
cord-006393-jcj9nqfu	155	58	your	-PRON-	PRP$
cord-006393-jcj9nqfu	155	59	experience	experience	NN
cord-006393-jcj9nqfu	155	60	with	with	IN
cord-006393-jcj9nqfu	155	61	autologous	autologous	JJ
cord-006393-jcj9nqfu	155	62	transplants	transplant	NNS
cord-006393-jcj9nqfu	155	63	?	?	.
cord-006393-jcj9nqfu	156	1	Do	do	VBP
cord-006393-jcj9nqfu	156	2	you	-PRON-	PRP
cord-006393-jcj9nqfu	156	3	need	need	VB
cord-006393-jcj9nqfu	156	4	to	to	TO
cord-006393-jcj9nqfu	156	5	do	do	VB
cord-006393-jcj9nqfu	156	6	all	all	PDT
cord-006393-jcj9nqfu	156	7	this	this	DT
cord-006393-jcj9nqfu	156	8	with	with	IN
cord-006393-jcj9nqfu	156	9	patients	patient	NNS
cord-006393-jcj9nqfu	156	10	who	who	WP
cord-006393-jcj9nqfu	156	11	are	be	VBP
cord-006393-jcj9nqfu	156	12	undergoing	undergo	VBG
cord-006393-jcj9nqfu	156	13	autologous	autologous	JJ
cord-006393-jcj9nqfu	156	14	transplants?Dr	transplants?dr	XX
cord-006393-jcj9nqfu	156	15	.	.	.
cord-006393-jcj9nqfu	157	1	Tutschka	Tutschka	NNP
cord-006393-jcj9nqfu	157	2	:	:	:
cord-006393-jcj9nqfu	158	1	I	-PRON-	PRP
cord-006393-jcj9nqfu	158	2	do	do	VBP
cord-006393-jcj9nqfu	158	3	not	not	RB
cord-006393-jcj9nqfu	158	4	think	think	VB
cord-006393-jcj9nqfu	158	5	so	so	RB
cord-006393-jcj9nqfu	158	6	.	.	.
cord-006393-jcj9nqfu	159	1	The	the	DT
cord-006393-jcj9nqfu	159	2	incidence	incidence	NN
cord-006393-jcj9nqfu	159	3	of	of	IN
cord-006393-jcj9nqfu	159	4	interstitial	interstitial	JJ
cord-006393-jcj9nqfu	159	5	pneumonia	pneumonia	NN
cord-006393-jcj9nqfu	159	6	as	as	RB
cord-006393-jcj9nqfu	159	7	well	well	RB
cord-006393-jcj9nqfu	159	8	as	as	IN
cord-006393-jcj9nqfu	159	9	hemorrhagic	hemorrhagic	JJ
cord-006393-jcj9nqfu	159	10	gastroenteritis	gastroenteritis	NN
cord-006393-jcj9nqfu	159	11	is	be	VBZ
cord-006393-jcj9nqfu	159	12	much	much	RB
cord-006393-jcj9nqfu	159	13	reduced	reduce	VBN
cord-006393-jcj9nqfu	159	14	in	in	IN
cord-006393-jcj9nqfu	159	15	autologous	autologous	JJ
cord-006393-jcj9nqfu	159	16	transplants	transplant	NNS
cord-006393-jcj9nqfu	159	17	-	-	:
cord-006393-jcj9nqfu	159	18	perhaps	perhaps	RB
cord-006393-jcj9nqfu	159	19	a	a	DT
cord-006393-jcj9nqfu	159	20	quarter	quarter	NN
cord-006393-jcj9nqfu	159	21	of	of	IN
cord-006393-jcj9nqfu	159	22	that	that	DT
cord-006393-jcj9nqfu	159	23	seen	see	VBN
cord-006393-jcj9nqfu	159	24	in	in	IN
cord-006393-jcj9nqfu	159	25	allogeneic	allogeneic	NN
cord-006393-jcj9nqfu	159	26	transplants	transplant	NNS
cord-006393-jcj9nqfu	159	27	.	.	.
cord-006393-jcj9nqfu	160	1	Furthermore	furthermore	RB
cord-006393-jcj9nqfu	160	2	,	,	,
cord-006393-jcj9nqfu	160	3	the	the	DT
cord-006393-jcj9nqfu	160	4	immune	immune	JJ
cord-006393-jcj9nqfu	160	5	system	system	NN
cord-006393-jcj9nqfu	160	6	recovers	recover	VBZ
cord-006393-jcj9nqfu	160	7	much	much	RB
cord-006393-jcj9nqfu	160	8	more	more	RBR
cord-006393-jcj9nqfu	160	9	readily	readily	RB
cord-006393-jcj9nqfu	160	10	after	after	IN
cord-006393-jcj9nqfu	160	11	autologous	autologous	JJ
cord-006393-jcj9nqfu	160	12	bone	bone	NN
cord-006393-jcj9nqfu	160	13	marrow	marrow	NN
cord-006393-jcj9nqfu	160	14	transplantation	transplantation	NN
cord-006393-jcj9nqfu	160	15	.	.	.
cord-006393-jcj9nqfu	161	1	On	on	IN
cord-006393-jcj9nqfu	161	2	the	the	DT
cord-006393-jcj9nqfu	161	3	other	other	JJ
cord-006393-jcj9nqfu	161	4	hand	hand	NN
cord-006393-jcj9nqfu	161	5	,	,	,
cord-006393-jcj9nqfu	161	6	autologous	autologous	JJ
cord-006393-jcj9nqfu	161	7	transplantation	transplantation	NN
cord-006393-jcj9nqfu	161	8	patients	patient	NNS
cord-006393-jcj9nqfu	161	9	might	may	MD
cord-006393-jcj9nqfu	161	10	provide	provide	VB
cord-006393-jcj9nqfu	161	11	an	an	DT
cord-006393-jcj9nqfu	161	12	excellent	excellent	JJ
cord-006393-jcj9nqfu	161	13	target	target	NN
cord-006393-jcj9nqfu	161	14	population	population	NN
cord-006393-jcj9nqfu	161	15	in	in	IN
cord-006393-jcj9nqfu	161	16	which	which	WDT
cord-006393-jcj9nqfu	161	17	to	to	TO
cord-006393-jcj9nqfu	161	18	study	study	VB
cord-006393-jcj9nqfu	161	19	more	more	RBR
cord-006393-jcj9nqfu	161	20	nonspecific	nonspecific	JJ
cord-006393-jcj9nqfu	161	21	effects	effect	NNS
cord-006393-jcj9nqfu	161	22	,	,	,
cord-006393-jcj9nqfu	161	23	such	such	JJ
cord-006393-jcj9nqfu	161	24	as	as	IN
cord-006393-jcj9nqfu	161	25	the	the	DT
cord-006393-jcj9nqfu	161	26	reduction	reduction	NN
cord-006393-jcj9nqfu	161	27	of	of	IN
cord-006393-jcj9nqfu	161	28	infections	infection	NNS
cord-006393-jcj9nqfu	161	29	during	during	IN
cord-006393-jcj9nqfu	161	30	aplasia	aplasia	NNP
cord-006393-jcj9nqfu	161	31	,	,	,
cord-006393-jcj9nqfu	161	32	because	because	IN
cord-006393-jcj9nqfu	161	33	we	-PRON-	PRP
cord-006393-jcj9nqfu	161	34	do	do	VBP
cord-006393-jcj9nqfu	161	35	not	not	RB
cord-006393-jcj9nqfu	161	36	have	have	VB
cord-006393-jcj9nqfu	161	37	the	the	DT
cord-006393-jcj9nqfu	161	38	compounding	compounding	NN
cord-006393-jcj9nqfu	161	39	variables	variable	NNS
cord-006393-jcj9nqfu	161	40	of	of	IN
cord-006393-jcj9nqfu	161	41	GVHD	GVHD	NNP
cord-006393-jcj9nqfu	161	42	,	,	,
cord-006393-jcj9nqfu	161	43	immune	immune	JJ
cord-006393-jcj9nqfu	161	44	modulation	modulation	NN
cord-006393-jcj9nqfu	161	45	phases	phase	NNS
cord-006393-jcj9nqfu	161	46	,	,	,
cord-006393-jcj9nqfu	161	47	and	and	CC
cord-006393-jcj9nqfu	161	48	so	so	RB
cord-006393-jcj9nqfu	161	49	on	on	RB
cord-006393-jcj9nqfu	161	50	.	.	.
cord-006393-jcj9nqfu	162	1	We	-PRON-	PRP
cord-006393-jcj9nqfu	162	2	are	be	VBP
cord-006393-jcj9nqfu	162	3	currently	currently	RB
cord-006393-jcj9nqfu	162	4	not	not	RB
cord-006393-jcj9nqfu	162	5	using	use	VBG
cord-006393-jcj9nqfu	162	6	IVIG	IVIG	NNP
cord-006393-jcj9nqfu	162	7	to	to	IN
cord-006393-jcj9nqfu	162	8	the	the	DT
cord-006393-jcj9nqfu	162	9	same	same	JJ
cord-006393-jcj9nqfu	162	10	extent	extent	NN
cord-006393-jcj9nqfu	162	11	in	in	IN
cord-006393-jcj9nqfu	162	12	autologous	autologous	JJ
cord-006393-jcj9nqfu	162	13	transplants	transplant	NNS
cord-006393-jcj9nqfu	162	14	as	as	IN
cord-006393-jcj9nqfu	162	15	we	-PRON-	PRP
cord-006393-jcj9nqfu	162	16	do	do	VBP
cord-006393-jcj9nqfu	162	17	in	in	IN
cord-006393-jcj9nqfu	162	18	aUogeneic	aUogeneic	NNP
cord-006393-jcj9nqfu	162	19	transplants	transplant	NNS
cord-006393-jcj9nqfu	163	1	but	but	CC
cord-006393-jcj9nqfu	163	2	I	-PRON-	PRP
cord-006393-jcj9nqfu	163	3	think	think	VBP
cord-006393-jcj9nqfu	163	4	it	-PRON-	PRP
cord-006393-jcj9nqfu	163	5	is	be	VBZ
cord-006393-jcj9nqfu	163	6	a	a	DT
cord-006393-jcj9nqfu	163	7	good	good	JJ
cord-006393-jcj9nqfu	163	8	study	study	NN
cord-006393-jcj9nqfu	163	9	population	population	NN
cord-006393-jcj9nqfu	163	10	.	.	.